SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

American Renal Associates Holdings, Inc. – ‘10-K’ for 12/31/17 – ‘EX-101.PRE’

On:  Tuesday, 3/6/18, at 4:29pm ET   ·   For:  12/31/17   ·   Accession #:  1498068-18-12   ·   File #:  1-37751

Previous ‘10-K’:  ‘10-K’ on 3/8/17 for 12/31/16   ·   Next:  ‘10-K’ on 9/5/19 for 12/31/18   ·   Latest:  ‘10-K’ on 3/16/20 for 12/31/19

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/06/18  American Renal Assocs Holdin… Inc 10-K       12/31/17  109:11M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.63M 
 2: EX-10.11    Material Contract                                   HTML     43K 
 3: EX-21.1     Subsidiaries List                                   HTML     90K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     27K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     35K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     35K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     30K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     30K 
15: R1          Document and Entity Information                     HTML     55K 
16: R2          Consolidated Balance Sheets                         HTML    121K 
17: R3          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
18: R4          Consolidated Statements of Operations               HTML     98K 
19: R5          Consolidated Statements of Comprehensive Income     HTML     42K 
20: R6          Consolidated Statements of Changes in Equity        HTML    126K 
21: R7          Consolidated Statements of Changes in Equity        HTML     31K 
                (Parenthetical)                                                  
22: R8          Consolidated Statements of Cash Flows               HTML    166K 
23: R9          Basis of Presentation and Organization              HTML     34K 
24: R10         Summary of Significant Accounting Policies          HTML     93K 
25: R11         Initial Public Offering                             HTML     50K 
26: R12         Cash                                                HTML     34K 
27: R13         Prepaid Expenses and Other Current Assets           HTML     36K 
28: R14         Acquisitions                                        HTML     45K 
29: R15         Fair Value Measurements                             HTML    102K 
30: R16         Property and Equipment                              HTML     44K 
31: R17         Intangible Assets and Goodwill                      HTML     57K 
32: R18         Accrued Expenses and Other Current Liabilities      HTML     43K 
33: R19         Variable Interest Entities                          HTML     36K 
34: R20         Noncontrolling Interests Subject to Put Provisions  HTML     59K 
35: R21         Changes in Ownership Interest in Consolidated       HTML     45K 
                Subsidiaries                                                     
36: R22         Debt                                                HTML     76K 
37: R23         Leases                                              HTML     53K 
38: R24         Income Taxes                                        HTML    101K 
39: R25         Earnings (Loss) Per Share                           HTML     69K 
40: R26         Equity                                              HTML     34K 
41: R27         Stock-Based Compensation                            HTML    113K 
42: R28         Related Party Transactions                          HTML     47K 
43: R29         Commitments and Contingencies                       HTML     36K 
44: R30         Certain Legal Matters                               HTML     47K 
45: R31         Employee Benefit Plan                               HTML     30K 
46: R32         Concentrations                                      HTML     32K 
47: R33         Selected Quarterly Financial Data (Unaudited)       HTML     76K 
48: R34         Subsequent Event                                    HTML     30K 
49: R35         Schedule Ii - Valuation and Qualifying Accounts     HTML     45K 
50: R36         Summary of Significant Accounting Policies          HTML    138K 
                (Policies)                                                       
51: R37         Summary of Significant Accounting Policies          HTML     31K 
                (Tables)                                                         
52: R38         Cash (Tables)                                       HTML     33K 
53: R39         Prepaid Expenses and Other Current Assets (Tables)  HTML     36K 
54: R40         Acquisitions (Tables)                               HTML     37K 
55: R41         Fair Value Measurements (Tables)                    HTML     98K 
56: R42         Property and Equipment (Tables)                     HTML     43K 
57: R43         Intangible Assets and Goodwill (Tables)             HTML     59K 
58: R44         Accrued Expenses and Other Current Liabilities      HTML     44K 
                (Tables)                                                         
59: R45         Noncontrolling Interests Subject to Put Provisions  HTML     53K 
                (Tables)                                                         
60: R46         Changes in Ownership Interest in Consolidated       HTML     46K 
                Subsidiaries (Tables)                                            
61: R47         Debt (Tables)                                       HTML     57K 
62: R48         Leases (Tables)                                     HTML     47K 
63: R49         Income Taxes (Tables)                               HTML     99K 
64: R50         Earnings (Loss) Per Share (Tables)                  HTML     67K 
65: R51         Stock-Based Compensation (Tables)                   HTML    100K 
66: R52         Selected Quarterly Financial Data (Unaudited)       HTML     75K 
                (Tables)                                                         
67: R53         Basis of Presentation and Organization (Details)    HTML     42K 
68: R54         Summary of Significant Accounting Policies          HTML     96K 
                (Details)                                                        
69: R55         Initial Public Offering (Details)                   HTML    124K 
70: R56         Cash (Details)                                      HTML     37K 
71: R57         Prepaid Expenses and Other Current Assets           HTML     34K 
                (Details)                                                        
72: R58         Acquisitions (Details)                              HTML     53K 
73: R59         Fair Value Measurements - Narrative (Details)       HTML     40K 
74: R60         Fair Value Measurements - Schedule of fair value    HTML     85K 
                (Details)                                                        
75: R61         Fair Value Measurements - Fair value rollforward    HTML     37K 
                of tax receivable agreement liability (Details)                  
76: R62         Property and Equipment (Details)                    HTML     50K 
77: R63         Intangible Assets and Goodwill - Schedule of        HTML     52K 
                intangible assets (Details)                                      
78: R64         Intangible Assets and Goodwill - Estimated annual   HTML     44K 
                amortization expense (Details)                                   
79: R65         Intangible Assets and Goodwill - Changes in the     HTML     38K 
                value of goodwilll (Details)                                     
80: R66         Accrued Expenses and Other Current Liabilities      HTML     45K 
                (Details)                                                        
81: R67         Variable Interest Entities (Details)                HTML     32K 
82: R68         Noncontrolling Interests Subject to Put Provisions  HTML     61K 
                (Details)                                                        
83: R69         Changes in Ownership Interest in Consolidated       HTML     45K 
                Subsidiaries (Details)                                           
84: R70         Debt - Schedule of long term-term debt (Details)    HTML     56K 
85: R71         Debt - Narrative (Detail)                           HTML    126K 
86: R72         Debt Debt - Scheduled maturities of long-term debt  HTML     47K 
                (Details)                                                        
87: R73         Leases (Details)                                    HTML     47K 
88: R74         Leases - Schedule of Future Minimum Lease Payments  HTML     82K 
                (Details)                                                        
89: R75         Income Taxes - Provision (Benefit) for Income       HTML     48K 
                Taxes (Details)                                                  
90: R76         Income Taxes - Significant components of deferred   HTML     67K 
                tax assets and liabilities (Details)                             
91: R77         Income Taxes Income Taxes - Narrative (Details)     HTML     37K 
92: R78         Income Taxes - Reconciliation of the federal        HTML     51K 
                statutory rate (Details)                                         
93: R79         Earnings (Loss) Per Share (Details)                 HTML     68K 
94: R80         Equity (Details)                                    HTML     50K 
95: R81         Stock-Based Compensation - Narrative (Details)      HTML     61K 
96: R82         Stock-Based Compensation - Equity Grants,           HTML     35K 
                Assumptions and Activity (Details)                               
97: R83         Stock-Based Compensation - Assumptions used for     HTML     50K 
                options granted (Details)                                        
98: R84         Stock-Based Compensation - Stock option activity    HTML     94K 
                (Details)                                                        
99: R85         Stock-Based Compensation - Restricted stock         HTML     62K 
                activity (Details)                                               
100: R86         Related Party Transactions (Details)                HTML     87K  
101: R87         Commitments and Contingencies (Details)             HTML     35K  
102: R88         Certain Legal Matters (Details)                     HTML     52K  
103: R89         Employee Benefit Plan (Details)                     HTML     29K  
104: R90         Concentrations (Details)                            HTML     28K  
105: R91         Selected Quarterly Financial Data (Unaudited)       HTML     51K  
                (Details)                                                        
106: R92         Schedule Ii - Valuation and Qualifying Accounts     HTML     37K  
                (Details)                                                        
108: XML         IDEA XML File -- Filing Summary                      XML    189K  
107: EXCEL       IDEA Workbook of Financial Reports                  XLSX    126K  
 9: EX-101.INS  XBRL Instance -- ara-20171231                        XML   2.46M 
11: EX-101.CAL  XBRL Calculations -- ara-20171231_cal                XML    342K 
12: EX-101.DEF  XBRL Definitions -- ara-20171231_def                 XML    725K 
13: EX-101.LAB  XBRL Labels -- ara-20171231_lab                      XML   2.22M 
14: EX-101.PRE  XBRL Presentations -- ara-20171231_pre               XML   1.28M 
10: EX-101.SCH  XBRL Schema -- ara-20171231                          XSD    218K 
109: ZIP         XBRL Zipped Folder -- 0001498068-18-000012-xbrl      Zip    306K

‘EX-101.PRE’   —   XBRL Presentations — ara-20171231_pre

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<link:roleRef roleURI="http://www.americanrenal.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="ara-20171231.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="ara-20171231.xsd#AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="ara-20171231.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/Acquisitions" xlink:href="ara-20171231.xsd#Acquisitions" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/AcquisitionsDetails" xlink:href="ara-20171231.xsd#AcquisitionsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/AcquisitionsTables" xlink:href="ara-20171231.xsd#AcquisitionsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/BasisOfPresentationAndOrganization" xlink:href="ara-20171231.xsd#BasisOfPresentationAndOrganization" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/BasisOfPresentationAndOrganizationDetails" xlink:href="ara-20171231.xsd#BasisOfPresentationAndOrganizationDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/Cash" xlink:href="ara-20171231.xsd#Cash" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/CashDetails" xlink:href="ara-20171231.xsd#CashDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/CashTables" xlink:href="ara-20171231.xsd#CashTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/CertainLegalMatters" xlink:href="ara-20171231.xsd#CertainLegalMatters" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/CertainLegalMattersDetails" xlink:href="ara-20171231.xsd#CertainLegalMattersDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ChangesInOwnershipInterestInConsolidatedSubsidiaries" xlink:href="ara-20171231.xsd#ChangesInOwnershipInterestInConsolidatedSubsidiaries" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ChangesInOwnershipInterestInConsolidatedSubsidiariesDetails" xlink:href="ara-20171231.xsd#ChangesInOwnershipInterestInConsolidatedSubsidiariesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ChangesInOwnershipInterestInConsolidatedSubsidiariesTables" xlink:href="ara-20171231.xsd#ChangesInOwnershipInterestInConsolidatedSubsidiariesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/CommitmentsAndContingencies" xlink:href="ara-20171231.xsd#CommitmentsAndContingencies" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/CommitmentsAndContingenciesDetails" xlink:href="ara-20171231.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/Concentrations" xlink:href="ara-20171231.xsd#Concentrations" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ConcentrationsDetails" xlink:href="ara-20171231.xsd#ConcentrationsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ConsolidatedBalanceSheets" xlink:href="ara-20171231.xsd#ConsolidatedBalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ara-20171231.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ara-20171231.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:href="ara-20171231.xsd#ConsolidatedStatementsOfChangesInEquity" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical" xlink:href="ara-20171231.xsd#ConsolidatedStatementsOfChangesInEquityParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="ara-20171231.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ConsolidatedStatementsOfOperations" xlink:href="ara-20171231.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/Debt" xlink:href="ara-20171231.xsd#Debt" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/DebtDebtScheduledMaturitiesOfLongTermDebtDetails" xlink:href="ara-20171231.xsd#DebtDebtScheduledMaturitiesOfLongTermDebtDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/DebtNarrativeDetail" xlink:href="ara-20171231.xsd#DebtNarrativeDetail" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/DebtScheduleOfLongTermTermDebtDetails" xlink:href="ara-20171231.xsd#DebtScheduleOfLongTermTermDebtDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/DebtTables" xlink:href="ara-20171231.xsd#DebtTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/DocumentAndEntityInformation" xlink:href="ara-20171231.xsd#DocumentAndEntityInformation" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/EarningsLossPerShare" xlink:href="ara-20171231.xsd#EarningsLossPerShare" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/EarningsLossPerShareDetails" xlink:href="ara-20171231.xsd#EarningsLossPerShareDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/EarningsLossPerShareTables" xlink:href="ara-20171231.xsd#EarningsLossPerShareTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/EmployeeBenefitPlan" xlink:href="ara-20171231.xsd#EmployeeBenefitPlan" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/EmployeeBenefitPlanDetails" xlink:href="ara-20171231.xsd#EmployeeBenefitPlanDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/Equity" xlink:href="ara-20171231.xsd#Equity" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/EquityDetails" xlink:href="ara-20171231.xsd#EquityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/FairValueMeasurements" xlink:href="ara-20171231.xsd#FairValueMeasurements" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/FairValueMeasurementsFairValueRollforwardOfTaxReceivableAgreementLiabilityDetails" xlink:href="ara-20171231.xsd#FairValueMeasurementsFairValueRollforwardOfTaxReceivableAgreementLiabilityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/FairValueMeasurementsNarrativeDetails" xlink:href="ara-20171231.xsd#FairValueMeasurementsNarrativeDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/FairValueMeasurementsScheduleOfFairValueDetails" xlink:href="ara-20171231.xsd#FairValueMeasurementsScheduleOfFairValueDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/FairValueMeasurementsTables" xlink:href="ara-20171231.xsd#FairValueMeasurementsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IncomeTaxes" xlink:href="ara-20171231.xsd#IncomeTaxes" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IncomeTaxesIncomeTaxesNarrativeDetails" xlink:href="ara-20171231.xsd#IncomeTaxesIncomeTaxesNarrativeDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IncomeTaxesProvisionBenefitForIncomeTaxesDetails" xlink:href="ara-20171231.xsd#IncomeTaxesProvisionBenefitForIncomeTaxesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IncomeTaxesReconciliationOfFederalStatutoryRateDetails" xlink:href="ara-20171231.xsd#IncomeTaxesReconciliationOfFederalStatutoryRateDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="ara-20171231.xsd#IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IncomeTaxesTables" xlink:href="ara-20171231.xsd#IncomeTaxesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/InitialPublicOffering" xlink:href="ara-20171231.xsd#InitialPublicOffering" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/InitialPublicOfferingDetails" xlink:href="ara-20171231.xsd#InitialPublicOfferingDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IntangibleAssetsAndGoodwill" xlink:href="ara-20171231.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IntangibleAssetsAndGoodwillChangesInValueOfGoodwilllDetails" xlink:href="ara-20171231.xsd#IntangibleAssetsAndGoodwillChangesInValueOfGoodwilllDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IntangibleAssetsAndGoodwillEstimatedAnnualAmortizationExpenseDetails" xlink:href="ara-20171231.xsd#IntangibleAssetsAndGoodwillEstimatedAnnualAmortizationExpenseDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetails" xlink:href="ara-20171231.xsd#IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/IntangibleAssetsAndGoodwillTables" xlink:href="ara-20171231.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/Leases" xlink:href="ara-20171231.xsd#Leases" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/LeasesDetails" xlink:href="ara-20171231.xsd#LeasesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/LeasesScheduleOfFutureMinimumLeasePaymentsDetails" xlink:href="ara-20171231.xsd#LeasesScheduleOfFutureMinimumLeasePaymentsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/LeasesTables" xlink:href="ara-20171231.xsd#LeasesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/NoncontrollingInterestsSubjectToPutProvisions" xlink:href="ara-20171231.xsd#NoncontrollingInterestsSubjectToPutProvisions" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/NoncontrollingInterestsSubjectToPutProvisionsDetails" xlink:href="ara-20171231.xsd#NoncontrollingInterestsSubjectToPutProvisionsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/NoncontrollingInterestsSubjectToPutProvisionsTables" xlink:href="ara-20171231.xsd#NoncontrollingInterestsSubjectToPutProvisionsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:href="ara-20171231.xsd#PrepaidExpensesAndOtherCurrentAssets" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="ara-20171231.xsd#PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:href="ara-20171231.xsd#PrepaidExpensesAndOtherCurrentAssetsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/PropertyAndEquipment" xlink:href="ara-20171231.xsd#PropertyAndEquipment" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/PropertyAndEquipmentDetails" xlink:href="ara-20171231.xsd#PropertyAndEquipmentDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/PropertyAndEquipmentTables" xlink:href="ara-20171231.xsd#PropertyAndEquipmentTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/RelatedPartyTransactions" xlink:href="ara-20171231.xsd#RelatedPartyTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/RelatedPartyTransactionsDetails" xlink:href="ara-20171231.xsd#RelatedPartyTransactionsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:href="ara-20171231.xsd#ScheduleIiValuationAndQualifyingAccounts" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:href="ara-20171231.xsd#ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/SelectedQuarterlyFinancialDataUnaudited" xlink:href="ara-20171231.xsd#SelectedQuarterlyFinancialDataUnaudited" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" xlink:href="ara-20171231.xsd#SelectedQuarterlyFinancialDataUnauditedDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/SelectedQuarterlyFinancialDataUnauditedTables" xlink:href="ara-20171231.xsd#SelectedQuarterlyFinancialDataUnauditedTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/StockBasedCompensation" xlink:href="ara-20171231.xsd#StockBasedCompensation" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/StockBasedCompensationAssumptionsUsedForOptionsGrantedDetails" xlink:href="ara-20171231.xsd#StockBasedCompensationAssumptionsUsedForOptionsGrantedDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/StockBasedCompensationEquityGrantsAssumptionsAndActivityDetails" xlink:href="ara-20171231.xsd#StockBasedCompensationEquityGrantsAssumptionsAndActivityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/StockBasedCompensationNarrativeDetails" xlink:href="ara-20171231.xsd#StockBasedCompensationNarrativeDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/StockBasedCompensationRestrictedStockActivityDetails" xlink:href="ara-20171231.xsd#StockBasedCompensationRestrictedStockActivityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/StockBasedCompensationStockOptionActivityDetails" xlink:href="ara-20171231.xsd#StockBasedCompensationStockOptionActivityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/StockBasedCompensationTables" xlink:href="ara-20171231.xsd#StockBasedCompensationTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/SubsequentEvent" xlink:href="ara-20171231.xsd#SubsequentEvent" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ara-20171231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="ara-20171231.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ara-20171231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ara-20171231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/VariableInterestEntities" xlink:href="ara-20171231.xsd#VariableInterestEntities" xlink:type="simple"/>
<link:roleRef roleURI="http://www.americanrenal.com/role/VariableInterestEntitiesDetails" xlink:href="ara-20171231.xsd#VariableInterestEntitiesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_1B4F6004F036C7ABB2C4F6A410EDF68E" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_58AEB4134F09193AC482F6A410ED3443" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_1B4F6004F036C7ABB2C4F6A410EDF68E" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_58AEB4134F09193AC482F6A410ED3443" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_2695079775561A8F072ABE3B43B78E80" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_42F7F19F3F459C5A720BBE3B43B71641" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_2695079775561A8F072ABE3B43B78E80" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_42F7F19F3F459C5A720BBE3B43B71641" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaap_AccruedSalariesCurrent_F4108F29DA4682B97EB9BE3B43B7FE17" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_42F7F19F3F459C5A720BBE3B43B71641" xlink:to="loc_us-gaap_AccruedSalariesCurrent_F4108F29DA4682B97EB9BE3B43B7FE17" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:label="loc_us-gaap_AccruedVacationCurrent_BA8554AD012D56C1C9EEBE3B43B7ABA0" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_42F7F19F3F459C5A720BBE3B43B71641" xlink:to="loc_us-gaap_AccruedVacationCurrent_BA8554AD012D56C1C9EEBE3B43B7ABA0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_702BE02EB79BDB15C8F6BE3B43BC2596" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAbstract_42F7F19F3F459C5A720BBE3B43B71641" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_702BE02EB79BDB15C8F6BE3B43BC2596" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_39177B1ACB1E689BF6C1BE3B43BCA3B9" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_2695079775561A8F072ABE3B43B78E80" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_39177B1ACB1E689BF6C1BE3B43BCA3B9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent_328D5E6056D8CEEF5398BE3B43BC1F75" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_39177B1ACB1E689BF6C1BE3B43BCA3B9" xlink:to="loc_us-gaap_CustomerRefundLiabilityCurrent_328D5E6056D8CEEF5398BE3B43BC1F75" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5E64B4E14B2461AA7B65BE3B43BD24EA" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_39177B1ACB1E689BF6C1BE3B43BCA3B9" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5E64B4E14B2461AA7B65BE3B43BD24EA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_B0BC17233FE438C9533FBE3B43BD409A" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_39177B1ACB1E689BF6C1BE3B43BCA3B9" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_B0BC17233FE438C9533FBE3B43BD409A" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_0236AB7254B9C77EBFD6BB403961C4D3" xlink:type="locator"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ScheduleOfEmployeeRelatedLiabilitiesTableTextblock" xlink:label="loc_ara_ScheduleOfEmployeeRelatedLiabilitiesTableTextblock_2259AE132B8249173DF4BB40396164E7" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_0236AB7254B9C77EBFD6BB403961C4D3" xlink:to="loc_ara_ScheduleOfEmployeeRelatedLiabilitiesTableTextblock_2259AE132B8249173DF4BB40396164E7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_BC0E99F68C1C61CFCE1DBB403961EAA6" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_0236AB7254B9C77EBFD6BB403961C4D3" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_BC0E99F68C1C61CFCE1DBB403961EAA6" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/Acquisitions" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_83D22F9751ABA5BF0447BE3B442D2FFD" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_7D0DDF90A4D3CAE7D3B7BE3B442D6885" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_83D22F9751ABA5BF0447BE3B442D2FFD" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_7D0DDF90A4D3CAE7D3B7BE3B442D6885" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/AcquisitionsDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_79961E0C8298456B75C0BE3B442898EE" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_474B1EA4A16FB98F2BE5BE3B4428C982" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_79961E0C8298456B75C0BE3B442898EE" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_474B1EA4A16FB98F2BE5BE3B4428C982" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6286396FC2448AA1BC97BE3B442809E4" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_474B1EA4A16FB98F2BE5BE3B4428C982" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6286396FC2448AA1BC97BE3B442809E4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ADE5EDBE631BFE26529BBE3B44288947" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6286396FC2448AA1BC97BE3B442809E4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ADE5EDBE631BFE26529BBE3B44288947" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_Acquisition2017Member" xlink:label="loc_ara_Acquisition2017Member_9A0185B999E589D74DFFBF1098D10E94" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ADE5EDBE631BFE26529BBE3B44288947" xlink:to="loc_ara_Acquisition2017Member_9A0185B999E589D74DFFBF1098D10E94" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_Acquisition2016Member" xlink:label="loc_ara_Acquisition2016Member_C140AEC165F892292072BE3B44292547" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ADE5EDBE631BFE26529BBE3B44288947" xlink:to="loc_ara_Acquisition2016Member_C140AEC165F892292072BE3B44292547" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_C57CE2924818FFADA4B9BE3B44290B41" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_474B1EA4A16FB98F2BE5BE3B4428C982" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_C57CE2924818FFADA4B9BE3B44290B41" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NumberOfDialysisCenters" xlink:label="loc_ara_NumberOfDialysisCenters_78E4CFAE699CBB64CD98BE3B44290388" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C57CE2924818FFADA4B9BE3B44290B41" xlink:to="loc_ara_NumberOfDialysisCenters_78E4CFAE699CBB64CD98BE3B44290388" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_71BCE74D9D38D859DBB9BE3B4429D207" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_C57CE2924818FFADA4B9BE3B44290B41" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_71BCE74D9D38D859DBB9BE3B4429D207" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_F290F1870DA194A0A2B7BE3B4429D6CA" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_71BCE74D9D38D859DBB9BE3B4429D207" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_F290F1870DA194A0A2B7BE3B4429D6CA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_43D3BDD51883D3D84B8EBE3B4429AED5" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_71BCE74D9D38D859DBB9BE3B4429D207" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_43D3BDD51883D3D84B8EBE3B4429AED5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_42F5C14B4F28859A21D1BE3B4429694A" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_71BCE74D9D38D859DBB9BE3B4429D207" xlink:to="loc_us-gaap_Goodwill_42F5C14B4F28859A21D1BE3B4429694A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_191A8F00EF64027312B1BE3B4429C6C4" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_71BCE74D9D38D859DBB9BE3B4429D207" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_191A8F00EF64027312B1BE3B4429C6C4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_976626EF9FBBA7A60876BE3B44299AE9" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_71BCE74D9D38D859DBB9BE3B4429D207" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_976626EF9FBBA7A60876BE3B44299AE9" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/AcquisitionsTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1239E82851C7A88075EABB4039ADDAFC" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_23DF8A7FF406B1D643C1BB4039AD2492" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1239E82851C7A88075EABB4039ADDAFC" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_23DF8A7FF406B1D643C1BB4039AD2492" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/BasisOfPresentationAndOrganization" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CF3CFDFF3A3E59582651BB403A0492C2" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_CB8568E8905E654EDB5BBB403A04987E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_CF3CFDFF3A3E59582651BB403A0492C2" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_CB8568E8905E654EDB5BBB403A04987E" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/BasisOfPresentationAndOrganizationDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3EDA16E73D91F048A498C393472293F8" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_512FD24BF7074EC68EDBC38B501DF75A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3EDA16E73D91F048A498C393472293F8" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_512FD24BF7074EC68EDBC38B501DF75A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_85BBCF1DF24A6D063C1FC38B501EBB63" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_512FD24BF7074EC68EDBC38B501DF75A" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_85BBCF1DF24A6D063C1FC38B501EBB63" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1709125F6612DECC60E2C38B501E7D66" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_85BBCF1DF24A6D063C1FC38B501EBB63" xlink:to="loc_us-gaap_RelatedPartyDomain_1709125F6612DECC60E2C38B501E7D66" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LimitedLiabilityCompanyMember" xlink:label="loc_us-gaap_LimitedLiabilityCompanyMember_89A99A9AC06F51272439C38B501E43FF" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1709125F6612DECC60E2C38B501E7D66" xlink:to="loc_us-gaap_LimitedLiabilityCompanyMember_89A99A9AC06F51272439C38B501E43FF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_269EFF00D21F4098A9BBC38B501EFB2D" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_512FD24BF7074EC68EDBC38B501DF75A" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_269EFF00D21F4098A9BBC38B501EFB2D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4F59471FBED13E17DA55C38B501E53D6" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_269EFF00D21F4098A9BBC38B501EFB2D" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4F59471FBED13E17DA55C38B501E53D6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_B82CA9FC0E742F4AC42CC38B501E59E3" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_269EFF00D21F4098A9BBC38B501EFB2D" xlink:to="loc_us-gaap_Assets_B82CA9FC0E742F4AC42CC38B501E59E3" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_EquityMethodInvestmentOwnershipParentPercentage" xlink:label="loc_ara_EquityMethodInvestmentOwnershipParentPercentage_83F79A12C305286312EDC38B501EEA0E" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_269EFF00D21F4098A9BBC38B501EFB2D" xlink:to="loc_ara_EquityMethodInvestmentOwnershipParentPercentage_83F79A12C305286312EDC38B501EEA0E" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NumberOfDialysisClinicsOwnedAndOperated" xlink:label="loc_ara_NumberOfDialysisClinicsOwnedAndOperated_3475320BA7957387708FC38B501E768A" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_269EFF00D21F4098A9BBC38B501EFB2D" xlink:to="loc_ara_NumberOfDialysisClinicsOwnedAndOperated_3475320BA7957387708FC38B501E768A" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NumberOfPatients" xlink:label="loc_ara_NumberOfPatients_D623FB2034DC97869EC5C38B501ECF9F" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_269EFF00D21F4098A9BBC38B501EFB2D" xlink:to="loc_ara_NumberOfPatients_D623FB2034DC97869EC5C38B501ECF9F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_3F4F2D16AE57C0C1D354C38B501E0C61" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_269EFF00D21F4098A9BBC38B501EFB2D" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_3F4F2D16AE57C0C1D354C38B501E0C61" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/Cash" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_C493510D2CC8F66E26E1BB49FF06DB63" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_224F2C8D27A15B221A18BB4B0725EB87" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_C493510D2CC8F66E26E1BB49FF06DB63" xlink:to="loc_us-gaap_CashAndCashEquivalentsDisclosureTextBlock_224F2C8D27A15B221A18BB4B0725EB87" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/CashDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_EDDC1F56D109579A494ABEEBC99CB640" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_F2CE7597BDF6EC316EC7BEEE34A1B586" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_EDDC1F56D109579A494ABEEBC99CB640" xlink:to="loc_us-gaap_Cash_F2CE7597BDF6EC316EC7BEEE34A1B586" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_0983056F8A331A62DD14BEEF0A9FAA47" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_EDDC1F56D109579A494ABEEBC99CB640" xlink:to="loc_us-gaap_RestrictedCash_0983056F8A331A62DD14BEEF0A9FAA47" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_AB5527697E9C5A3441DABEEF78409E1D" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_EDDC1F56D109579A494ABEEBC99CB640" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_AB5527697E9C5A3441DABEEF78409E1D" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/CashTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_68845863D96322BBA9F4BEEBCA310D78" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_B2D2557649DDA49D43A8BEECE494FBBC" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_68845863D96322BBA9F4BEEBCA310D78" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_B2D2557649DDA49D43A8BEECE494FBBC" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/CertainLegalMatters" xlink:type="extended">
<link:loc xlink:href="ara-20171231.xsd#ara_LegalMattersAbstract" xlink:label="loc_ara_LegalMattersAbstract_4F9BBF108E1C346728B2BB4037E0BBC6" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_3AE175B25700C5705DF7BB4037E078A4" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_LegalMattersAbstract_4F9BBF108E1C346728B2BB4037E0BBC6" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_3AE175B25700C5705DF7BB4037E078A4" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/CertainLegalMattersDetails" xlink:type="extended">
<link:loc xlink:href="ara-20171231.xsd#ara_LegalMattersAbstract" xlink:label="loc_ara_LegalMattersAbstract_CC75D1DC64657DC324F2F938952FFADA" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_4FC8B7DF633E3AB7180AF938952F732C" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_LegalMattersAbstract_CC75D1DC64657DC324F2F938952FFADA" xlink:to="loc_us-gaap_LossContingenciesTable_4FC8B7DF633E3AB7180AF938952F732C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5BB5526CABD076B17726F938952FB085" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4FC8B7DF633E3AB7180AF938952F732C" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5BB5526CABD076B17726F938952FB085" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1D32B480ACEED3C430E6F938952FB60D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5BB5526CABD076B17726F938952FB085" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1D32B480ACEED3C430E6F938952FB60D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_0142E348319A80FD52C6F938952F0539" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1D32B480ACEED3C430E6F938952FB60D" xlink:to="loc_us-gaap_SubsequentEventMember_0142E348319A80FD52C6F938952F0539" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseAxis" xlink:label="loc_us-gaap_LitigationCaseAxis_0AADE1FA0B0D04CA5AD2F9389530836B" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4FC8B7DF633E3AB7180AF938952F732C" xlink:to="loc_us-gaap_LitigationCaseAxis_0AADE1FA0B0D04CA5AD2F9389530836B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationCaseTypeDomain" xlink:label="loc_us-gaap_LitigationCaseTypeDomain_6981094E92439B31E8F1F9389530EB5C" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseAxis_0AADE1FA0B0D04CA5AD2F9389530836B" xlink:to="loc_us-gaap_LitigationCaseTypeDomain_6981094E92439B31E8F1F9389530EB5C" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ARAARAOpCoAndARMvsUnitedHealthGroupInc.Member" xlink:label="loc_ara_ARAARAOpCoAndARMvsUnitedHealthGroupInc.Member_02159C677B3147D5FF84F93895322F4D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_6981094E92439B31E8F1F9389530EB5C" xlink:to="loc_ara_ARAARAOpCoAndARMvsUnitedHealthGroupInc.Member_02159C677B3147D5FF84F93895322F4D" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_EspositoEtAl.v.AmericanRenalAssociatesHoldingsInc.EtAlMember" xlink:label="loc_ara_EspositoEtAl.v.AmericanRenalAssociatesHoldingsInc.EtAlMember_6F2AD8E22C0B5501C29CF938953267C8" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_6981094E92439B31E8F1F9389530EB5C" xlink:to="loc_ara_EspositoEtAl.v.AmericanRenalAssociatesHoldingsInc.EtAlMember_6F2AD8E22C0B5501C29CF938953267C8" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_BushanskyOnBehalfOfCompanyV.BoardOfDirectorsMember" xlink:label="loc_ara_BushanskyOnBehalfOfCompanyV.BoardOfDirectorsMember_7E4035264FD4D053324AF93895325CF2" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_6981094E92439B31E8F1F9389530EB5C" xlink:to="loc_ara_BushanskyOnBehalfOfCompanyV.BoardOfDirectorsMember_7E4035264FD4D053324AF93895325CF2" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_EspositoActionAndDerivativeLawsuitMember" xlink:label="loc_ara_EspositoActionAndDerivativeLawsuitMember_44D442C8C7067A8EC617F938953313EC" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_6981094E92439B31E8F1F9389530EB5C" xlink:to="loc_ara_EspositoActionAndDerivativeLawsuitMember_44D442C8C7067A8EC617F938953313EC" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_AllOthersMember" xlink:label="loc_ara_AllOthersMember_C099E095EDF6B259B6B5F93895339BBB" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationCaseTypeDomain_6981094E92439B31E8F1F9389530EB5C" xlink:to="loc_ara_AllOthersMember_C099E095EDF6B259B6B5F93895339BBB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_1E175DE84FD3F84E162AF9389533D144" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_4FC8B7DF633E3AB7180AF938952F732C" xlink:to="loc_us-gaap_LossContingenciesLineItems_1E175DE84FD3F84E162AF9389533D144" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NumberOfPlaintiffAffiliates" xlink:label="loc_ara_NumberOfPlaintiffAffiliates_B4FC4CCB0EBCEFE13D66F93895332A3A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1E175DE84FD3F84E162AF9389533D144" xlink:to="loc_ara_NumberOfPlaintiffAffiliates_B4FC4CCB0EBCEFE13D66F93895332A3A" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NumberOfPatientsMentionedInComplaint" xlink:label="loc_ara_NumberOfPatientsMentionedInComplaint_AFF5190ED3F572B196DEF9389535ECC7" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1E175DE84FD3F84E162AF9389533D144" xlink:to="loc_ara_NumberOfPatientsMentionedInComplaint_AFF5190ED3F572B196DEF9389535ECC7" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NumberOfClinics" xlink:label="loc_ara_NumberOfClinics_B8578144E631BD180BE5F9389535AA72" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1E175DE84FD3F84E162AF9389533D144" xlink:to="loc_ara_NumberOfClinics_B8578144E631BD180BE5F9389535AA72" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NumberOfInsuranceProducts" xlink:label="loc_ara_NumberOfInsuranceProducts_B4D0EA3AA01704DDBAA6F9389535F023" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1E175DE84FD3F84E162AF9389533D144" xlink:to="loc_ara_NumberOfInsuranceProducts_B4D0EA3AA01704DDBAA6F9389535F023" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_37C1EC0893EF5F04982EF9389535CE8A" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1E175DE84FD3F84E162AF9389533D144" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_37C1EC0893EF5F04982EF9389535CE8A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_C354C476F25E7F59E93CF9389536F4C7" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_1E175DE84FD3F84E162AF9389533D144" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_C354C476F25E7F59E93CF9389536F4C7" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ChangesInOwnershipInterestInConsolidatedSubsidiaries" xlink:type="extended">
<link:loc xlink:href="ara-20171231.xsd#ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES" xlink:label="loc_ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES_958353C979EB97B79523F6A410CD00AA" xlink:type="locator"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ChangesInOwnershipInterestInConsolidatedSubsidiariesDisclosureTextblock" xlink:label="loc_ara_ChangesInOwnershipInterestInConsolidatedSubsidiariesDisclosureTextblock_99467DE3300462D050BFF6A410CD9F15" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES_958353C979EB97B79523F6A410CD00AA" xlink:to="loc_ara_ChangesInOwnershipInterestInConsolidatedSubsidiariesDisclosureTextblock_99467DE3300462D050BFF6A410CD9F15" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ChangesInOwnershipInterestInConsolidatedSubsidiariesDetails" xlink:type="extended">
<link:loc xlink:href="ara-20171231.xsd#ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES" xlink:label="loc_ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES_5B89428823263D72F543DA41B5D071F8" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_517B70C49030C974F81CDA41B5D0CE74" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES_5B89428823263D72F543DA41B5D071F8" xlink:to="loc_us-gaap_NetIncomeLoss_517B70C49030C974F81CDA41B5D0CE74" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_7C4A06B117F40C0248D6DA41B5D12119" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES_5B89428823263D72F543DA41B5D071F8" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_7C4A06B117F40C0248D6DA41B5D12119" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_D514A9B3FD3C1DF9380ADA41B5D19CAB" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES_5B89428823263D72F543DA41B5D071F8" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_D514A9B3FD3C1DF9380ADA41B5D19CAB" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NoncontrollingInterestNetTransfers" xlink:label="loc_ara_NoncontrollingInterestNetTransfers_899DD2E8587685F0A017DA41B5D117AD" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES_5B89428823263D72F543DA41B5D071F8" xlink:to="loc_ara_NoncontrollingInterestNetTransfers_899DD2E8587685F0A017DA41B5D117AD" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NetIncomeLossAttributableToParentNetOfTransfersToNoncontrollingInterest" xlink:label="loc_ara_NetIncomeLossAttributableToParentNetOfTransfersToNoncontrollingInterest_61692687153F0499DE2CDA41B5D1486D" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES_5B89428823263D72F543DA41B5D071F8" xlink:to="loc_ara_NetIncomeLossAttributableToParentNetOfTransfersToNoncontrollingInterest_61692687153F0499DE2CDA41B5D1486D" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ChangesInOwnershipInterestInConsolidatedSubsidiariesTables" xlink:type="extended">
<link:loc xlink:href="ara-20171231.xsd#ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES" xlink:label="loc_ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES_2ADDA2FB9DD33292AC0ABB403948F1D7" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_CB21AD56494FE2274BCFBB887E1BEDDC" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_CHANGESINOWNERSHIPINTERESTINCONSOLIDATEDSUBSIDIARIES_2ADDA2FB9DD33292AC0ABB403948F1D7" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_CB21AD56494FE2274BCFBB887E1BEDDC" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/CommitmentsAndContingencies" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_FABD991B50FB320F72CEBB4037ECDABB" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6F74137D8B85FD2F8501BB4037ECE59F" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_FABD991B50FB320F72CEBB4037ECDABB" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6F74137D8B85FD2F8501BB4037ECE59F" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_023FA2313D412D7CCCCAF8B81463CA8A" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_C47A84B6F216152A58E1F8B814669C03" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_023FA2313D412D7CCCCAF8B81463CA8A" xlink:to="loc_us-gaap_ContractualObligation_C47A84B6F216152A58E1F8B814669C03" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_2B4E0B23602B58208974F8B817B3872B" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_023FA2313D412D7CCCCAF8B81463CA8A" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_2B4E0B23602B58208974F8B817B3872B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_0428FE0AD1B81955217FF8BA13B18605" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_023FA2313D412D7CCCCAF8B81463CA8A" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_0428FE0AD1B81955217FF8BA13B18605" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PercentageTaxSavingsPayableToStockholders" xlink:label="loc_ara_PercentageTaxSavingsPayableToStockholders_301319A2B3CB8B13CC4FF8B814668551" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_023FA2313D412D7CCCCAF8B81463CA8A" xlink:to="loc_ara_PercentageTaxSavingsPayableToStockholders_301319A2B3CB8B13CC4FF8B814668551" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/Concentrations" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_560661E56418EB9781E7BB4037C53E40" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_D9E33F1CC8A8006BF572BB4037C5DC0C" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_560661E56418EB9781E7BB4037C53E40" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_D9E33F1CC8A8006BF572BB4037C5DC0C" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ConcentrationsDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_B12770F1284462B6CD2CBB4037BCC29A" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnusualRiskOrUncertaintyTable" xlink:label="loc_us-gaap_UnusualRiskOrUncertaintyTable_208B28077D17B449664FBB4037BC8979" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_B12770F1284462B6CD2CBB4037BCC29A" xlink:to="loc_us-gaap_UnusualRiskOrUncertaintyTable_208B28077D17B449664FBB4037BC8979" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_F9127DFEE7F3BA1C1130BB4037BC6910" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyTable_208B28077D17B449664FBB4037BC8979" xlink:to="loc_us-gaap_RangeAxis_F9127DFEE7F3BA1C1130BB4037BC6910" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_D83F0F64DEBD027904D7BB4037BC79E7" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_F9127DFEE7F3BA1C1130BB4037BC6910" xlink:to="loc_us-gaap_RangeMember_D83F0F64DEBD027904D7BB4037BC79E7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_016BE0BBF4EE13929253BB4037BC0819" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_D83F0F64DEBD027904D7BB4037BC79E7" xlink:to="loc_us-gaap_MaximumMember_016BE0BBF4EE13929253BB4037BC0819" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_30547469848282EA440ABB4037BCDFBF" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualRiskOrUncertaintyTable_208B28077D17B449664FBB4037BC8979" xlink:to="loc_us-gaap_StatementLineItems_30547469848282EA440ABB4037BCDFBF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaap_CashFDICInsuredAmount_FA16BB6B3FEDF889E57CBB4037BDDCD1" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30547469848282EA440ABB4037BCDFBF" xlink:to="loc_us-gaap_CashFDICInsuredAmount_FA16BB6B3FEDF889E57CBB4037BDDCD1" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_B751311032B8E5FD98ACBB403A756F0A" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_B751311032B8E5FD98ACBB403A756F0A" xlink:to="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_1E3E8EDA820A85309AEABB403A75D948" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_Cash_1E3E8EDA820A85309AEABB403A75D948" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_B0F910137F36E8114B7CBB403A75A36A" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_B0F910137F36E8114B7CBB403A75A36A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_A52CB85909A083EF5ECFBB403A7510FA" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_InventoryNet_A52CB85909A083EF5ECFBB403A7510FA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2E3C35CD4B30E01C5C31BB403A75F81E" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2E3C35CD4B30E01C5C31BB403A75F81E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="loc_us-gaap_IncomeTaxesReceivable_6F7B15164FEEF4D193DEBB403A755B8D" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_IncomeTaxesReceivable_6F7B15164FEEF4D193DEBB403A755B8D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_5F94F3147B0BFDA7ABF4BB403A7533AD" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_AssetsCurrent_5F94F3147B0BFDA7ABF4BB403A7533AD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_F3F52FCC1B1003D0412EBB403A75C7BC" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_F3F52FCC1B1003D0412EBB403A75C7BC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_319740C4C907A9BF3050BB403A75418A" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_319740C4C907A9BF3050BB403A75418A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_CEBBA6BDE96A39962A4CBB403A757969" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_CEBBA6BDE96A39962A4CBB403A757969" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_D6FAEE7BDDAF3F7EA0C7BB403A752B08" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_Goodwill_D6FAEE7BDDAF3F7EA0C7BB403A752B08" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_EE8972824D49141A369ABB403A752C7B" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_F8736A16B5B900B97B25BB403A7553CC" xlink:to="loc_us-gaap_Assets_EE8972824D49141A369ABB403A752C7B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_B751311032B8E5FD98ACBB403A756F0A" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_26471A0F51678189EFD2BB403A764A72" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_AccountsPayableCurrent_26471A0F51678189EFD2BB403A764A72" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_41CF2691C93F13636438BB403A76A769" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_41CF2691C93F13636438BB403A76A769" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8C2A23F244F5358CE950BB403A76BA6B" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8C2A23F244F5358CE950BB403A76BA6B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_49A639E09541CC66D1F8BB403A76B4D6" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_LongTermDebtCurrent_49A639E09541CC66D1F8BB403A76B4D6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_4778C7AFC4C64D9B06EABB403A7612D0" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_LiabilitiesCurrent_4778C7AFC4C64D9B06EABB403A7612D0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6F2F1CA25016D61765C9BB403A76AD8E" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6F2F1CA25016D61765C9BB403A76AD8E" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_IncomeTaxReceivableAgreementPayable" xlink:label="loc_ara_IncomeTaxReceivableAgreementPayable_B4530CC6D724AE1675C1BB403A76D7C5" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_ara_IncomeTaxReceivableAgreementPayable_B4530CC6D724AE1675C1BB403A76D7C5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_739C94E8409763E06BEEBB403A76254B" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_739C94E8409763E06BEEBB403A76254B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_E6CCB0DAA9EB57485F00BB403A76B562" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_E6CCB0DAA9EB57485F00BB403A76B562" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_AB40B12FD4B6B8905EC8BB403A76607B" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_Liabilities_AB40B12FD4B6B8905EC8BB403A76607B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_463CBEC5DDD100F995D6BB403A76CC8C" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_463CBEC5DDD100F995D6BB403A76CC8C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_A4DEC893985B6B65A721BB403A7690BC" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_A4DEC893985B6B65A721BB403A7690BC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_C6CA0C0C381261A4EA92BB403A764CA0" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:to="loc_us-gaap_PreferredStockValue_C6CA0C0C381261A4EA92BB403A764CA0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_E36AB36C4B4703453576BB403A763F0A" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:to="loc_us-gaap_CommonStockValue_E36AB36C4B4703453576BB403A763F0A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_38C2317E2459764AB407BB403A760E36" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:to="loc_us-gaap_AdditionalPaidInCapital_38C2317E2459764AB407BB403A760E36" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ReceivableFromNoncontrollingInterest" xlink:label="loc_ara_ReceivableFromNoncontrollingInterest_1D14B70634E4294B3083BB403A779AA9" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:to="loc_ara_ReceivableFromNoncontrollingInterest_1D14B70634E4294B3083BB403A779AA9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_F63A637FF1EBEEE2EB74BB403A778356" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_F63A637FF1EBEEE2EB74BB403A778356" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_E61D5C32218A4F0D252EBB403A7769CF" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_E61D5C32218A4F0D252EBB403A7769CF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_2933F655297707B08B85BB403A77532A" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:to="loc_us-gaap_StockholdersEquity_2933F655297707B08B85BB403A77532A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaap_MinorityInterest_FFDC7434A4983FE6BAC8BB403A77631B" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:to="loc_us-gaap_MinorityInterest_FFDC7434A4983FE6BAC8BB403A77631B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_C8180D8EBAC4D52F8B0ABB403A772439" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_09BFF5BC4D942F413C97BB403A76C586" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_C8180D8EBAC4D52F8B0ABB403A772439" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_779DC12C47DBFA914CB5BB403A77FECC" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1B99CCD208837D87A2FABB403A76EFA1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_779DC12C47DBFA914CB5BB403A77FECC" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8983187987E711CA643C741F252385AD" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9A1437D69A0DC19C4738741F25235343" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8983187987E711CA643C741F252385AD" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9A1437D69A0DC19C4738741F25235343" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_CB01A6E159026DD2D16B741F2523071C" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8983187987E711CA643C741F252385AD" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_CB01A6E159026DD2D16B741F2523071C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_44A00827547C2F768442741F2523F64C" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8983187987E711CA643C741F252385AD" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_44A00827547C2F768442741F2523F64C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6C8431E3C3FD2F8C2F04741F252370B2" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8983187987E711CA643C741F252385AD" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6C8431E3C3FD2F8C2F04741F252370B2" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_D232DC335D0D9A215761741F2523D137" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8983187987E711CA643C741F252385AD" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_D232DC335D0D9A215761741F2523D137" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_A92F859E8643F88C3691741F2523C55D" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8983187987E711CA643C741F252385AD" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_A92F859E8643F88C3691741F2523C55D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_43F63A0B58D77B9E269A741F25234059" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8983187987E711CA643C741F252385AD" xlink:to="loc_us-gaap_CommonStockSharesIssued_43F63A0B58D77B9E269A741F25234059" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_C8DA2E4DD84ADB62090D741F2524D433" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8983187987E711CA643C741F252385AD" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_C8DA2E4DD84ADB62090D741F2524D433" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_E55FEBF0A308E2F560D0F698FBCC6074" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0101F16710DB6B629F12F698FBCC101A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_E55FEBF0A308E2F560D0F698FBCC6074" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0101F16710DB6B629F12F698FBCC101A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_09181881FE9E8383C2F2F698FBCCF4DC" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0101F16710DB6B629F12F698FBCC101A" xlink:to="loc_us-gaap_ProfitLoss_09181881FE9E8383C2F2F698FBCCF4DC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0101F16710DB6B629F12F698FBCC101A" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_87F4EDD95AC1AAEECC91F698FBCC6AAA" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_87F4EDD95AC1AAEECC91F698FBCC6AAA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_0EC9591CEB2DBA442D5DF698FBCCBB71" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_0EC9591CEB2DBA442D5DF698FBCCBB71" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4042CCE095E28EBD7C3AF698FBCCD5E4" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4042CCE095E28EBD7C3AF698FBCCD5E4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_C4C925929B2C09E72E51F698FBCC93B4" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_us-gaap_ShareBasedCompensation_C4C925929B2C09E72E51F698FBCC93B4" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PaymentsforPremiumonInterestRateCapAgreements" xlink:label="loc_ara_PaymentsforPremiumonInterestRateCapAgreements_65DBA4227F7130A49549F698FBCC009B" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_ara_PaymentsforPremiumonInterestRateCapAgreements_65DBA4227F7130A49549F698FBCC009B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_2C683E5465EAF14CBC30F698FBCC69B9" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities_2C683E5465EAF14CBC30F698FBCC69B9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_B48831E35140E6BEA632F698FBCC4F97" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_B48831E35140E6BEA632F698FBCC4F97" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_IncomeTaxReceivableAgreementIncome" xlink:label="loc_ara_IncomeTaxReceivableAgreementIncome_AF0AAB166DB92D835103F698FBCC303A" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_ara_IncomeTaxReceivableAgreementIncome_AF0AAB166DB92D835103F698FBCC303A" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PaymentsOnTaxReceivableAgreement" xlink:label="loc_ara_PaymentsOnTaxReceivableAgreement_087DD084D8D716D19884F698FBCC5445" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_ara_PaymentsOnTaxReceivableAgreement_087DD084D8D716D19884F698FBCC5445" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities_3ED84273A2828FC75726F698FBCD9C72" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities_3ED84273A2828FC75726F698FBCD9C72" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaap_OtherNoncashExpense_E456A2F2A197B49C4DAFF698FBCD2E97" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_us-gaap_OtherNoncashExpense_E456A2F2A197B49C4DAFF698FBCD2E97" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_LossOnDispositionOfAssets" xlink:label="loc_ara_LossOnDispositionOfAssets_A44C79D7A61FB26AAEC8F698FBCDE686" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_ara_LossOnDispositionOfAssets_A44C79D7A61FB26AAEC8F698FBCDE686" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_GainOnDispositionOfAssets" xlink:label="loc_ara_GainOnDispositionOfAssets_0FA528093240E96BEECBF698FBCDD9CE" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_ara_GainOnDispositionOfAssets_0FA528093240E96BEECBF698FBCDD9CE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FD8183BAE5005911326BF698FBCDC0CC" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FD8183BAE5005911326BF698FBCDC0CC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_611A5DC0F1DED015B8DEF698FBCD5E7A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FD8183BAE5005911326BF698FBCDC0CC" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_611A5DC0F1DED015B8DEF698FBCD5E7A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_EBF3D6C1B734B164ACE6F698FBCD2961" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FD8183BAE5005911326BF698FBCDC0CC" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_EBF3D6C1B734B164ACE6F698FBCD2961" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_97F1D9E3962668FA876FF698FBCDDCC0" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FD8183BAE5005911326BF698FBCDC0CC" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_97F1D9E3962668FA876FF698FBCDDCC0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7C883E83978846F40CC4F698FBCDCEA6" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FD8183BAE5005911326BF698FBCDC0CC" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7C883E83978846F40CC4F698FBCDCEA6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9BD6D92D443E881CF396F698FBCDD9F5" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FD8183BAE5005911326BF698FBCDC0CC" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9BD6D92D443E881CF396F698FBCDD9F5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_836EEB0945ED0A7A5E0BF698FBCD0FB1" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FD8183BAE5005911326BF698FBCDC0CC" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_836EEB0945ED0A7A5E0BF698FBCD0FB1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1EEAAB11915D98F934BBF698FBCD0F5C" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_FD8183BAE5005911326BF698FBCDC0CC" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1EEAAB11915D98F934BBF698FBCD0F5C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_86045907FF09CB0CD35DF698FBCD2039" xlink:type="locator"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2C4FA404E429F6D3C20BF698FBCC231D" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_86045907FF09CB0CD35DF698FBCD2039" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2437B52666D64F68FC36F698FBCDCBBA" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_E55FEBF0A308E2F560D0F698FBCC6074" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2437B52666D64F68FC36F698FBCDCBBA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_B8E89BA64E0E2A3806F7F698FBCDA758" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2437B52666D64F68FC36F698FBCDCBBA" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_B8E89BA64E0E2A3806F7F698FBCDA758" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_A4B92A7746F887A14C29F698FBCD16C7" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2437B52666D64F68FC36F698FBCDCBBA" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_A4B92A7746F887A14C29F698FBCD16C7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CE23710595B4DE5D9785F698FBCE703F" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2437B52666D64F68FC36F698FBCDCBBA" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_CE23710595B4DE5D9785F698FBCE703F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6DC1763A13D82D077A9AF698FBCE50BE" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2437B52666D64F68FC36F698FBCDCBBA" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6DC1763A13D82D077A9AF698FBCE50BE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_E55FEBF0A308E2F560D0F698FBCC6074" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_36C0D60E5A43577493C3F698FBCE9E3A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_36C0D60E5A43577493C3F698FBCE9E3A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_57C37A9B07838D48BF13F698FBCEE928" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_57C37A9B07838D48BF13F698FBCEE928" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_14EC1CF92600274C9F88F698FBCE358A" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel" priority="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_14EC1CF92600274C9F88F698FBCE358A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_8900C81A80F0B01EB5B5F698FBCEC854" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_8900C81A80F0B01EB5B5F698FBCEC854" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_3FA4F15B499763D04A74F698FBCE9AE1" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_3FA4F15B499763D04A74F698FBCE9AE1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_8C60E37E54EA5EC91FBDF698FBCE9CF3" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_8C60E37E54EA5EC91FBDF698FBCE9CF3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaap_PaymentsOfDividends_7EBE724D3A41B9CFE9F5F698FBCE4DBF" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_PaymentsOfDividends_7EBE724D3A41B9CFE9F5F698FBCE4DBF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_EE8B7F4FA2AF81A974B7F698FBCE23A2" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_EE8B7F4FA2AF81A974B7F698FBCE23A2" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6673C067BE48BE87CD22F698FBCEB751" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6673C067BE48BE87CD22F698FBCEB751" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_05B8FF8683F6BF9AE27BF698FBCEE47E" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_05B8FF8683F6BF9AE27BF698FBCEE47E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_AC9444AD8FEB5C208A67F698FBCEBA53" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_AC9444AD8FEB5C208A67F698FBCEBA53" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_4D876D3C097650059C89F698FBCEEFE8" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_4D876D3C097650059C89F698FBCEEFE8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDistributionsToAffiliates" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_1D722887D9773D514FCAF698FBCEDB77" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_1D722887D9773D514FCAF698FBCEDB77" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromContributionsFromAffiliates" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_CF3A7F77C16CFB9A23D7F698FBCE6888" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_CF3A7F77C16CFB9A23D7F698FBCE6888" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToMinorityShareholders" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_08E89416EA2977354E6CF698FBCFC092" xlink:type="locator"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_08E89416EA2977354E6CF698FBCFC092" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_1562A165562156686C71F698FBCF5640" xlink:type="locator"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_1562A165562156686C71F698FBCF5640" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2CAD604E2781C1CF3768F698FBCF314C" xlink:type="locator"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_C78EC2A25E1709102179F698FBCE6778" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2CAD604E2781C1CF3768F698FBCF314C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_138F861B9E528AF24C43F698FBCFFF25" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_E55FEBF0A308E2F560D0F698FBCC6074" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_138F861B9E528AF24C43F698FBCFFF25" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6DE8B5F05307DA90F6E4F698FBCF6465" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_E55FEBF0A308E2F560D0F698FBCC6074" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6DE8B5F05307DA90F6E4F698FBCF6465" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_134852052D91044EC09DF698FBCF1A7D" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_E55FEBF0A308E2F560D0F698FBCC6074" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_134852052D91044EC09DF698FBCF1A7D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_A0D5D51C51A3BD45F97DF698FBD4BE98" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_E55FEBF0A308E2F560D0F698FBCC6074" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_A0D5D51C51A3BD45F97DF698FBD4BE98" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_FBA050D721B6554F635EF698FBD436BB" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_A0D5D51C51A3BD45F97DF698FBD4BE98" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_FBA050D721B6554F635EF698FBD436BB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_8AF6D7ED07484168C44CF698FBD42D83" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_A0D5D51C51A3BD45F97DF698FBD4BE98" xlink:to="loc_us-gaap_InterestPaid_8AF6D7ED07484168C44CF698FBD42D83" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_CA7E5EAB03054B5FE48DF698FBD460E9" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_E55FEBF0A308E2F560D0F698FBCC6074" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_CA7E5EAB03054B5FE48DF698FBD460E9" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_TaxReceivableAgreement" xlink:label="loc_ara_TaxReceivableAgreement_0B84CED12673A86DD67BF698FBD451C6" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_CA7E5EAB03054B5FE48DF698FBD460E9" xlink:to="loc_ara_TaxReceivableAgreement_0B84CED12673A86DD67BF698FBD451C6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPaidinkind" xlink:label="loc_us-gaap_DividendsPaidinkind_39CF26B2E77D2FEB45EEF698FBD53D9C" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_CA7E5EAB03054B5FE48DF698FBD460E9" xlink:to="loc_us-gaap_DividendsPaidinkind_39CF26B2E77D2FEB45EEF698FBD53D9C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="loc_us-gaap_LiabilitiesAssumed1_6E28E90C0CBF2BD8E0E4F698FBD56AD6" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_CA7E5EAB03054B5FE48DF698FBD460E9" xlink:to="loc_us-gaap_LiabilitiesAssumed1_6E28E90C0CBF2BD8E0E4F698FBD56AD6" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ContributionsFromNoncontrollingInterestsInFormOfReceivable" xlink:label="loc_ara_ContributionsFromNoncontrollingInterestsInFormOfReceivable_4D71004F39E6FD928D3BF698FBD52974" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_CA7E5EAB03054B5FE48DF698FBD460E9" xlink:to="loc_ara_ContributionsFromNoncontrollingInterestsInFormOfReceivable_4D71004F39E6FD928D3BF698FBD52974" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaap_DeferredOfferingCosts_F918C568EE579CEA8F21F698FBD59588" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_CA7E5EAB03054B5FE48DF698FBD460E9" xlink:to="loc_us-gaap_DeferredOfferingCosts_F918C568EE579CEA8F21F698FBD59588" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_AccruedPurchasesOfNoncontrollingInterests" xlink:label="loc_ara_AccruedPurchasesOfNoncontrollingInterests_7FE2EAA98BFF97EC916EF698FBD5930A" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_CA7E5EAB03054B5FE48DF698FBD460E9" xlink:to="loc_ara_AccruedPurchasesOfNoncontrollingInterests_7FE2EAA98BFF97EC916EF698FBD5930A" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NonCashPortionOfLongTermDebtRefinancing" xlink:label="loc_ara_NonCashPortionOfLongTermDebtRefinancing_9A9EAAAFEE6310594F56F698FBD515A8" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_CA7E5EAB03054B5FE48DF698FBD460E9" xlink:to="loc_ara_NonCashPortionOfLongTermDebtRefinancing_9A9EAAAFEE6310594F56F698FBD515A8" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ConsolidatedStatementsOfChangesInEquity" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_F706894E9A983C0265E6F83B287CF278" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_150B42705BBD5DECF23DF83B287C1BFE" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_F706894E9A983C0265E6F83B287CF278" xlink:to="loc_us-gaap_StatementTable_150B42705BBD5DECF23DF83B287C1BFE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_25C6DE0C8B2343A1F0F5F83B287C6E76" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_150B42705BBD5DECF23DF83B287C1BFE" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_25C6DE0C8B2343A1F0F5F83B287C6E76" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_54A7493BBD0F93578625F83B287C6D9E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25C6DE0C8B2343A1F0F5F83B287C6E76" xlink:to="loc_us-gaap_EquityComponentDomain_54A7493BBD0F93578625F83B287C6D9E" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NoncontrollingInterestPutProvisionMember" xlink:label="loc_ara_NoncontrollingInterestPutProvisionMember_2424415F09A676EEF82EF83B287C968F" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54A7493BBD0F93578625F83B287C6D9E" xlink:to="loc_ara_NoncontrollingInterestPutProvisionMember_2424415F09A676EEF82EF83B287C968F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_515A907995115352DEAFF83B287C36D4" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54A7493BBD0F93578625F83B287C6D9E" xlink:to="loc_us-gaap_CommonStockMember_515A907995115352DEAFF83B287C36D4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_59BA1849092328E88DEEF83B287C2756" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54A7493BBD0F93578625F83B287C6D9E" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_59BA1849092328E88DEEF83B287C2756" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesFromStockholderMember" xlink:label="loc_us-gaap_ReceivablesFromStockholderMember_A8D36C3041EFB474DEF2F83B287C9A54" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54A7493BBD0F93578625F83B287C6D9E" xlink:to="loc_us-gaap_ReceivablesFromStockholderMember_A8D36C3041EFB474DEF2F83B287C9A54" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_8DA51D2E3509770D87D3F83B287CD22B" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54A7493BBD0F93578625F83B287C6D9E" xlink:to="loc_us-gaap_RetainedEarningsMember_8DA51D2E3509770D87D3F83B287CD22B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_C43A2B74CD082104B09CF83B287C96C3" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54A7493BBD0F93578625F83B287C6D9E" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_C43A2B74CD082104B09CF83B287C96C3" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NoncontrollingInterestNoPutProvisionMember" xlink:label="loc_ara_NoncontrollingInterestNoPutProvisionMember_AB4C84E8CB24BDE901BAF83B287CB8CB" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_54A7493BBD0F93578625F83B287C6D9E" xlink:to="loc_ara_NoncontrollingInterestNoPutProvisionMember_AB4C84E8CB24BDE901BAF83B287CB8CB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_150B42705BBD5DECF23DF83B287C1BFE" xlink:to="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_74D3C3F8B50B0EE38E0BF83B287D945C" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_StockholdersEquity_74D3C3F8B50B0EE38E0BF83B287D945C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_C659DD467627682AD1D3F83B287D3463" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_SharesOutstanding_C659DD467627682AD1D3F83B287D3463" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_48CF10FB4FA68723AFB5F83B287DC57A" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_NetIncomeLoss_48CF10FB4FA68723AFB5F83B287DC57A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_001484FB4D274B643362F83B287D4265" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_001484FB4D274B643362F83B287D4265" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_62A8F22DE0CAD85FAC2BF83B287DBAC6" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_62A8F22DE0CAD85FAC2BF83B287DBAC6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7E399FAB039CD6613AE0F83B287D1B40" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7E399FAB039CD6613AE0F83B287D1B40" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4142563999F17F50A8F6F83B287D63A1" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4142563999F17F50A8F6F83B287D63A1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_DF34B36178E1904DCF89F83B287D1A79" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_DF34B36178E1904DCF89F83B287D1A79" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet" xlink:label="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_81FFDA21A06E41A6FCDEF83B287D9B94" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_81FFDA21A06E41A6FCDEF83B287D9B94" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_88B8D27689BD14D08CA5F83B287DE380" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_88B8D27689BD14D08CA5F83B287DE380" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NoncontrollingInterestIncreaseFromContributions" xlink:label="loc_ara_NoncontrollingInterestIncreaseFromContributions_3B2A878F05D34C8C76B6F83B287D1A1B" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_ara_NoncontrollingInterestIncreaseFromContributions_3B2A878F05D34C8C76B6F83B287D1A1B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_84734145F24D012C804DF83B287D40DB" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_84734145F24D012C804DF83B287D40DB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_79CD2963F10FA2737EB5F83B287D6134" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_79CD2963F10FA2737EB5F83B287D6134" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_FD51422A36867311C34BF83B287DA71A" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_FD51422A36867311C34BF83B287DA71A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_60AB3A9B06CD38EC0D5DF83B287DADBD" xlink:type="locator"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_60AB3A9B06CD38EC0D5DF83B287DADBD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_AC66BB5258E10C4998A8F83B287D5420" xlink:type="locator"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_AC66BB5258E10C4998A8F83B287D5420" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCommonStockCash" xlink:label="loc_us-gaap_DividendsCommonStockCash_0197CB99502245527864F83B287D6D27" xlink:type="locator"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_DividendsCommonStockCash_0197CB99502245527864F83B287D6D27" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_DividendsShareBasedCompensationCashPaid" xlink:label="loc_ara_DividendsShareBasedCompensationCashPaid_860CAE929F1ACBA4C4CBF83B287D7BCB" xlink:type="locator"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_ara_DividendsShareBasedCompensationCashPaid_860CAE929F1ACBA4C4CBF83B287D7BCB" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_DividendsShareBasedCompensationCashAccrued" xlink:label="loc_ara_DividendsShareBasedCompensationCashAccrued_73D832D8B92EC4AB7D95F83B287EC746" xlink:type="locator"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_ara_DividendsShareBasedCompensationCashAccrued_73D832D8B92EC4AB7D95F83B287EC746" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsPaidinkind" xlink:label="loc_us-gaap_DividendsPaidinkind_BE1B2B3281A078CA821BF83B287EFC62" xlink:type="locator"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_DividendsPaidinkind_BE1B2B3281A078CA821BF83B287EFC62" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_IncomeTaxReceivableAgreement" xlink:label="loc_ara_IncomeTaxReceivableAgreement_1EFD6C52EAF45AD23DCFF83B287EB6B6" xlink:type="locator"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_ara_IncomeTaxReceivableAgreement_1EFD6C52EAF45AD23DCFF83B287EB6B6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_C944067F9CF907AC580CF83B287EE7F3" xlink:type="locator"/>
<link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_C944067F9CF907AC580CF83B287EE7F3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_6131D297ADBD27B58BADF83B287EA899" xlink:type="locator"/>
<link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_6131D297ADBD27B58BADF83B287EA899" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_EB74394860D2727CFF5BF83B287EA984" xlink:type="locator"/>
<link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_EB74394860D2727CFF5BF83B287EA984" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_B0BC887ECF220485CFD4F83B287E7786" xlink:type="locator"/>
<link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_B0BC887ECF220485CFD4F83B287E7786" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_C3AFD05E1B2389C09451F83B287EEBAF" xlink:type="locator"/>
<link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_StockholdersEquity_C3AFD05E1B2389C09451F83B287EEBAF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaap_SharesOutstanding_AF1977ED512BC441FBDFF83B287E2BD9" xlink:type="locator"/>
<link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_008F4DE6F4B39D85D9FEF83B287C2795" xlink:to="loc_us-gaap_SharesOutstanding_AF1977ED512BC441FBDFF83B287E2BD9" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_B335F3F0D615836672AA741F250B7165" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_0401DF1C11431DC2B8FD741F250BB98E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_B335F3F0D615836672AA741F250B7165" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_0401DF1C11431DC2B8FD741F250BB98E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_25DAA4E6F4A19B7B8A82741F250BA192" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_B335F3F0D615836672AA741F250B7165" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_25DAA4E6F4A19B7B8A82741F250BA192" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C3D01ABC759ABAED41CBE3B44D3376A" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_F20346E783609367103EBE3B44D3B8EF" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C3D01ABC759ABAED41CBE3B44D3376A" xlink:to="loc_us-gaap_ProfitLoss_F20346E783609367103EBE3B44D3B8EF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_77D02359C57EEBDDBE5BBE3B44D307AF" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C3D01ABC759ABAED41CBE3B44D3376A" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_77D02359C57EEBDDBE5BBE3B44D307AF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1A3F04375572257F6C41BE3B44D3DA1F" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C3D01ABC759ABAED41CBE3B44D3376A" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1A3F04375572257F6C41BE3B44D3DA1F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_EE66442F5C100DDF0594BE3F7FEFEA23" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C3D01ABC759ABAED41CBE3B44D3376A" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_EE66442F5C100DDF0594BE3F7FEFEA23" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2C840D24FC82A5275ADDBE3B44D399CC" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4C3D01ABC759ABAED41CBE3B44D3376A" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_2C840D24FC82A5275ADDBE3B44D399CC" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="loc_us-gaap_HealthCareOrganizationPatientServiceRevenue_7C603A35DCA5B1B59FD9C004099D69F5" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_HealthCareOrganizationPatientServiceRevenue_7C603A35DCA5B1B59FD9C004099D69F5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="loc_us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_3F67CF644909043C2C58C004099E37D0" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_3F67CF644909043C2C58C004099E37D0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:label="loc_us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_DA01000C4834DBCF66E4C004099EA064" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_DA01000C4834DBCF66E4C004099EA064" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_BCA7C2AC4C79CEAB0770C004099E6129" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_OperatingExpensesAbstract_BCA7C2AC4C79CEAB0770C004099E6129" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HealthCareOrganizationExpensesNet" xlink:label="loc_us-gaap_HealthCareOrganizationExpensesNet_9EF76E651B3A4E4F1F6AC004099EBE68" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_BCA7C2AC4C79CEAB0770C004099E6129" xlink:to="loc_us-gaap_HealthCareOrganizationExpensesNet_9EF76E651B3A4E4F1F6AC004099EBE68" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_75567D3A21458808ABB1C004099EBC2C" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_BCA7C2AC4C79CEAB0770C004099E6129" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_75567D3A21458808ABB1C004099EBC2C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaap_ProfessionalFees_7F5B8368408112789063C004099EFEB0" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_BCA7C2AC4C79CEAB0770C004099E6129" xlink:to="loc_us-gaap_ProfessionalFees_7F5B8368408112789063C004099EFEB0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_ADEA31DDF762549EA134C004099EFE7F" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_BCA7C2AC4C79CEAB0770C004099E6129" xlink:to="loc_us-gaap_DepreciationAndAmortization_ADEA31DDF762549EA134C004099EFE7F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaap_LegalFees_78973536F9A593A5BDFCC004099EDF42" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_BCA7C2AC4C79CEAB0770C004099E6129" xlink:to="loc_us-gaap_LegalFees_78973536F9A593A5BDFCC004099EDF42" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_1B14ADB6BEEB8B161CAAC004099ED69E" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_BCA7C2AC4C79CEAB0770C004099E6129" xlink:to="loc_us-gaap_CostsAndExpenses_1B14ADB6BEEB8B161CAAC004099ED69E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_6AB5F54EB2E8B2F1D186C004099E0F67" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_OperatingIncomeLoss_6AB5F54EB2E8B2F1D186C004099E0F67" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_452E3A718A1AE70CECAFC004099E27C3" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_452E3A718A1AE70CECAFC004099E27C3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_F4C3ED5D641A639116CFC004099EB4F1" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_F4C3ED5D641A639116CFC004099EB4F1" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_IncomeTaxReceivableAgreementIncome" xlink:label="loc_ara_IncomeTaxReceivableAgreementIncome_C8C8E5FCE02698252FD7C004099EC29D" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_ara_IncomeTaxReceivableAgreementIncome_C8C8E5FCE02698252FD7C004099EC29D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DE79E55E4361B8D9E697C004099F2CCF" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_DE79E55E4361B8D9E697C004099F2CCF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_53C667D29C59938EBB10C004099F45EC" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_53C667D29C59938EBB10C004099F45EC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_5FB24559B559BDAD7C72C004099FEB93" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_ProfitLoss_5FB24559B559BDAD7C72C004099FEB93" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_014AED4F8CDCE89DB8A4C004099F1458" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_014AED4F8CDCE89DB8A4C004099F1458" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_F8443323A268664C4DC1C004099FBCE5" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_NetIncomeLoss_F8443323A268664C4DC1C004099FBCE5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_270EFCC8BA3E68C24EB2C004099F7BE7" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_270EFCC8BA3E68C24EB2C004099F7BE7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_BBB26F0EE57F33D1A7A6C004099FF449" xlink:type="locator"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_BBB26F0EE57F33D1A7A6C004099FF449" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_00892A98D262562E78FAC004099FD11F" xlink:type="locator"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_EarningsPerShareAbstract_00892A98D262562E78FAC004099FD11F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_2DDD85DDD288B1C42C21C004099FABF4" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00892A98D262562E78FAC004099FD11F" xlink:to="loc_us-gaap_EarningsPerShareBasic_2DDD85DDD288B1C42C21C004099FABF4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8A4F867DE886FE21113EC004099F5DF8" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_00892A98D262562E78FAC004099FD11F" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8A4F867DE886FE21113EC004099F5DF8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2D7A184877B9A7E3A5DBC004099FA152" xlink:type="locator"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2D7A184877B9A7E3A5DBC004099FA152" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C06596BE052EB17821D4C004099F2696" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2D7A184877B9A7E3A5DBC004099FA152" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_C06596BE052EB17821D4C004099F2696" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A9E20C6275A9C1ADB216C004099FBE85" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2D7A184877B9A7E3A5DBC004099FA152" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_A9E20C6275A9C1ADB216C004099FBE85" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_FED98D6E78E152AC39D3C004099FA8A1" xlink:type="locator"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_A9D4E157AEAE6B0FCACBC004099DE232" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_FED98D6E78E152AC39D3C004099FA8A1" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/Debt" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_128FFE5E2281C6FEF5EDF6A410C629DF" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_E6CA34E525781438D5F2F6A410C6B33D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_128FFE5E2281C6FEF5EDF6A410C629DF" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_E6CA34E525781438D5F2F6A410C6B33D" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/DebtDebtScheduledMaturitiesOfLongTermDebtDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_A306BAC1509A726950A2BB40391BCEEA" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_B81E7E2EF81FA16E8BB5BB40391B2620" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_A306BAC1509A726950A2BB40391BCEEA" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_B81E7E2EF81FA16E8BB5BB40391B2620" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_F263492FF9DCD12FA8EEBB40391BB598" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_A306BAC1509A726950A2BB40391BCEEA" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_F263492FF9DCD12FA8EEBB40391BB598" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8C798DC2D2A4B86A5714BB40391BB33B" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_A306BAC1509A726950A2BB40391BCEEA" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_8C798DC2D2A4B86A5714BB40391BB33B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_A1E9596E0456D6173BBBBB40391BCB5F" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_A306BAC1509A726950A2BB40391BCEEA" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_A1E9596E0456D6173BBBBB40391BCB5F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_970C9DACE043EE61ED96BB40391BC443" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_A306BAC1509A726950A2BB40391BCEEA" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_970C9DACE043EE61ED96BB40391BC443" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_C384CD3144A0E56B137CBB40391B5F61" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_A306BAC1509A726950A2BB40391BCEEA" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_C384CD3144A0E56B137CBB40391B5F61" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_06E735B98CF8A114580BBB40391CD68E" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_A306BAC1509A726950A2BB40391BCEEA" xlink:to="loc_us-gaap_LongTermDebt_06E735B98CF8A114580BBB40391CD68E" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/DebtNarrativeDetail" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_981343D486A3C3C4E787F9235A48348B" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_981343D486A3C3C4E787F9235A48348B" xlink:to="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_97B1C52BC6F5403E9E4DF9235A4821D8" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_97B1C52BC6F5403E9E4DF9235A4821D8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:label="loc_us-gaap_HedgingRelationshipDomain_30020F6E0BB1B4633BE7F9235A49EF95" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_97B1C52BC6F5403E9E4DF9235A4821D8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_30020F6E0BB1B4633BE7F9235A49EF95" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:label="loc_us-gaap_CashFlowHedgingMember_8FCC6336AC48E6B977A3F9235A49F4F6" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_30020F6E0BB1B4633BE7F9235A49EF95" xlink:to="loc_us-gaap_CashFlowHedgingMember_8FCC6336AC48E6B977A3F9235A49F4F6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_ED9CE89DFAAF4A69A21FF9235A4A4CA5" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:to="loc_us-gaap_HedgingDesignationAxis_ED9CE89DFAAF4A69A21FF9235A4A4CA5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_1886F11B2E83FCC6AE74F9235A4AFA44" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_ED9CE89DFAAF4A69A21FF9235A4A4CA5" xlink:to="loc_us-gaap_HedgingDesignationDomain_1886F11B2E83FCC6AE74F9235A4AFA44" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_A8DDF35CC80D9F6E08AAF9235A4CE517" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1886F11B2E83FCC6AE74F9235A4AFA44" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_A8DDF35CC80D9F6E08AAF9235A4CE517" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_C98617F568791FF51981F9235A4D2B9F" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:to="loc_us-gaap_RangeAxis_C98617F568791FF51981F9235A4D2B9F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_4A310A092CA85174472BF9235A4D3784" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_C98617F568791FF51981F9235A4D2B9F" xlink:to="loc_us-gaap_RangeMember_4A310A092CA85174472BF9235A4D3784" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_37A68940AAF27DF7E9CDF9235A4D2961" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_4A310A092CA85174472BF9235A4D3784" xlink:to="loc_us-gaap_MinimumMember_37A68940AAF27DF7E9CDF9235A4D2961" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_A2B2048587B0CD8C4FADF9235A4D0824" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_4A310A092CA85174472BF9235A4D3784" xlink:to="loc_us-gaap_MaximumMember_A2B2048587B0CD8C4FADF9235A4D0824" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_CF10B2DB7043500323E2F9235A4D4DE6" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_CF10B2DB7043500323E2F9235A4D4DE6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_C20B7FF208BDC84EB6C5F9235A4D94EB" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_CF10B2DB7043500323E2F9235A4D4DE6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_C20B7FF208BDC84EB6C5F9235A4D94EB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MediumTermNotesMember" xlink:label="loc_us-gaap_MediumTermNotesMember_DFC43FC62C705D78322CF9235A4FF807" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_C20B7FF208BDC84EB6C5F9235A4D94EB" xlink:to="loc_us-gaap_MediumTermNotesMember_DFC43FC62C705D78322CF9235A4FF807" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_FirstLienCreditAgreementMember" xlink:label="loc_ara_FirstLienCreditAgreementMember_F36F290400281FE197FAF9235A4F94D9" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_C20B7FF208BDC84EB6C5F9235A4D94EB" xlink:to="loc_ara_FirstLienCreditAgreementMember_F36F290400281FE197FAF9235A4F94D9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_8319702A3DE54675BEB3F9235A50F3D0" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_C20B7FF208BDC84EB6C5F9235A4D94EB" xlink:to="loc_us-gaap_LineOfCreditMember_8319702A3DE54675BEB3F9235A50F3D0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_740486C745605B96D165F9235A50D574" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_C20B7FF208BDC84EB6C5F9235A4D94EB" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_740486C745605B96D165F9235A50D574" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_55981916997BD94240CCF9235A504415" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:to="loc_us-gaap_DebtInstrumentAxis_55981916997BD94240CCF9235A504415" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0F8DDD0222B7F401730DF9235A50A973" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_55981916997BD94240CCF9235A504415" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0F8DDD0222B7F401730DF9235A50A973" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_FirstLienCreditAgreementSecondAmendmentMember" xlink:label="loc_ara_FirstLienCreditAgreementSecondAmendmentMember_EA3AD397D767B1B125CDF9235A50B9C6" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0F8DDD0222B7F401730DF9235A50A973" xlink:to="loc_ara_FirstLienCreditAgreementSecondAmendmentMember_EA3AD397D767B1B125CDF9235A50B9C6" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_FirstLienCreditAgreementMember" xlink:label="loc_ara_FirstLienCreditAgreementMember_C7C3AABFE3E366656DADF9235A521D12" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0F8DDD0222B7F401730DF9235A50A973" xlink:to="loc_ara_FirstLienCreditAgreementMember_C7C3AABFE3E366656DADF9235A521D12" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_TermBLoansDueSeptember2019Member" xlink:label="loc_ara_TermBLoansDueSeptember2019Member_77F64E24E875A9BBAA67F9235A522D47" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0F8DDD0222B7F401730DF9235A50A973" xlink:to="loc_ara_TermBLoansDueSeptember2019Member_77F64E24E875A9BBAA67F9235A522D47" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_51409E3720758E562D78F9235A52485E" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:to="loc_us-gaap_VariableRateAxis_51409E3720758E562D78F9235A52485E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_85B6DF2AA32EE4A73C23F9235A528A86" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_51409E3720758E562D78F9235A52485E" xlink:to="loc_us-gaap_VariableRateDomain_85B6DF2AA32EE4A73C23F9235A528A86" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FederalFundsEffectiveSwapRateMember" xlink:label="loc_us-gaap_FederalFundsEffectiveSwapRateMember_B2FD5BC147D617DD6F32F9235A53DCDD" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_85B6DF2AA32EE4A73C23F9235A528A86" xlink:to="loc_us-gaap_FederalFundsEffectiveSwapRateMember_B2FD5BC147D617DD6F32F9235A53DCDD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_7F27A9DF7ADC744905F4F9235A53438C" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_85B6DF2AA32EE4A73C23F9235A528A86" xlink:to="loc_us-gaap_EurodollarMember_7F27A9DF7ADC744905F4F9235A53438C" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_AlternateBaseRateMember" xlink:label="loc_ara_AlternateBaseRateMember_9EF81AB258FFA3D1C90CF9235A530935" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_85B6DF2AA32EE4A73C23F9235A528A86" xlink:to="loc_ara_AlternateBaseRateMember_9EF81AB258FFA3D1C90CF9235A530935" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_925EDC4F4145393F66F4F9235A536D85" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_85B6DF2AA32EE4A73C23F9235A528A86" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_925EDC4F4145393F66F4F9235A536D85" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_A50C47F75C2BF97119F7F9235A554AF9" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_A50C47F75C2BF97119F7F9235A554AF9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_C3B81FEBDB7F8F9C0839F9235A5566D1" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_A50C47F75C2BF97119F7F9235A554AF9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_C3B81FEBDB7F8F9C0839F9235A5566D1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateSwapMember" xlink:label="loc_us-gaap_InterestRateSwapMember_BF67FAA026B2DA1612A3F9235A55673A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_C3B81FEBDB7F8F9C0839F9235A5566D1" xlink:to="loc_us-gaap_InterestRateSwapMember_BF67FAA026B2DA1612A3F9235A55673A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCapMember" xlink:label="loc_us-gaap_InterestRateCapMember_AA773877111CB31B56BEF9235A564E37" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_C3B81FEBDB7F8F9C0839F9235A5566D1" xlink:to="loc_us-gaap_InterestRateCapMember_AA773877111CB31B56BEF9235A564E37" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_75D3EE892D2B9B504D51F9235A56022A" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:to="loc_us-gaap_CreditFacilityAxis_75D3EE892D2B9B504D51F9235A56022A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_76934A2FBEDF633CA6EEF9235A5677A4" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_75D3EE892D2B9B504D51F9235A56022A" xlink:to="loc_us-gaap_CreditFacilityDomain_76934A2FBEDF633CA6EEF9235A5677A4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_81A1CFD22B39451C2850F9235A569DD3" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_76934A2FBEDF633CA6EEF9235A5677A4" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_81A1CFD22B39451C2850F9235A569DD3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_D7C53DB9D90C83C23EA7F9235A48A898" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_F7E65C710D12CFC27C02F9235A586E90" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_F7E65C710D12CFC27C02F9235A586E90" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_E30C2751A4CA2D218F3EF9235A5807A8" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_E30C2751A4CA2D218F3EF9235A5807A8" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:label="loc_ara_LineOfCreditFacilityAccordionFeatureIncreaseLimit_BB269F238AB173C5BC41F9235A59952C" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_ara_LineOfCreditFacilityAccordionFeatureIncreaseLimit_BB269F238AB173C5BC41F9235A59952C" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_LineOfCreditFacilityAccordionFeatureIncreaseLimitPercentageOfConsolidatedEBITDA" xlink:label="loc_ara_LineOfCreditFacilityAccordionFeatureIncreaseLimitPercentageOfConsolidatedEBITDA_00F1E192EA2FBC386754F9235A599E84" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_ara_LineOfCreditFacilityAccordionFeatureIncreaseLimitPercentageOfConsolidatedEBITDA_00F1E192EA2FBC386754F9235A599E84" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_DebtIssuanceCostsDiscountAndTransactionCosts" xlink:label="loc_ara_DebtIssuanceCostsDiscountAndTransactionCosts_3A8E3D8C9A27419B0F0EF9235A591E56" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_ara_DebtIssuanceCostsDiscountAndTransactionCosts_3A8E3D8C9A27419B0F0EF9235A591E56" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_TransactionCosts" xlink:label="loc_ara_TransactionCosts_DAC6DAB37FD1B39AD57DF9235A59E23B" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_ara_TransactionCosts_DAC6DAB37FD1B39AD57DF9235A59E23B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1245B3AACDFF729C10C5F9235A5B64C7" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1245B3AACDFF729C10C5F9235A5B64C7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_762F38A2C8733B1CA89DF9235A5AAC3C" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_762F38A2C8733B1CA89DF9235A5AAC3C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_4378A0165D5E65B8231FF9235A5CEC1E" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_4378A0165D5E65B8231FF9235A5CEC1E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4472D0B2A75BDBCFD266F9235A5DA6EB" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4472D0B2A75BDBCFD266F9235A5DA6EB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2114CA7B12FF483D7A87F9235A5CF343" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2114CA7B12FF483D7A87F9235A5CF343" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_DebtInstrumentRequiredPrepayment" xlink:label="loc_ara_DebtInstrumentRequiredPrepayment_6AF37B366D1872318CBEF9235A5D904C" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_ara_DebtInstrumentRequiredPrepayment_6AF37B366D1872318CBEF9235A5D904C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_155111DD63D327BEBBD3F9235A5D93F5" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_155111DD63D327BEBBD3F9235A5D93F5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaap_LineOfCredit_4EB33AC7A9F6E7BFB75AF9235A5DAA7A" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_LineOfCredit_4EB33AC7A9F6E7BFB75AF9235A5DAA7A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_93863042ECDF7E176105F9235A5D497A" xlink:type="locator"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_93863042ECDF7E176105F9235A5D497A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_12CFF9543F2EF13036CBF9235A5D913F" xlink:type="locator"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_12CFF9543F2EF13036CBF9235A5D913F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_invest_DerivativeNotionalAmount_86041544D68185EE904CF9235A5EE925" xlink:type="locator"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_invest_DerivativeNotionalAmount_86041544D68185EE904CF9235A5EE925" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_58BE0C67589C9F1FA94EF9235A5F5BCE" xlink:type="locator"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_58BE0C67589C9F1FA94EF9235A5F5BCE" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOciIntoIncomePortionNet" xlink:label="loc_ara_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOciIntoIncomePortionNet_39D9CFA22E035E8D3870F9235A5FC4C7" xlink:type="locator"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_ara_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOciIntoIncomePortionNet_39D9CFA22E035E8D3870F9235A5FC4C7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_DD669856D63DE4552FBEF9235A609728" xlink:type="locator"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5236BB05679999803C7EF9235A58BECC" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_DD669856D63DE4552FBEF9235A609728" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/DebtScheduleOfLongTermTermDebtDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_037CA30EA4309C9E946BE46853BA4539" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_AC5B92487CE462960E65E46853BA560E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_037CA30EA4309C9E946BE46853BA4539" xlink:to="loc_us-gaap_DebtInstrumentTable_AC5B92487CE462960E65E46853BA560E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_F838A9E279099ED97B1FE46853BA8792" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_AC5B92487CE462960E65E46853BA560E" xlink:to="loc_us-gaap_RangeAxis_F838A9E279099ED97B1FE46853BA8792" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_65B179440322CD049513E46853BA8FC2" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_F838A9E279099ED97B1FE46853BA8792" xlink:to="loc_us-gaap_RangeMember_65B179440322CD049513E46853BA8FC2" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_896541C30350BE40CC23E46853BA2775" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_65B179440322CD049513E46853BA8FC2" xlink:to="loc_us-gaap_MinimumMember_896541C30350BE40CC23E46853BA2775" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_1ADA2081986D88F47DCEE46853BBDF42" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_65B179440322CD049513E46853BA8FC2" xlink:to="loc_us-gaap_MaximumMember_1ADA2081986D88F47DCEE46853BBDF42" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2C6DB32B3F2B8BA63841E46853BD13A8" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_AC5B92487CE462960E65E46853BA560E" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2C6DB32B3F2B8BA63841E46853BD13A8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_14AC1F38F71C0376E3F1E46853BD1562" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2C6DB32B3F2B8BA63841E46853BD13A8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_14AC1F38F71C0376E3F1E46853BD1562" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_FirstLienCreditAgreementMember" xlink:label="loc_ara_FirstLienCreditAgreementMember_54C961A3CB1E99F45DEDE46853BE1204" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_14AC1F38F71C0376E3F1E46853BD1562" xlink:to="loc_ara_FirstLienCreditAgreementMember_54C961A3CB1E99F45DEDE46853BE1204" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MediumTermNotesMember" xlink:label="loc_us-gaap_MediumTermNotesMember_331A7EFBB9B5F305E5A3E46853BE9316" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_14AC1F38F71C0376E3F1E46853BD1562" xlink:to="loc_us-gaap_MediumTermNotesMember_331A7EFBB9B5F305E5A3E46853BE9316" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_1455D2CAB9BAB37C398FE46853BE71FB" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_14AC1F38F71C0376E3F1E46853BD1562" xlink:to="loc_us-gaap_LineOfCreditMember_1455D2CAB9BAB37C398FE46853BE71FB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_945009E845D7FD5846F2E46853BE38EC" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_14AC1F38F71C0376E3F1E46853BD1562" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_945009E845D7FD5846F2E46853BE38EC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4DB83F2E48817B10C098E46853BEC45D" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_AC5B92487CE462960E65E46853BA560E" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4DB83F2E48817B10C098E46853BEC45D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3224AC783F9EF0121A5FE46853BFFD2E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4DB83F2E48817B10C098E46853BEC45D" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3224AC783F9EF0121A5FE46853BFFD2E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_04023EDD0F12097EFE50E46853C06946" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4DB83F2E48817B10C098E46853BEC45D" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_04023EDD0F12097EFE50E46853C06946" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_CD57783A727C009E37B8E46853C0E9E1" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4DB83F2E48817B10C098E46853BEC45D" xlink:to="loc_us-gaap_LongTermDebtCurrent_CD57783A727C009E37B8E46853C0E9E1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_35EF43AE7546B66244CFE46853C14520" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4DB83F2E48817B10C098E46853BEC45D" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_35EF43AE7546B66244CFE46853C14520" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_C338CD6C38CD53D394D3E46853C1BC94" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4DB83F2E48817B10C098E46853BEC45D" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_C338CD6C38CD53D394D3E46853C1BC94" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/DebtTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentsAbstract" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_693122251DEB11631A06BE3B436444E4" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_46B92C7A8E7D9CCF1136BE3B436408CE" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_693122251DEB11631A06BE3B436444E4" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_46B92C7A8E7D9CCF1136BE3B436408CE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_760AF940B57A8B8EA694BE3B4364C0C0" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_693122251DEB11631A06BE3B436444E4" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_760AF940B57A8B8EA694BE3B4364C0C0" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/DocumentAndEntityInformation" xlink:type="extended">
<link:loc xlink:href="ara-20171231.xsd#ara_DocumentAndEntityInformationAbstract" xlink:label="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_28FBD3CA79A3C1F0AD9CCA94C0EBC243" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_EntityRegistrantName_28FBD3CA79A3C1F0AD9CCA94C0EBC243" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_81E8853ECFA7B1516990CA94C0EB13A5" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_EntityCentralIndexKey_81E8853ECFA7B1516990CA94C0EB13A5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_03B4C049ADECE65ABF9ECA94C0EB4C0A" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_DocumentType_03B4C049ADECE65ABF9ECA94C0EB4C0A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_DA78AB6243926C19CF5ECA94C0EB6685" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_DocumentPeriodEndDate_DA78AB6243926C19CF5ECA94C0EB6685" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_892C2EF69722C4E0FB63CA94C0EC65C7" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_AmendmentFlag_892C2EF69722C4E0FB63CA94C0EC65C7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_9F0FC45A5B9038966886CA94C0EC3215" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_CurrentFiscalYearEndDate_9F0FC45A5B9038966886CA94C0EC3215" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_F016D53467D4600C85EFCA94C0EC79F6" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_F016D53467D4600C85EFCA94C0EC79F6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_3AEAFB853A24FD49E8CECA94C0EC274A" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_EntityVoluntaryFilers_3AEAFB853A24FD49E8CECA94C0EC274A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_F60AFD9909C5F51E6084CA94C0ECA3A3" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_EntityCurrentReportingStatus_F60AFD9909C5F51E6084CA94C0ECA3A3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_3D33EBB1D68F4A79A0C5CA94C0ECFFFD" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_EntityFilerCategory_3D33EBB1D68F4A79A0C5CA94C0ECFFFD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_D490465C396FD77CD505CA94C0EC474E" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_EntityPublicFloat_D490465C396FD77CD505CA94C0EC474E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9319C459A5427F17879CCA94C0ECDC47" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9319C459A5427F17879CCA94C0ECDC47" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_4A4A53A02A9C559D75E9CA94C0ECE1F6" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_DocumentFiscalYearFocus_4A4A53A02A9C559D75E9CA94C0ECE1F6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_500F447532151C7728DECA94C0ECAF12" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_DocumentAndEntityInformationAbstract_D549B64FB4266ADF5699CA94C0EB6EC8" xlink:to="loc_dei_DocumentFiscalPeriodFocus_500F447532151C7728DECA94C0ECAF12" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/EarningsLossPerShare" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4819B933461755F270FBF6A410776C9D" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_6DB29F58F3438ED2247AF6A41078803A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4819B933461755F270FBF6A410776C9D" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_6DB29F58F3438ED2247AF6A41078803A" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/EarningsLossPerShareDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_D49F9D06D889B0B81C2FC00408B53DD4" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_342DEE3E3968C146915FC00408B5E258" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_D49F9D06D889B0B81C2FC00408B53DD4" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_342DEE3E3968C146915FC00408B5E258" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_B4213D9B1C1ADE76A67CC00408B5F015" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_342DEE3E3968C146915FC00408B5E258" xlink:to="loc_us-gaap_NetIncomeLoss_B4213D9B1C1ADE76A67CC00408B5F015" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_2551F4EDF35AD282DC5BC00408B51EC8" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_342DEE3E3968C146915FC00408B5E258" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_2551F4EDF35AD282DC5BC00408B51EC8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_F30639959C9A8C3F3B32C00408B5EBCC" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_342DEE3E3968C146915FC00408B5E258" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_F30639959C9A8C3F3B32C00408B5EBCC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_B609CC2B2B6B65A7A667C00408B5FA8C" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_342DEE3E3968C146915FC00408B5E258" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_B609CC2B2B6B65A7A667C00408B5FA8C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_D4A06F196356CFE97F5EC00408B6F690" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_342DEE3E3968C146915FC00408B5E258" xlink:to="loc_us-gaap_EarningsPerShareBasic_D4A06F196356CFE97F5EC00408B6F690" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="loc_us-gaap_NetIncomeLossAbstract_F6EDAF1A44F83A5D1584C00408B6530A" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_D49F9D06D889B0B81C2FC00408B53DD4" xlink:to="loc_us-gaap_NetIncomeLossAbstract_F6EDAF1A44F83A5D1584C00408B6530A" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_F6EDAF1A44F83A5D1584C00408B6530A" xlink:to="loc_us-gaap_NetIncomeLoss_B4213D9B1C1ADE76A67CC00408B5F015" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_F6EDAF1A44F83A5D1584C00408B6530A" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_2551F4EDF35AD282DC5BC00408B51EC8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2C13E37654DA7FBC6BA0C00408B6FAFC" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_F6EDAF1A44F83A5D1584C00408B6530A" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2C13E37654DA7FBC6BA0C00408B6FAFC" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_F6EDAF1A44F83A5D1584C00408B6530A" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_B609CC2B2B6B65A7A667C00408B5FA8C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_CC77C23C2E2209EDD541C00408B6A4CF" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_D49F9D06D889B0B81C2FC00408B53DD4" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_CC77C23C2E2209EDD541C00408B6A4CF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_37A2C207B9F97E0154AAC00408B676D2" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_CC77C23C2E2209EDD541C00408B6A4CF" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_37A2C207B9F97E0154AAC00408B676D2" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80A9C5D4732CDB152DECC00408B6A358" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_CC77C23C2E2209EDD541C00408B6A4CF" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80A9C5D4732CDB152DECC00408B6A358" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_BFA197EA35F1E27A8D52C00408B67FA4" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_CC77C23C2E2209EDD541C00408B6A4CF" xlink:to="loc_us-gaap_EarningsPerShareDiluted_BFA197EA35F1E27A8D52C00408B67FA4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7242EA077CA829ED09EAC00408B6A26C" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_CC77C23C2E2209EDD541C00408B6A4CF" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7242EA077CA829ED09EAC00408B6A26C" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/EarningsLossPerShareTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_F52672F1669D15889FBABB4038A2AD73" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9654A495599767EDCFDFBB4038A2D607" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_F52672F1669D15889FBABB4038A2AD73" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9654A495599767EDCFDFBB4038A2D607" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/EmployeeBenefitPlan" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_DFB0C66458C4F6C83A41BB4037D1B233" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_CB832E0FB013D7773915BB4037D29328" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_DFB0C66458C4F6C83A41BB4037D1B233" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_CB832E0FB013D7773915BB4037D29328" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/EmployeeBenefitPlanDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0F51CE61016F3D7607CEE42A4EE4CC28" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_A950A022FD5295EFD4ADE42A4EE60D9D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0F51CE61016F3D7607CEE42A4EE4CC28" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_A950A022FD5295EFD4ADE42A4EE60D9D" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/Equity" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_A4F0047AF3ECAA295D43F6A4106D95F0" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_54E7308FFF30282F261AF6A4106D7306" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_A4F0047AF3ECAA295D43F6A4106D95F0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_54E7308FFF30282F261AF6A4106D7306" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/EquityDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_F0047C5B825DFFFDEF03BB40387EDECB" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_4A573F4D70B8C669FE9FBB40387FF1FE" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_F0047C5B825DFFFDEF03BB40387EDECB" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_4A573F4D70B8C669FE9FBB40387FF1FE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_277A4DE451A02E184641BB40387F618C" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_F0047C5B825DFFFDEF03BB40387EDECB" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_277A4DE451A02E184641BB40387F618C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6540CD0679A488702B38BB40387FCC31" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_F0047C5B825DFFFDEF03BB40387EDECB" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6540CD0679A488702B38BB40387FCC31" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_5CB5F18129BB63B92943BB40387FF329" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_F0047C5B825DFFFDEF03BB40387EDECB" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_5CB5F18129BB63B92943BB40387FF329" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_753CE5258ECB1C481159BB40387F2598" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_F0047C5B825DFFFDEF03BB40387EDECB" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_753CE5258ECB1C481159BB40387F2598" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0CF83126A52B1C0BB8E1BB40387FBC23" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_F0047C5B825DFFFDEF03BB40387EDECB" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0CF83126A52B1C0BB8E1BB40387FBC23" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_5E724A80EDDAC3E07CCEBB40387F51E7" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_F0047C5B825DFFFDEF03BB40387EDECB" xlink:to="loc_us-gaap_CommonStockSharesIssued_5E724A80EDDAC3E07CCEBB40387F51E7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_668D778F2D68A2A79136BB40387F6C59" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_F0047C5B825DFFFDEF03BB40387EDECB" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_668D778F2D68A2A79136BB40387F6C59" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9CACABB51894394339CDBB4038804524" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_F0047C5B825DFFFDEF03BB40387EDECB" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_9CACABB51894394339CDBB4038804524" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/FairValueMeasurements" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_C5FE2040EF93FD762236BB40399F906D" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_399F397953E3E0CB3057BB40399FA65F" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_C5FE2040EF93FD762236BB40399F906D" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_399F397953E3E0CB3057BB40399FA65F" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/FairValueMeasurementsFairValueRollforwardOfTaxReceivableAgreementLiabilityDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_B01364900A62BF6A9124E468550687FF" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_B5BDB48A0134EDAD6F14E46855067F35" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_B01364900A62BF6A9124E468550687FF" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_B5BDB48A0134EDAD6F14E46855067F35" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_A37B6EC1CD82DB2873CFE46855075BB1" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_B5BDB48A0134EDAD6F14E46855067F35" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_A37B6EC1CD82DB2873CFE46855075BB1" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityOptionsExercisedandDividendEquivalentPaymentVesting" xlink:label="loc_ara_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityOptionsExercisedandDividendEquivalentPaymentVesting_F674AE285A3AF374D73AE4685507A683" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_B5BDB48A0134EDAD6F14E46855067F35" xlink:to="loc_ara_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityOptionsExercisedandDividendEquivalentPaymentVesting_F674AE285A3AF374D73AE4685507A683" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarningsAbstract" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarningsAbstract_DFDA5461C4AB5766E07DE4685509CB45" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_B5BDB48A0134EDAD6F14E46855067F35" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarningsAbstract_DFDA5461C4AB5766E07DE4685509CB45" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_C8D8B7D9AC5E963F04CCE4685509D886" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarningsAbstract_DFDA5461C4AB5766E07DE4685509CB45" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_C8D8B7D9AC5E963F04CCE4685509D886" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_B8752CAAB8CEE9BC46F7E46855098554" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_B5BDB48A0134EDAD6F14E46855067F35" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_B8752CAAB8CEE9BC46F7E46855098554" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_09D76D54C1C991D27CB6C343FB53C21F" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_AB0FAFF8AAFB29ABD10EC343FB54F1A7" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_09D76D54C1C991D27CB6C343FB53C21F" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_AB0FAFF8AAFB29ABD10EC343FB54F1A7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5AD704FE2EE5887235BFC343FB54956F" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_AB0FAFF8AAFB29ABD10EC343FB54F1A7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5AD704FE2EE5887235BFC343FB54956F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4E2A5986943AE74F0D6EC343FB54B065" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5AD704FE2EE5887235BFC343FB54956F" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4E2A5986943AE74F0D6EC343FB54B065" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MediumTermNotesMember" xlink:label="loc_us-gaap_MediumTermNotesMember_2D8DA64F1CB596492B4DC343FB5477A8" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4E2A5986943AE74F0D6EC343FB54B065" xlink:to="loc_us-gaap_MediumTermNotesMember_2D8DA64F1CB596492B4DC343FB5477A8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LienCategoryAxis" xlink:label="loc_us-gaap_LienCategoryAxis_F3D047A9E994C85626DAC343FB5462EF" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_AB0FAFF8AAFB29ABD10EC343FB54F1A7" xlink:to="loc_us-gaap_LienCategoryAxis_F3D047A9E994C85626DAC343FB5462EF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LienCategoryDomain" xlink:label="loc_us-gaap_LienCategoryDomain_90C5F58F43F0AAE0CA59C343FB54B8CF" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LienCategoryAxis_F3D047A9E994C85626DAC343FB5462EF" xlink:to="loc_us-gaap_LienCategoryDomain_90C5F58F43F0AAE0CA59C343FB54B8CF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeniorLienMember" xlink:label="loc_us-gaap_SeniorLienMember_6F40554EC722D2FB8626C343FB540F00" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LienCategoryDomain_90C5F58F43F0AAE0CA59C343FB54B8CF" xlink:to="loc_us-gaap_SeniorLienMember_6F40554EC722D2FB8626C343FB540F00" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07A498E0B0FDA85110C3C343FB547B48" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_AB0FAFF8AAFB29ABD10EC343FB54F1A7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07A498E0B0FDA85110C3C343FB547B48" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F0493583167F194B6FCCC343FB54D95E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_07A498E0B0FDA85110C3C343FB547B48" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F0493583167F194B6FCCC343FB54D95E" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_FairValueAssetsBetweenLevel1Level2Level3TransfersAmount" xlink:label="loc_ara_FairValueAssetsBetweenLevel1Level2Level3TransfersAmount_BD0FF5A4624519192783C343FB541750" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F0493583167F194B6FCCC343FB54D95E" xlink:to="loc_ara_FairValueAssetsBetweenLevel1Level2Level3TransfersAmount_BD0FF5A4624519192783C343FB541750" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_AAA5C947F103EC022227C343FB543D90" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F0493583167F194B6FCCC343FB54D95E" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_AAA5C947F103EC022227C343FB543D90" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_61118D33B4412900B15FC343FB544AA6" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_F0493583167F194B6FCCC343FB54D95E" xlink:to="loc_us-gaap_DebtInstrumentFairValue_61118D33B4412900B15FC343FB544AA6" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/FairValueMeasurementsScheduleOfFairValueDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6208FE0F021637D0B961E46855258AD1" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8E1B171B6FB29836F139E4685525DDBA" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6208FE0F021637D0B961E46855258AD1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8E1B171B6FB29836F139E4685525DDBA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C7AB21D86EA74CE2EBF6E46855250376" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8E1B171B6FB29836F139E4685525DDBA" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C7AB21D86EA74CE2EBF6E46855250376" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4626A5963A7D8F0B5607E46855262B02" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_C7AB21D86EA74CE2EBF6E46855250376" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4626A5963A7D8F0B5607E46855262B02" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_C3A7251418F5C5B24F9FE468552623AB" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4626A5963A7D8F0B5607E46855262B02" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_C3A7251418F5C5B24F9FE468552623AB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_FF44D2BE55162F59C5D3E4685526E004" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8E1B171B6FB29836F139E4685525DDBA" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_FF44D2BE55162F59C5D3E4685526E004" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BABC0CB7BB3F2DCA4C75E4685526A3DA" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_FF44D2BE55162F59C5D3E4685526E004" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BABC0CB7BB3F2DCA4C75E4685526A3DA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_F4BD8B1109D436FF4D8EE4685528B8FE" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BABC0CB7BB3F2DCA4C75E4685526A3DA" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_F4BD8B1109D436FF4D8EE4685528B8FE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_57512023808CF3BEE7B1E46855295A3E" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BABC0CB7BB3F2DCA4C75E4685526A3DA" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_57512023808CF3BEE7B1E46855295A3E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_11DCCCBD52DDACAC1C0AE46855295785" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_BABC0CB7BB3F2DCA4C75E4685526A3DA" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_11DCCCBD52DDACAC1C0AE46855295785" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_E28554AE66483FAD3795E468552ADAE9" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8E1B171B6FB29836F139E4685525DDBA" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_E28554AE66483FAD3795E468552ADAE9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_759D9BA026CB36D672CAE468552A566D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_E28554AE66483FAD3795E468552ADAE9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_759D9BA026CB36D672CAE468552A566D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_BB46FF6B33054F58ABF4E468552AF010" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_759D9BA026CB36D672CAE468552A566D" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_BB46FF6B33054F58ABF4E468552AF010" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_158229ADAC7A93F16054E468552CBEE2" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_759D9BA026CB36D672CAE468552A566D" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_158229ADAC7A93F16054E468552CBEE2" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_IncomeTaxReceivableAgreementPayableMember" xlink:label="loc_ara_IncomeTaxReceivableAgreementPayableMember_E9E2B5C7F3ECF953BCCEE468552CB888" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_759D9BA026CB36D672CAE468552A566D" xlink:to="loc_ara_IncomeTaxReceivableAgreementPayableMember_E9E2B5C7F3ECF953BCCEE468552CB888" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_F0437FA6EEB46FBC264FE468552CF3C4" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_759D9BA026CB36D672CAE468552A566D" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_F0437FA6EEB46FBC264FE468552CF3C4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_160936E41FA6EA7F2E93E468552C624D" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_759D9BA026CB36D672CAE468552A566D" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_160936E41FA6EA7F2E93E468552C624D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34A7B2E72193E4D30F63E468552C7B71" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8E1B171B6FB29836F139E4685525DDBA" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34A7B2E72193E4D30F63E468552C7B71" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeAssets" xlink:label="loc_us-gaap_DerivativeAssets_86A483C1C58B94D9FC47E468552DAE51" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34A7B2E72193E4D30F63E468552C7B71" xlink:to="loc_us-gaap_DerivativeAssets_86A483C1C58B94D9FC47E468552DAE51" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_0883AD8D54DC53535A9CE468552DC4FD" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34A7B2E72193E4D30F63E468552C7B71" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_0883AD8D54DC53535A9CE468552DC4FD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaap_DerivativeLiabilities_E8B094A14812BDFF66DCE468552DF2AE" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34A7B2E72193E4D30F63E468552C7B71" xlink:to="loc_us-gaap_DerivativeLiabilities_E8B094A14812BDFF66DCE468552DF2AE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_A815F7BC5C691F0ECA74E468552D2109" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34A7B2E72193E4D30F63E468552C7B71" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_A815F7BC5C691F0ECA74E468552D2109" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_79A2DA93DC58158128F7E468552FB353" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_34A7B2E72193E4D30F63E468552C7B71" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_79A2DA93DC58158128F7E468552FB353" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/FairValueMeasurementsTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1FD6B61C0DA03434A54EBB40399C92AB" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_412E483A12D5CD8D40C6BB40399C1E98" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1FD6B61C0DA03434A54EBB40399C92AB" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_412E483A12D5CD8D40C6BB40399C1E98" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_C0E9DDE548A970D1D65BBB40399C918D" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1FD6B61C0DA03434A54EBB40399C92AB" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_C0E9DDE548A970D1D65BBB40399C918D" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IncomeTaxes" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_31FC776D14C3BAD53080F6A4109372D6" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_A0AFB3CE4F1803AC219DF6A410934AFB" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31FC776D14C3BAD53080F6A4109372D6" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_A0AFB3CE4F1803AC219DF6A410934AFB" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IncomeTaxesIncomeTaxesNarrativeDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_EC1CA7F7A09B4F211AD4E421FDA23D32" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_BF871335CF55CE123C0EE421FDA2DDBD" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_EC1CA7F7A09B4F211AD4E421FDA23D32" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_BF871335CF55CE123C0EE421FDA2DDBD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_6EE4B726F06663F6D6B8E421FDA38C6D" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_EC1CA7F7A09B4F211AD4E421FDA23D32" xlink:to="loc_us-gaap_DeferredTaxAssetsCharitableContributionCarryforwards_6EE4B726F06663F6D6B8E421FDA38C6D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_A8C52EA3F083DD918C9BE421FDA314B4" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_EC1CA7F7A09B4F211AD4E421FDA23D32" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_A8C52EA3F083DD918C9BE421FDA314B4" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ara_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_83B4276D775B027CFF27E421FDA35779" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_EC1CA7F7A09B4F211AD4E421FDA23D32" xlink:to="loc_ara_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_83B4276D775B027CFF27E421FDA35779" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IncomeTaxesProvisionBenefitForIncomeTaxesDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_FB9AF68C5EABCB25F9B1BB4038D53905" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_84912A356A4C7450546CBB4038D5D389" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_FB9AF68C5EABCB25F9B1BB4038D53905" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_84912A356A4C7450546CBB4038D5D389" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_3C3222CE8759F00CC9D0BB4038DA4911" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_84912A356A4C7450546CBB4038D5D389" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_3C3222CE8759F00CC9D0BB4038DA4911" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_38EBDA09F1605F6DA79EBB4038DBF7DE" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_3C3222CE8759F00CC9D0BB4038DA4911" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_38EBDA09F1605F6DA79EBB4038DBF7DE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2C082A17BAA9788BF2A1BB4038DB807B" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_3C3222CE8759F00CC9D0BB4038DA4911" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2C082A17BAA9788BF2A1BB4038DB807B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_3B2C404B18460740447CBB4038DB237A" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_3C3222CE8759F00CC9D0BB4038DA4911" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_3B2C404B18460740447CBB4038DB237A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_28B71A71018E64FDFBB7BB4038DB8AB6" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_84912A356A4C7450546CBB4038D5D389" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_28B71A71018E64FDFBB7BB4038DB8AB6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_20124DAB039ABFF0F6A0BB4038DB2310" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_28B71A71018E64FDFBB7BB4038DB8AB6" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_20124DAB039ABFF0F6A0BB4038DB2310" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E599AC193968AF1B6BB8BB4038DBD44D" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_28B71A71018E64FDFBB7BB4038DB8AB6" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_E599AC193968AF1B6BB8BB4038DBD44D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2FF78E851EEA20EB40A5BB4038DB6F44" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_28B71A71018E64FDFBB7BB4038DB8AB6" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2FF78E851EEA20EB40A5BB4038DB6F44" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_37C093C0920ED9ED9A6DBB4038DCFA36" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_84912A356A4C7450546CBB4038D5D389" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_37C093C0920ED9ED9A6DBB4038DCFA36" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IncomeTaxesReconciliationOfFederalStatutoryRateDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_946A78087E9D24800F8FC0CA9AF75CF5" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_E20A90E055AA70AA6334C0CA9AF7AABD" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_946A78087E9D24800F8FC0CA9AF75CF5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_E20A90E055AA70AA6334C0CA9AF7AABD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_42C2A8A6C5DE626FF4D9C0CA9AF71C94" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_E20A90E055AA70AA6334C0CA9AF7AABD" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_42C2A8A6C5DE626FF4D9C0CA9AF71C94" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_IncreaseDecreaseInEffectiveIncomeTaxRateReconciliationPercentAbstract" xlink:label="loc_ara_IncreaseDecreaseInEffectiveIncomeTaxRateReconciliationPercentAbstract_C3E2D625CD2E827C41F1C0CA9AF7A579" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_946A78087E9D24800F8FC0CA9AF75CF5" xlink:to="loc_ara_IncreaseDecreaseInEffectiveIncomeTaxRateReconciliationPercentAbstract_C3E2D625CD2E827C41F1C0CA9AF7A579" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_438D20E8C115EA8B11E7C0CA9AF7CD92" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_IncreaseDecreaseInEffectiveIncomeTaxRateReconciliationPercentAbstract_C3E2D625CD2E827C41F1C0CA9AF7A579" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_438D20E8C115EA8B11E7C0CA9AF7CD92" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_7D8DC7A95E2DD2C17149C0CA9AF7201F" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_IncreaseDecreaseInEffectiveIncomeTaxRateReconciliationPercentAbstract_C3E2D625CD2E827C41F1C0CA9AF7A579" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_7D8DC7A95E2DD2C17149C0CA9AF7201F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_3339BBD9F09E0AE1F4D9C0DCBB9762CE" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_IncreaseDecreaseInEffectiveIncomeTaxRateReconciliationPercentAbstract_C3E2D625CD2E827C41F1C0CA9AF7A579" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_3339BBD9F09E0AE1F4D9C0DCBB9762CE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_0E41C1D6688A29236FFDC0CA9AF79B2B" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_IncreaseDecreaseInEffectiveIncomeTaxRateReconciliationPercentAbstract_C3E2D625CD2E827C41F1C0CA9AF7A579" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_0E41C1D6688A29236FFDC0CA9AF79B2B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_60ABC4039CA596BA53CAC0CA9AF8DE3C" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_946A78087E9D24800F8FC0CA9AF75CF5" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_60ABC4039CA596BA53CAC0CA9AF8DE3C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_B0A09D55CA2CF3AEAE56C0CA9AF8FBAE" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_946A78087E9D24800F8FC0CA9AF75CF5" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_B0A09D55CA2CF3AEAE56C0CA9AF8FBAE" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5939510E89F450940065F6A41087FF69" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5939510E89F450940065F6A41087FF69" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5884D7E8689319EEFAC4F6A41087FD3D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5884D7E8689319EEFAC4F6A41087FD3D" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_DeferredTaxAssetsLeases" xlink:label="loc_ara_DeferredTaxAssetsLeases_02B9F9D13C6972422664F6A410878DC0" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_ara_DeferredTaxAssetsLeases_02B9F9D13C6972422664F6A410878DC0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_748677896F6BF2CEABA7F6A4108718DA" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_748677896F6BF2CEABA7F6A4108718DA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_7A2404C3ACF07E166759F6A4108779FD" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_7A2404C3ACF07E166759F6A4108779FD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_BDBCC74C56ECD549DF2BF6A410873B1C" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_BDBCC74C56ECD549DF2BF6A410873B1C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsDerivativeInstruments" xlink:label="loc_us-gaap_DeferredTaxAssetsDerivativeInstruments_76D3038CD67A52B7FD28F6A41088B611" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxAssetsDerivativeInstruments_76D3038CD67A52B7FD28F6A41088B611" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_F28EF1E6F0F72D209A16F6A410886806" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_F28EF1E6F0F72D209A16F6A410886806" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_36D4BD7ACDFC60224CFAF6A41088E1C3" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_36D4BD7ACDFC60224CFAF6A41088E1C3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_9891C63EF186720450B0F6A41088AE6C" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_9891C63EF186720450B0F6A41088AE6C" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_DeferredTaxLiabilitiesInvestmentInJointVentures" xlink:label="loc_ara_DeferredTaxLiabilitiesInvestmentInJointVentures_5CA33CB8CE137FFF5041F6A410884F65" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_ara_DeferredTaxLiabilitiesInvestmentInJointVentures_5CA33CB8CE137FFF5041F6A410884F65" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_6A0AD912EEC229342B87F6A41088950E" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_6A0AD912EEC229342B87F6A41088950E" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_ara_DeferredTaxLiabilitiesDepreciation_EF00B2F4CB73F9C008DDF6A41088B888" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_ara_DeferredTaxLiabilitiesDepreciation_EF00B2F4CB73F9C008DDF6A41088B888" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDerivatives" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDerivatives_73C4F1D4590B22E4DD39F6A41088309B" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDerivatives_73C4F1D4590B22E4DD39F6A41088309B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_56B887D9B78ACEC55D88F6A41088581F" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_56B887D9B78ACEC55D88F6A41088581F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_85BBE83C810FF12AB4E3F6A4108804DE" xlink:type="locator"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_571DE0163791BA6EE1DFF6A410875680" xlink:to="loc_us-gaap_DeferredTaxLiabilities_85BBE83C810FF12AB4E3F6A4108804DE" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IncomeTaxesTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6850822D8B7E6E975CE4BB4038DFE147" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_77D826F6FC874BF2088FBB4038E0E4E9" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6850822D8B7E6E975CE4BB4038DFE147" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_77D826F6FC874BF2088FBB4038E0E4E9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_03F86E3C63442AB6A9C0BB4038E009D5" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6850822D8B7E6E975CE4BB4038DFE147" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_03F86E3C63442AB6A9C0BB4038E009D5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_BD8D92BDBBF386B5B11BBB4038E09D76" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6850822D8B7E6E975CE4BB4038DFE147" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_BD8D92BDBBF386B5B11BBB4038E09D76" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/InitialPublicOffering" xlink:type="extended">
<link:loc xlink:href="ara-20171231.xsd#ara_InitialPublicOfferingDisclosureAbstract" xlink:label="loc_ara_InitialPublicOfferingDisclosureAbstract_A9C5133CFC7125CCFFBEBB4039D0DC70" xlink:type="locator"/>
<link:loc xlink:href="ara-20171231.xsd#ara_InitialPublicOfferingDisclosureTextBlock" xlink:label="loc_ara_InitialPublicOfferingDisclosureTextBlock_004DBA9FF3543531E501BB4039D09FD0" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_InitialPublicOfferingDisclosureAbstract_A9C5133CFC7125CCFFBEBB4039D0DC70" xlink:to="loc_ara_InitialPublicOfferingDisclosureTextBlock_004DBA9FF3543531E501BB4039D09FD0" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/InitialPublicOfferingDetails" xlink:type="extended">
<link:loc xlink:href="ara-20171231.xsd#ara_InitialPublicOfferingDisclosureAbstract" xlink:label="loc_ara_InitialPublicOfferingDisclosureAbstract_157EDD4DCD1E322015E8C343FBC25F0A" xlink:type="locator"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ScheduleofInitialPublicOfferingTable" xlink:label="loc_ara_ScheduleofInitialPublicOfferingTable_8757A4997772FC44830CC343FBC253B2" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_InitialPublicOfferingDisclosureAbstract_157EDD4DCD1E322015E8C343FBC25F0A" xlink:to="loc_ara_ScheduleofInitialPublicOfferingTable_8757A4997772FC44830CC343FBC253B2" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_F58F653F6442A278B63AC343FBC2DE23" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingTable_8757A4997772FC44830CC343FBC253B2" xlink:to="loc_dei_LegalEntityAxis_F58F653F6442A278B63AC343FBC2DE23" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_F37B644DBEBDD4EBACE0C343FBC39C2B" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_F58F653F6442A278B63AC343FBC2DE23" xlink:to="loc_dei_EntityDomain_F37B644DBEBDD4EBACE0C343FBC39C2B" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_TermLoanHoldingsLLCMember" xlink:label="loc_ara_TermLoanHoldingsLLCMember_C87AEBDCC7A64BDD50F8C343FBC36B4B" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_F37B644DBEBDD4EBACE0C343FBC39C2B" xlink:to="loc_ara_TermLoanHoldingsLLCMember_C87AEBDCC7A64BDD50F8C343FBC36B4B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_AA68E992F7B90BEBAB6BC343FBC3AF8E" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingTable_8757A4997772FC44830CC343FBC253B2" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_AA68E992F7B90BEBAB6BC343FBC3AF8E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_666555BDF4DEAC5F9B66C343FBC3DED7" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_AA68E992F7B90BEBAB6BC343FBC3AF8E" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_666555BDF4DEAC5F9B66C343FBC3DED7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_56833E16F400F47E49FDC343FBC35083" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_666555BDF4DEAC5F9B66C343FBC3DED7" xlink:to="loc_us-gaap_IPOMember_56833E16F400F47E49FDC343FBC35083" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_VestedOptionStockholdersMember" xlink:label="loc_ara_VestedOptionStockholdersMember_1523A9DEA0FC652C9BFCC343FBC33B50" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_666555BDF4DEAC5F9B66C343FBC3DED7" xlink:to="loc_ara_VestedOptionStockholdersMember_1523A9DEA0FC652C9BFCC343FBC33B50" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_UnvestedOptionStockholdersMember" xlink:label="loc_ara_UnvestedOptionStockholdersMember_74C330D2CBD1ECE292E3C343FBC3F084" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_666555BDF4DEAC5F9B66C343FBC3DED7" xlink:to="loc_ara_UnvestedOptionStockholdersMember_74C330D2CBD1ECE292E3C343FBC3F084" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_5DB3C8F27DE635608E52C343FBC37759" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingTable_8757A4997772FC44830CC343FBC253B2" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_5DB3C8F27DE635608E52C343FBC37759" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_FA5662F7BD8F41405B55C343FBC3A1C4" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_5DB3C8F27DE635608E52C343FBC37759" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_FA5662F7BD8F41405B55C343FBC3A1C4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LoansPayableMember" xlink:label="loc_us-gaap_LoansPayableMember_2036F4404899D5A2313DC343FBC34A21" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_FA5662F7BD8F41405B55C343FBC3A1C4" xlink:to="loc_us-gaap_LoansPayableMember_2036F4404899D5A2313DC343FBC34A21" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_372BE690F3F4B2127F2DC343FBC3C6B9" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingTable_8757A4997772FC44830CC343FBC253B2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_372BE690F3F4B2127F2DC343FBC3C6B9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="loc_us-gaap_LossContingencyNatureDomain_E203E29E7A88C4E1C4B0C343FBC39726" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_372BE690F3F4B2127F2DC343FBC3C6B9" xlink:to="loc_us-gaap_LossContingencyNatureDomain_E203E29E7A88C4E1C4B0C343FBC39726" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeOfIndebtednessOfOthersMember" xlink:label="loc_us-gaap_GuaranteeOfIndebtednessOfOthersMember_1B20D169954BE78F3E62C343FBC3D909" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_E203E29E7A88C4E1C4B0C343FBC39726" xlink:to="loc_us-gaap_GuaranteeOfIndebtednessOfOthersMember_1B20D169954BE78F3E62C343FBC3D909" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_D7F4D4A823F9FE1B7388C343FBC421F8" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingTable_8757A4997772FC44830CC343FBC253B2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_D7F4D4A823F9FE1B7388C343FBC421F8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9BFC24DE8D60386A22C4C343FBC42567" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_D7F4D4A823F9FE1B7388C343FBC421F8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9BFC24DE8D60386A22C4C343FBC42567" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_SecondLienCreditAgreementMember" xlink:label="loc_ara_SecondLienCreditAgreementMember_9188B536DAC5F5754DDBC343FBC480A4" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9BFC24DE8D60386A22C4C343FBC42567" xlink:to="loc_ara_SecondLienCreditAgreementMember_9188B536DAC5F5754DDBC343FBC480A4" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_FirstLienCreditAgreementMember" xlink:label="loc_ara_FirstLienCreditAgreementMember_144DE402216040C5BD18C343FBC4262A" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9BFC24DE8D60386A22C4C343FBC42567" xlink:to="loc_ara_FirstLienCreditAgreementMember_144DE402216040C5BD18C343FBC4262A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MediumTermNotesMember" xlink:label="loc_us-gaap_MediumTermNotesMember_4E85B103F5B262D50FE8C343FBC4856A" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9BFC24DE8D60386A22C4C343FBC42567" xlink:to="loc_us-gaap_MediumTermNotesMember_4E85B103F5B262D50FE8C343FBC4856A" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ScheduleofInitialPublicOfferingLineItems" xlink:label="loc_ara_ScheduleofInitialPublicOfferingLineItems_5FF52D96771874CA2C2EC343FBC44F24" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingTable_8757A4997772FC44830CC343FBC253B2" xlink:to="loc_ara_ScheduleofInitialPublicOfferingLineItems_5FF52D96771874CA2C2EC343FBC44F24" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_AF5B7A85CD6810D1B894C343FBC4CD0A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingLineItems_5FF52D96771874CA2C2EC343FBC44F24" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_AF5B7A85CD6810D1B894C343FBC4CD0A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_02713FC679F0279DEB6DC343FBC4D792" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingLineItems_5FF52D96771874CA2C2EC343FBC44F24" xlink:to="loc_us-gaap_SharePrice_02713FC679F0279DEB6DC343FBC4D792" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_E34498994C5BE842D61AC343FBC44600" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingLineItems_5FF52D96771874CA2C2EC343FBC44F24" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_E34498994C5BE842D61AC343FBC44600" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_TransactionCosts" xlink:label="loc_ara_TransactionCosts_C0C175F884768E0C3778C343FBC5F9EE" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingLineItems_5FF52D96771874CA2C2EC343FBC44F24" xlink:to="loc_ara_TransactionCosts_C0C175F884768E0C3778C343FBC5F9EE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_569FB828E1E8D323D53BC343FBC5B10A" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingLineItems_5FF52D96771874CA2C2EC343FBC44F24" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_569FB828E1E8D323D53BC343FBC5B10A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_03B73AA7F895460E2D96C343FBC5659F" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_569FB828E1E8D323D53BC343FBC5B10A" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_03B73AA7F895460E2D96C343FBC5659F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_644F00FB4A092B5AD407C343FBC52D6A" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_569FB828E1E8D323D53BC343FBC5B10A" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_644F00FB4A092B5AD407C343FBC52D6A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_2C243F2618B7959EE5AFC343FBC52496" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_569FB828E1E8D323D53BC343FBC5B10A" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_2C243F2618B7959EE5AFC343FBC52496" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrentAbstract" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrentAbstract_56ED8BEB5D677882321CC343FBC57704" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingLineItems_5FF52D96771874CA2C2EC343FBC44F24" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrentAbstract_56ED8BEB5D677882321CC343FBC57704" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NotesPayableCurrentAndNoncurrent" xlink:label="loc_ara_NotesPayableCurrentAndNoncurrent_571AE139F8E125015CA0C343FBC5CA89" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrentAbstract_56ED8BEB5D677882321CC343FBC57704" xlink:to="loc_ara_NotesPayableCurrentAndNoncurrent_571AE139F8E125015CA0C343FBC5CA89" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ClinicLoanGuarantee" xlink:label="loc_ara_ClinicLoanGuarantee_C2DB19A1477E46B36C34C343FBC5C3E9" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrentAndNoncurrentAbstract_56ED8BEB5D677882321CC343FBC57704" xlink:to="loc_ara_ClinicLoanGuarantee_C2DB19A1477E46B36C34C343FBC5C3E9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ScheduleofInitialPublicOfferingLineItems_5FF52D96771874CA2C2EC343FBC44F24" xlink:to="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_FA7B241DE69928267D47C343FBC5240E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_FA7B241DE69928267D47C343FBC5240E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ED3A0887839FA4C66C0AC343FBC50F50" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ED3A0887839FA4C66C0AC343FBC50F50" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_D1B802273F8FD2A09793C343FBC57E18" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_us-gaap_DebtInstrumentInterestRateIncreaseDecrease_D1B802273F8FD2A09793C343FBC57E18" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_DC8C2A878B175502A077C343FBC5F958" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_DC8C2A878B175502A077C343FBC5F958" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsCurrentNet_C31DF4B4589B4C0B3ACDC343FBC6B351" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_us-gaap_DeferredFinanceCostsCurrentNet_C31DF4B4589B4C0B3ACDC343FBC6B351" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_430A2125BEB306BE7191C343FBC6CF63" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_430A2125BEB306BE7191C343FBC6CF63" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PercentageTaxSavingsPayableToStockholders" xlink:label="loc_ara_PercentageTaxSavingsPayableToStockholders_1923758E4AF77A22DDA0C343FBC668AC" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_ara_PercentageTaxSavingsPayableToStockholders_1923758E4AF77A22DDA0C343FBC668AC" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_IncomeTaxReceivableAgreementLiabilityTotal" xlink:label="loc_ara_IncomeTaxReceivableAgreementLiabilityTotal_E5D3613F4C05020C0DB7C343FBC67F85" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_ara_IncomeTaxReceivableAgreementLiabilityTotal_E5D3613F4C05020C0DB7C343FBC67F85" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_IncomeTaxReceivableAgreementLiabilityCurrent" xlink:label="loc_ara_IncomeTaxReceivableAgreementLiabilityCurrent_2FF8E96375B40E8511EBC343FBC63EEC" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_ara_IncomeTaxReceivableAgreementLiabilityCurrent_2FF8E96375B40E8511EBC343FBC63EEC" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PaymentsOnTaxReceivableAgreement" xlink:label="loc_ara_PaymentsOnTaxReceivableAgreement_34DAE1D41A19358C1AF7C343FBC66E26" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_ara_PaymentsOnTaxReceivableAgreement_34DAE1D41A19358C1AF7C343FBC66E26" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_DividendsCashPerShare" xlink:label="loc_ara_DividendsCashPerShare_257CFECEE6E567061059C343FBC61AE7" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_ara_DividendsCashPerShare_257CFECEE6E567061059C343FBC61AE7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DividendsCash" xlink:label="loc_us-gaap_DividendsCash_E6E06C4E0594DFE6D0EFC343FBC6E8F0" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_us-gaap_DividendsCash_E6E06C4E0594DFE6D0EFC343FBC6E8F0" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_EquitableAdjustmentCashDividendEquivalentPaymentPerShare" xlink:label="loc_ara_EquitableAdjustmentCashDividendEquivalentPaymentPerShare_3762B706C0DB815EC4BEC343FBC6EF43" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_ara_EquitableAdjustmentCashDividendEquivalentPaymentPerShare_3762B706C0DB815EC4BEC343FBC6EF43" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_EquitableAdjustmentCashDividendEquivalentPayment" xlink:label="loc_ara_EquitableAdjustmentCashDividendEquivalentPayment_FC2A9FD996BE2CBF0105C343FBC6A067" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_ara_EquitableAdjustmentCashDividendEquivalentPayment_FC2A9FD996BE2CBF0105C343FBC6A067" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_68B70209AB79F5C8D239C343FBC6CCAF" xlink:type="locator"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_68B70209AB79F5C8D239C343FBC6CCAF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_E72601545011BC82E2A6C343FBC6400C" xlink:type="locator"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_E72601545011BC82E2A6C343FBC6400C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_B51177CF20F009A7BC85C343FBC6EC3D" xlink:type="locator"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseNetAbstract_F00C02F9B4169FEE8FEEC343FBC5665E" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_B51177CF20F009A7BC85C343FBC6EC3D" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IntangibleAssetsAndGoodwill" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_CBA4E1D73CC87298E25DF6A4110F0E6E" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_88FFAA7DBD76CCC2520EF6A4110FA9FC" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_CBA4E1D73CC87298E25DF6A4110F0E6E" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_88FFAA7DBD76CCC2520EF6A4110FA9FC" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IntangibleAssetsAndGoodwillChangesInValueOfGoodwilllDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_769DE550585EDB0E2520BE3B43E80BEA" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillRollForward" xlink:label="loc_us-gaap_GoodwillRollForward_C8FDA71489321D8E8C55BE3B43E864B7" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_769DE550585EDB0E2520BE3B43E80BEA" xlink:to="loc_us-gaap_GoodwillRollForward_C8FDA71489321D8E8C55BE3B43E864B7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_088C31A8875AEECABC7EBE3B43E8DB88" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_C8FDA71489321D8E8C55BE3B43E864B7" xlink:to="loc_us-gaap_Goodwill_088C31A8875AEECABC7EBE3B43E8DB88" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_592088729F292B6D2696BE3B43E8AE71" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_C8FDA71489321D8E8C55BE3B43E864B7" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_592088729F292B6D2696BE3B43E8AE71" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillSubsequentRecognitionOfDeferredTaxAsset" xlink:label="loc_us-gaap_GoodwillSubsequentRecognitionOfDeferredTaxAsset_6FCDDD8E6831E92DE9ECBE3B43E938B3" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_C8FDA71489321D8E8C55BE3B43E864B7" xlink:to="loc_us-gaap_GoodwillSubsequentRecognitionOfDeferredTaxAsset_6FCDDD8E6831E92DE9ECBE3B43E938B3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_3346AD8A459491D0B903BF46F2B539C1" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_C8FDA71489321D8E8C55BE3B43E864B7" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_3346AD8A459491D0B903BF46F2B539C1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_17F18E7A4CAFF1C834D9BE3B43E94473" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_C8FDA71489321D8E8C55BE3B43E864B7" xlink:to="loc_us-gaap_Goodwill_17F18E7A4CAFF1C834D9BE3B43E94473" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IntangibleAssetsAndGoodwillEstimatedAnnualAmortizationExpenseDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0CD26B25FF5558D2AB9BBB40396BF347" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_CEF2EB53D92984D1663FBB40396B0C76" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0CD26B25FF5558D2AB9BBB40396BF347" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_CEF2EB53D92984D1663FBB40396B0C76" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_68CD7C17DC773193A9AABB40396C416B" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_CEF2EB53D92984D1663FBB40396B0C76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_68CD7C17DC773193A9AABB40396C416B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_C357E1A14D8D9CC73E8EBB40396CC468" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_CEF2EB53D92984D1663FBB40396B0C76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_C357E1A14D8D9CC73E8EBB40396CC468" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EB52D2ED1B42B284E9B8BB40396CC916" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_CEF2EB53D92984D1663FBB40396B0C76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_EB52D2ED1B42B284E9B8BB40396CC916" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0AAB874376C4B1FD5B73BB40396C0A8A" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_CEF2EB53D92984D1663FBB40396B0C76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0AAB874376C4B1FD5B73BB40396C0A8A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5CF9C491AB650C178BB4BB40396C0C70" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_CEF2EB53D92984D1663FBB40396B0C76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_5CF9C491AB650C178BB4BB40396C0C70" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C8FDE995B6D1E2A9CDB4BB40396C6B1F" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_CEF2EB53D92984D1663FBB40396B0C76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C8FDE995B6D1E2A9CDB4BB40396C6B1F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_B1A15E9E3F5EB5B27A47BB40396C4F0F" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_CEF2EB53D92984D1663FBB40396B0C76" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_B1A15E9E3F5EB5B27A47BB40396C4F0F" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_E28A6FCADF6A07E88CB9E46854D6E651" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_AC47B96B2DF91FE38D91E46854D79F46" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_E28A6FCADF6A07E88CB9E46854D6E651" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_AC47B96B2DF91FE38D91E46854D79F46" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6DD8A65EA0861FC8FEC3E46854D74EA0" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_AC47B96B2DF91FE38D91E46854D79F46" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6DD8A65EA0861FC8FEC3E46854D74EA0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CD127A96F8309996C04E46854D7DE79" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6DD8A65EA0861FC8FEC3E46854D74EA0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CD127A96F8309996C04E46854D7DE79" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_629D7BA90CDAA30F78E2E46854D7C65C" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CD127A96F8309996C04E46854D7DE79" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_629D7BA90CDAA30F78E2E46854D7C65C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_74EBCCB410A997DDE493E46854D77A8A" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8CD127A96F8309996C04E46854D7DE79" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_74EBCCB410A997DDE493E46854D77A8A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_96E8E3A9CD9308771B5AE46854D97690" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_AC47B96B2DF91FE38D91E46854D79F46" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_96E8E3A9CD9308771B5AE46854D97690" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_216ED36F4D6DDDD5D795E46854D99D23" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_96E8E3A9CD9308771B5AE46854D97690" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_216ED36F4D6DDDD5D795E46854D99D23" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_418E64B88E55489EC095E46854DABABF" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_216ED36F4D6DDDD5D795E46854D99D23" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_418E64B88E55489EC095E46854DABABF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0BF83F97E205680CBD92E46854DA1D25" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_AC47B96B2DF91FE38D91E46854D79F46" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0BF83F97E205680CBD92E46854DA1D25" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_7967A8A290513B0C8A8CE46854DAC980" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0BF83F97E205680CBD92E46854DA1D25" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_7967A8A290513B0C8A8CE46854DAC980" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedNoncompeteAgreementsGross" xlink:label="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross_2B7A3C07A2D90A75A8DAE46854DBDBAE" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_7967A8A290513B0C8A8CE46854DAC980" xlink:to="loc_us-gaap_FiniteLivedNoncompeteAgreementsGross_2B7A3C07A2D90A75A8DAE46854DBDBAE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_D78B932B41FD56121D09E46854DB9D1B" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_7967A8A290513B0C8A8CE46854DAC980" xlink:to="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_D78B932B41FD56121D09E46854DB9D1B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2BB1D40E99FD07628BDDE46854DD4FF5" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_7967A8A290513B0C8A8CE46854DAC980" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2BB1D40E99FD07628BDDE46854DD4FF5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_076472F4EC4C6D3A2FACE46854DD148B" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_7967A8A290513B0C8A8CE46854DAC980" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_076472F4EC4C6D3A2FACE46854DD148B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_F5983F3759BB7763A1D0E46854DD70DD" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_7967A8A290513B0C8A8CE46854DAC980" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_F5983F3759BB7763A1D0E46854DD70DD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_95044CA498077536272BE46854DE06BB" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_7967A8A290513B0C8A8CE46854DAC980" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_95044CA498077536272BE46854DE06BB" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_TotalDeferredFinancingCostsAndIntangibleAssets" xlink:label="loc_ara_TotalDeferredFinancingCostsAndIntangibleAssets_33BB0DC6B5DA3ACC445FE46854DE0745" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_7967A8A290513B0C8A8CE46854DAC980" xlink:to="loc_ara_TotalDeferredFinancingCostsAndIntangibleAssets_33BB0DC6B5DA3ACC445FE46854DE0745" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_468EEE7432AF3F937882E46854DEA780" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_7967A8A290513B0C8A8CE46854DAC980" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_468EEE7432AF3F937882E46854DEA780" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1EF421FD1FF28D5D4F5BBB4039779A26" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_8DCE9C39EF2E5125E842BB403977B481" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1EF421FD1FF28D5D4F5BBB4039779A26" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_8DCE9C39EF2E5125E842BB403977B481" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_C998C1C7A69476246D73BB4039778049" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1EF421FD1FF28D5D4F5BBB4039779A26" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_C998C1C7A69476246D73BB4039778049" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_9AB6515C7C706B382459BB403978E142" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1EF421FD1FF28D5D4F5BBB4039779A26" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_9AB6515C7C706B382459BB403978E142" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/Leases" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_50FA5DC09ACF041E8E17F6A410A9D64B" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeasesOfLessorDisclosureTextBlock" xlink:label="loc_us-gaap_LeasesOfLessorDisclosureTextBlock_9CEA9B7B0B7E870E213DF6A410A98F32" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_50FA5DC09ACF041E8E17F6A410A9D64B" xlink:to="loc_us-gaap_LeasesOfLessorDisclosureTextBlock_9CEA9B7B0B7E870E213DF6A410A98F32" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/LeasesDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_41C5BE79758E8D715705BB40390EAB47" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_00E9C6E8259E72395540BB40390FDD57" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41C5BE79758E8D715705BB40390EAB47" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_00E9C6E8259E72395540BB40390FDD57" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_F27D4842952283C56CE5BB40390F9C28" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_00E9C6E8259E72395540BB40390FDD57" xlink:to="loc_us-gaap_RangeAxis_F27D4842952283C56CE5BB40390F9C28" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_4C22F9AC71DB95795EEDBB40390F3FDF" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_F27D4842952283C56CE5BB40390F9C28" xlink:to="loc_us-gaap_RangeMember_4C22F9AC71DB95795EEDBB40390F3FDF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_358093A62C244F8E3ECBBB40390FB7F3" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_4C22F9AC71DB95795EEDBB40390F3FDF" xlink:to="loc_us-gaap_MinimumMember_358093A62C244F8E3ECBBB40390FB7F3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_6A5DFF223D66646E2042BB40390FD53A" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_4C22F9AC71DB95795EEDBB40390F3FDF" xlink:to="loc_us-gaap_MaximumMember_6A5DFF223D66646E2042BB40390FD53A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3D219D18C0BEA1921E97BB40390F1220" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_00E9C6E8259E72395540BB40390FDD57" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3D219D18C0BEA1921E97BB40390F1220" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_9A6ED12E1F7FAFD11425BB40390FA87F" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3D219D18C0BEA1921E97BB40390F1220" xlink:to="loc_us-gaap_EquityComponentDomain_9A6ED12E1F7FAFD11425BB40390FA87F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaap_NoncontrollingInterestMember_C0C7E2764F8AED2799BABB40390F3C19" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9A6ED12E1F7FAFD11425BB40390FA87F" xlink:to="loc_us-gaap_NoncontrollingInterestMember_C0C7E2764F8AED2799BABB40390F3C19" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_3552912E5E8A9CCE1742BB40390F8595" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_00E9C6E8259E72395540BB40390FDD57" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_3552912E5E8A9CCE1742BB40390F8595" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LessorLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="loc_us-gaap_LessorLeasingArrangementsOperatingLeasesTermOfContract_D3E58452E281362AD644BB4039100F3E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3552912E5E8A9CCE1742BB40390F8595" xlink:to="loc_us-gaap_LessorLeasingArrangementsOperatingLeasesTermOfContract_D3E58452E281362AD644BB4039100F3E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LessorLeasingArrangementsOperatingLeasesRenewalTerm" xlink:label="loc_us-gaap_LessorLeasingArrangementsOperatingLeasesRenewalTerm_88F29C651951C5BC179FBB4039107D4F" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3552912E5E8A9CCE1742BB40390F8595" xlink:to="loc_us-gaap_LessorLeasingArrangementsOperatingLeasesRenewalTerm_88F29C651951C5BC179FBB4039107D4F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_C9C60384B36B34155764BB403910D784" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3552912E5E8A9CCE1742BB40390F8595" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_C9C60384B36B34155764BB403910D784" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue" xlink:label="loc_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue_31632680051B3517CE1EBB40391007D1" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3552912E5E8A9CCE1742BB40390F8595" xlink:to="loc_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue_31632680051B3517CE1EBB40391007D1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="loc_us-gaap_DueFromRelatedParties_1E698C80EBC834F08DB2BB4039102942" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_3552912E5E8A9CCE1742BB40390F8595" xlink:to="loc_us-gaap_DueFromRelatedParties_1E698C80EBC834F08DB2BB4039102942" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/LeasesScheduleOfFutureMinimumLeasePaymentsDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_EF468192BA76A6EAE65AC38B4EC71D48" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_39B3775B05B2592EA35FC38B4EC777F5" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EF468192BA76A6EAE65AC38B4EC71D48" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_39B3775B05B2592EA35FC38B4EC777F5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_CC312B513445A340C0CDC38B4EC787BB" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_39B3775B05B2592EA35FC38B4EC777F5" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_CC312B513445A340C0CDC38B4EC787BB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_6DFBF91D7C779FBAC416C38B4EC8FA20" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_39B3775B05B2592EA35FC38B4EC777F5" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_6DFBF91D7C779FBAC416C38B4EC8FA20" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_5EC27EB1FE539E68AAFDC38B4EC837ED" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_39B3775B05B2592EA35FC38B4EC777F5" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_5EC27EB1FE539E68AAFDC38B4EC837ED" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_FD016706C1544A26A3FDC38B4EC87462" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_39B3775B05B2592EA35FC38B4EC777F5" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_FD016706C1544A26A3FDC38B4EC87462" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_FA28A04CBD3C6D1B447AC38B4EC84C0A" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_39B3775B05B2592EA35FC38B4EC777F5" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_FA28A04CBD3C6D1B447AC38B4EC84C0A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1CB02A4D36BF802F3847C38B4EC8C45B" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_39B3775B05B2592EA35FC38B4EC777F5" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_1CB02A4D36BF802F3847C38B4EC8C45B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_7C8E0D61E3CA6812DCD2C38B4EC8024C" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_39B3775B05B2592EA35FC38B4EC777F5" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_7C8E0D61E3CA6812DCD2C38B4EC8024C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract" xlink:label="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract_78E94AA49C2AA59C63C6C38B4EC8AD3C" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EF468192BA76A6EAE65AC38B4EC71D48" xlink:to="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract_78E94AA49C2AA59C63C6C38B4EC8AD3C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear" xlink:label="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_60789F37B4364F36E8B0C38B4EC82049" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract_78E94AA49C2AA59C63C6C38B4EC8AD3C" xlink:to="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear_60789F37B4364F36E8B0C38B4EC82049" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears" xlink:label="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_172D0871D9AA1763DA56C38B4EC85911" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract_78E94AA49C2AA59C63C6C38B4EC8AD3C" xlink:to="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears_172D0871D9AA1763DA56C38B4EC85911" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears" xlink:label="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_28B8B33839426F8DC5F0C38B4EC8E7C6" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract_78E94AA49C2AA59C63C6C38B4EC8AD3C" xlink:to="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears_28B8B33839426F8DC5F0C38B4EC8E7C6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears" xlink:label="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears_F5B380FA0493791739B6C38B4EC85C66" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract_78E94AA49C2AA59C63C6C38B4EC8AD3C" xlink:to="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears_F5B380FA0493791739B6C38B4EC85C66" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFiveYears" xlink:label="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFiveYears_E2CD40EFB47BAA7072DDC38B4EC98073" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract_78E94AA49C2AA59C63C6C38B4EC8AD3C" xlink:to="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFiveYears_E2CD40EFB47BAA7072DDC38B4EC98073" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter" xlink:label="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter_5164D715B3F5F227822DC38B4EC94291" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract_78E94AA49C2AA59C63C6C38B4EC8AD3C" xlink:to="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter_5164D715B3F5F227822DC38B4EC94291" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions" xlink:label="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions_EBCF56B30A085EE6651CC38B4EC9E20B" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactionsAbstract_78E94AA49C2AA59C63C6C38B4EC8AD3C" xlink:to="loc_us-gaap_FutureMinimumSubleaseRentalsSaleLeasebackTransactions_EBCF56B30A085EE6651CC38B4EC9E20B" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueFiscalYearMaturityAbstract" xlink:label="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueFiscalYearMaturityAbstract_F4655F62BBC907C9C7D8C38B4EC90A35" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_EF468192BA76A6EAE65AC38B4EC71D48" xlink:to="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueFiscalYearMaturityAbstract_F4655F62BBC907C9C7D8C38B4EC90A35" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsNextTwelveMonths" xlink:label="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsNextTwelveMonths_585807A77167DD6AF26BC38B4EC9BAB2" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueFiscalYearMaturityAbstract_F4655F62BBC907C9C7D8C38B4EC90A35" xlink:to="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsNextTwelveMonths_585807A77167DD6AF26BC38B4EC9BAB2" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInTwoYears_34E292F14C303C63E794C38B4EC953DE" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueFiscalYearMaturityAbstract_F4655F62BBC907C9C7D8C38B4EC90A35" xlink:to="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInTwoYears_34E292F14C303C63E794C38B4EC953DE" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInThreeYears_7E4021E9025FCFAFB1C7C38B4EC9CAA7" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueFiscalYearMaturityAbstract_F4655F62BBC907C9C7D8C38B4EC90A35" xlink:to="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInThreeYears_7E4021E9025FCFAFB1C7C38B4EC9CAA7" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInFourYears" xlink:label="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInFourYears_B7368282D734F1AFD9F1C38B4EC9D938" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueFiscalYearMaturityAbstract_F4655F62BBC907C9C7D8C38B4EC90A35" xlink:to="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInFourYears_B7368282D734F1AFD9F1C38B4EC9D938" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInFiveYears_5117B2DCA3DC71B09766C38B4EC97D16" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueFiscalYearMaturityAbstract_F4655F62BBC907C9C7D8C38B4EC90A35" xlink:to="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueInFiveYears_5117B2DCA3DC71B09766C38B4EC97D16" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueThereafter" xlink:label="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueThereafter_CC8A10C640F90D048AFEC38B4EC9F1B7" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueFiscalYearMaturityAbstract_F4655F62BBC907C9C7D8C38B4EC90A35" xlink:to="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueThereafter_CC8A10C640F90D048AFEC38B4EC9F1B7" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDue" xlink:label="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDue_222B3254141979977043C38B4EC9156B" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDueFiscalYearMaturityAbstract_F4655F62BBC907C9C7D8C38B4EC90A35" xlink:to="loc_ara_OperatingLeasesNetOfSubleaseReceiptsFutureMinimumPaymentsDue_222B3254141979977043C38B4EC9156B" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/LeasesTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaap_LeasesAbstract_C1FBE2C4CC9E940138C9BB4039131135" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_B3459E72736C965779BCBB403913A29B" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_C1FBE2C4CC9E940138C9BB4039131135" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_B3459E72736C965779BCBB403913A29B" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/NoncontrollingInterestsSubjectToPutProvisions" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_19BE766BDB8824CEEF46F6A410DBF54D" xlink:type="locator"/>
<link:loc xlink:href="ara-20171231.xsd#ara_TemporaryEquityTextblock" xlink:label="loc_ara_TemporaryEquityTextblock_F7D7496C7B946B5F9846F6A410DB0691" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_19BE766BDB8824CEEF46F6A410DBF54D" xlink:to="loc_ara_TemporaryEquityTextblock_F7D7496C7B946B5F9846F6A410DB0691" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/NoncontrollingInterestsSubjectToPutProvisionsDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_FECDFE4C650E0C6CAC4CE41F26FFC996" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6EBB9A3E08318C8FEE7AE41F27028BE7" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_FECDFE4C650E0C6CAC4CE41F26FFC996" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6EBB9A3E08318C8FEE7AE41F27028BE7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_DB36D3F3A15C949385A9E41F2702C830" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6EBB9A3E08318C8FEE7AE41F27028BE7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_DB36D3F3A15C949385A9E41F2702C830" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_41010B8EE4A174C27574E41F2703A4C1" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_DB36D3F3A15C949385A9E41F2702C830" xlink:to="loc_us-gaap_EquityComponentDomain_41010B8EE4A174C27574E41F2703A4C1" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NoncontrollingInterestPutProvisionMember" xlink:label="loc_ara_NoncontrollingInterestPutProvisionMember_7BD3DC70354B903039D8E41F27045727" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41010B8EE4A174C27574E41F2703A4C1" xlink:to="loc_ara_NoncontrollingInterestPutProvisionMember_7BD3DC70354B903039D8E41F27045727" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_CC14E7C2BE201C9A9EF6E41F27051A4A" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6EBB9A3E08318C8FEE7AE41F27028BE7" xlink:to="loc_us-gaap_RangeAxis_CC14E7C2BE201C9A9EF6E41F27051A4A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_AE32D5C35344B4257F32E41F2705385E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_CC14E7C2BE201C9A9EF6E41F27051A4A" xlink:to="loc_us-gaap_RangeMember_AE32D5C35344B4257F32E41F2705385E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_DEBC56ED59AB99037D02E41F2706AEEF" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_AE32D5C35344B4257F32E41F2705385E" xlink:to="loc_us-gaap_MinimumMember_DEBC56ED59AB99037D02E41F2706AEEF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_9D70DD32A2239CCCC6DFE41F2706DA1D" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_AE32D5C35344B4257F32E41F2705385E" xlink:to="loc_us-gaap_MaximumMember_9D70DD32A2239CCCC6DFE41F2706DA1D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6EBB9A3E08318C8FEE7AE41F27028BE7" xlink:to="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_CAF3C34164CD4F3CBAE9E41F270736D4" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_us-gaap_FairValueInputsDiscountRate_CAF3C34164CD4F3CBAE9E41F270736D4" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PotentialObligationsUnderTimeBasedPutProvisions" xlink:label="loc_ara_PotentialObligationsUnderTimeBasedPutProvisions_F6284E26F6CC3EE2D8C5E41F270C714D" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_ara_PotentialObligationsUnderTimeBasedPutProvisions_F6284E26F6CC3EE2D8C5E41F270C714D" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PotentialAdditionalObligationsUnderEventBasedPutProvisions" xlink:label="loc_ara_PotentialAdditionalObligationsUnderEventBasedPutProvisions_D686183A47912CF7C9A7E41F270DD08D" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_ara_PotentialAdditionalObligationsUnderEventBasedPutProvisions_D686183A47912CF7C9A7E41F270DD08D" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_RedeemableNoncontrollingInterestEquityAcceleratedPortionRedemptionValue" xlink:label="loc_ara_RedeemableNoncontrollingInterestEquityAcceleratedPortionRedemptionValue_4E27C56765180115376DE41F270D37D5" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_ara_RedeemableNoncontrollingInterestEquityAcceleratedPortionRedemptionValue_4E27C56765180115376DE41F270D37D5" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_RedeemableNoncontrollingInterestEquityFairValueAcceleratedPortion" xlink:label="loc_ara_RedeemableNoncontrollingInterestEquityFairValueAcceleratedPortion_5CAA9ACDD7F0D0E42C07E41F270E682A" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_ara_RedeemableNoncontrollingInterestEquityFairValueAcceleratedPortion_5CAA9ACDD7F0D0E42C07E41F270E682A" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_RedeemableNoncontrollingInterestEquityFairValueAcceleratedPortionFairValueAdjustment" xlink:label="loc_ara_RedeemableNoncontrollingInterestEquityFairValueAcceleratedPortionFairValueAdjustment_739E1963B41EBAAF3E9CE41F270EFF2C" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_ara_RedeemableNoncontrollingInterestEquityFairValueAcceleratedPortionFairValueAdjustment_739E1963B41EBAAF3E9CE41F270EFF2C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_0B929518A0EA03918F9CE41F270F2390" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_0B929518A0EA03918F9CE41F270F2390" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_23F5D75BFA76CE23BB64E41F270FBCAB" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_23F5D75BFA76CE23BB64E41F270FBCAB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_9FA397F28C688C34309AE41F270FA185" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_9FA397F28C688C34309AE41F270FA185" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_TemporaryEquityAccretiontoRedemptionValueContractual" xlink:label="loc_ara_TemporaryEquityAccretiontoRedemptionValueContractual_23445A8AF8DEF070BB4DE41F270F95FD" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_ara_TemporaryEquityAccretiontoRedemptionValueContractual_23445A8AF8DEF070BB4DE41F270F95FD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_D2B0B97FC5329925E3B7E41F2710495E" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_928FEE029D5FA2D0E99DE41F2706CB13" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_D2B0B97FC5329925E3B7E41F2710495E" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/NoncontrollingInterestsSubjectToPutProvisionsTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_1DA52C54449D3E7324F9E43501F78B36" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_83282ACA0D9A9292D6DFE4351857EC41" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_1DA52C54449D3E7324F9E43501F78B36" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_83282ACA0D9A9292D6DFE4351857EC41" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/PrepaidExpensesAndOtherCurrentAssets" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_CA4661AF9B93D5B94828F925E8B5344B" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock_246925999A1145795461F925E8B6D477" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_CA4661AF9B93D5B94828F925E8B5344B" xlink:to="loc_us-gaap_OtherCurrentAssetsTextBlock_246925999A1145795461F925E8B6D477" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/PrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_D2ECD9576A064E0C80B6F6A41133B8F5" xlink:type="locator"/>
<link:loc xlink:href="ara-20171231.xsd#ara_HealthCareOrganizationPatientServiceRevenueEstimate" xlink:label="loc_ara_HealthCareOrganizationPatientServiceRevenueEstimate_4A5AF5EFFDBCE61200FEF6C10710BD35" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_D2ECD9576A064E0C80B6F6A41133B8F5" xlink:to="loc_ara_HealthCareOrganizationPatientServiceRevenueEstimate_4A5AF5EFFDBCE61200FEF6C10710BD35" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_E9C6631A342ADA8BCDD3F6A41133D3CD" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_D2ECD9576A064E0C80B6F6A41133B8F5" xlink:to="loc_us-gaap_OtherAssetsCurrent_E9C6631A342ADA8BCDD3F6A41133D3CD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3E53266BCF8A4777B60BF6A411332659" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_D2ECD9576A064E0C80B6F6A41133B8F5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3E53266BCF8A4777B60BF6A411332659" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_B3EB52ECA444F34D85B8BEF8EB434308" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_3D6EAF2B91B7F86743A3BEF9AD91837D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_B3EB52ECA444F34D85B8BEF8EB434308" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_3D6EAF2B91B7F86743A3BEF9AD91837D" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/PropertyAndEquipment" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7E37EF8D40F3543DAD14F6A410F9F79F" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_644BDCE0DD17E2465DABF6A410F9A7D4" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7E37EF8D40F3543DAD14F6A410F9F79F" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_644BDCE0DD17E2465DABF6A410F9A7D4" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/PropertyAndEquipmentDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4D934BBF970B48206281C38B4FB48C78" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6CBB1B5655CAEDB40CFAC38B4FB4B576" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4D934BBF970B48206281C38B4FB48C78" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6CBB1B5655CAEDB40CFAC38B4FB4B576" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_27914591157491EF70D1C38B4FB45706" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6CBB1B5655CAEDB40CFAC38B4FB4B576" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_27914591157491EF70D1C38B4FB45706" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1084FC7AFB1CC869840DC38B4FB4187B" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_27914591157491EF70D1C38B4FB45706" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1084FC7AFB1CC869840DC38B4FB4187B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LandMember" xlink:label="loc_us-gaap_LandMember_1CA3522786607105CA56C38B4FB499FE" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1084FC7AFB1CC869840DC38B4FB4187B" xlink:to="loc_us-gaap_LandMember_1CA3522786607105CA56C38B4FB499FE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_7E2369E8DB039CAFA37FC38B4FB4DAE9" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1084FC7AFB1CC869840DC38B4FB4187B" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_7E2369E8DB039CAFA37FC38B4FB4DAE9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_412EF1433326CCEC381BC38B4FB46B65" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1084FC7AFB1CC869840DC38B4FB4187B" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_412EF1433326CCEC381BC38B4FB46B65" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_EquipmentAndInformationSystemMember" xlink:label="loc_ara_EquipmentAndInformationSystemMember_8EA908400AAA6FC3FC74C38B4FB4DD4F" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1084FC7AFB1CC869840DC38B4FB4187B" xlink:to="loc_ara_EquipmentAndInformationSystemMember_8EA908400AAA6FC3FC74C38B4FB4DD4F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_9D089691DD60969B29BFC38B4FB40D33" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1084FC7AFB1CC869840DC38B4FB4187B" xlink:to="loc_us-gaap_ConstructionInProgressMember_9D089691DD60969B29BFC38B4FB40D33" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_33281616B9EBDC69862CC38B4FB53E85" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6CBB1B5655CAEDB40CFAC38B4FB4B576" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_33281616B9EBDC69862CC38B4FB53E85" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9EA17DCBE74E771EC1CDC38B4FB51ACF" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_33281616B9EBDC69862CC38B4FB53E85" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9EA17DCBE74E771EC1CDC38B4FB51ACF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_57B66226BC382BD55CE0C38B4FB5BE95" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_33281616B9EBDC69862CC38B4FB53E85" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_57B66226BC382BD55CE0C38B4FB5BE95" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7A5B5E9EAE8682DB6D9DC38B4FB55DE4" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_33281616B9EBDC69862CC38B4FB53E85" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7A5B5E9EAE8682DB6D9DC38B4FB55DE4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_F00F0C1692B914951C56C38B4FB5F239" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_33281616B9EBDC69862CC38B4FB53E85" xlink:to="loc_us-gaap_Depreciation_F00F0C1692B914951C56C38B4FB5F239" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/PropertyAndEquipmentTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3CC3F32C566750A95B79BB403983E2B9" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_87D61D8E2DDEA75959E0BB403983A448" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3CC3F32C566750A95B79BB403983E2B9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_87D61D8E2DDEA75959E0BB403983A448" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/RelatedPartyTransactions" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_1F75DDAB4B61665BE24BF6A410347B1D" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_049434C26DE1A0718662F6A41034EB15" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_1F75DDAB4B61665BE24BF6A410347B1D" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_049434C26DE1A0718662F6A41034EB15" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_9B895D27082DD829162BF698FA1471D6" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_595A903E796AFF9DA212F698FA14860E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_9B895D27082DD829162BF698FA1471D6" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_595A903E796AFF9DA212F698FA14860E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_D530CC45F4357FA95B06F698FA14EEFE" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_595A903E796AFF9DA212F698FA14860E" xlink:to="loc_dei_LegalEntityAxis_D530CC45F4357FA95B06F698FA14EEFE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_467D3A04AEC428FDCF46F698FA14962A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_D530CC45F4357FA95B06F698FA14EEFE" xlink:to="loc_dei_EntityDomain_467D3A04AEC428FDCF46F698FA14962A" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_KineticMember" xlink:label="loc_ara_KineticMember_E5D210500D97C3E4D5DEF698FA14B214" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_467D3A04AEC428FDCF46F698FA14962A" xlink:to="loc_ara_KineticMember_E5D210500D97C3E4D5DEF698FA14B214" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_1DC43E077476418735FCF698FA144407" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_595A903E796AFF9DA212F698FA14860E" xlink:to="loc_us-gaap_RangeAxis_1DC43E077476418735FCF698FA144407" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_91C7CC5A48084CF53A93F698FA1436F2" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_1DC43E077476418735FCF698FA144407" xlink:to="loc_us-gaap_RangeMember_91C7CC5A48084CF53A93F698FA1436F2" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_8F680DB139EA0BAE5670F698FA144F88" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_91C7CC5A48084CF53A93F698FA1436F2" xlink:to="loc_us-gaap_MinimumMember_8F680DB139EA0BAE5670F698FA144F88" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_9EFB7F9242E67E39CE91F698FA1574FF" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_91C7CC5A48084CF53A93F698FA1436F2" xlink:to="loc_us-gaap_MaximumMember_9EFB7F9242E67E39CE91F698FA1574FF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_13B7480B267F91F14A90F698FA1520CD" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_595A903E796AFF9DA212F698FA14860E" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_13B7480B267F91F14A90F698FA1520CD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_0719055D78DCCCB71136F698FA151FEA" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_13B7480B267F91F14A90F698FA1520CD" xlink:to="loc_us-gaap_RelatedPartyDomain_0719055D78DCCCB71136F698FA151FEA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BeneficialOwnerMember" xlink:label="loc_us-gaap_BeneficialOwnerMember_15A5846BB809D9E99A15F698FA15C9CA" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0719055D78DCCCB71136F698FA151FEA" xlink:to="loc_us-gaap_BeneficialOwnerMember_15A5846BB809D9E99A15F698FA15C9CA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="loc_us-gaap_ExecutiveOfficerMember_D8307A2FEF312A731CE5F698FA15EA5C" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0719055D78DCCCB71136F698FA151FEA" xlink:to="loc_us-gaap_ExecutiveOfficerMember_D8307A2FEF312A731CE5F698FA15EA5C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" xlink:label="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_3CD41945CD02AD7CA611F698FA15661D" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0719055D78DCCCB71136F698FA151FEA" xlink:to="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_3CD41945CD02AD7CA611F698FA15661D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AffiliatedEntityMember" xlink:label="loc_us-gaap_AffiliatedEntityMember_42E79CA6A297180E4F1AF698FA154988" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0719055D78DCCCB71136F698FA151FEA" xlink:to="loc_us-gaap_AffiliatedEntityMember_42E79CA6A297180E4F1AF698FA154988" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_30A33A6A642D82EBE04DF698FA1570EF" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_595A903E796AFF9DA212F698FA14860E" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_30A33A6A642D82EBE04DF698FA1570EF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_4BA8E2B6E0779C32EA4EF698FA1502A1" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_30A33A6A642D82EBE04DF698FA1570EF" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_4BA8E2B6E0779C32EA4EF698FA1502A1" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_AdvisoryServicesAgreementMember" xlink:label="loc_ara_AdvisoryServicesAgreementMember_C11E31A08DDA695FC763F698FA15BDD1" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4BA8E2B6E0779C32EA4EF698FA1502A1" xlink:to="loc_ara_AdvisoryServicesAgreementMember_C11E31A08DDA695FC763F698FA15BDD1" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_SubleaseAgreementMember" xlink:label="loc_ara_SubleaseAgreementMember_2D08A7741D50F47FDA62F698FA151F88" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4BA8E2B6E0779C32EA4EF698FA1502A1" xlink:to="loc_ara_SubleaseAgreementMember_2D08A7741D50F47FDA62F698FA151F88" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_SoftwareServicesAgreementMember" xlink:label="loc_ara_SoftwareServicesAgreementMember_16DEF9A66BB794871302F698FA156F3B" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4BA8E2B6E0779C32EA4EF698FA1502A1" xlink:to="loc_ara_SoftwareServicesAgreementMember_16DEF9A66BB794871302F698FA156F3B" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_FinancingTransactionsMember" xlink:label="loc_ara_FinancingTransactionsMember_5367383CFFF1C2038B91F698FA154003" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_4BA8E2B6E0779C32EA4EF698FA1502A1" xlink:to="loc_ara_FinancingTransactionsMember_5367383CFFF1C2038B91F698FA154003" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_595A903E796AFF9DA212F698FA14860E" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NotesPayableCurrentAndNoncurrent" xlink:label="loc_ara_NotesPayableCurrentAndNoncurrent_A8F7C3A70DD411B7581DF698FA15CAF6" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_ara_NotesPayableCurrentAndNoncurrent_A8F7C3A70DD411B7581DF698FA15CAF6" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PeriodOfWeightedAverageMaturity" xlink:label="loc_ara_PeriodOfWeightedAverageMaturity_22883B8A1D3C586CFA41F698FA166B4F" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_ara_PeriodOfWeightedAverageMaturity_22883B8A1D3C586CFA41F698FA166B4F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6E964AD9A29206565E42F698FA1663BF" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6E964AD9A29206565E42F698FA1663BF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_7DF2D75FAEF035837D71F698FA16A838" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_7DF2D75FAEF035837D71F698FA16A838" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_7F7A9593DBAA80CCE7E4F698FA162A5D" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_7F7A9593DBAA80CCE7E4F698FA162A5D" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_LossContingencyAccrualAtCarryingValueClinicLoans" xlink:label="loc_ara_LossContingencyAccrualAtCarryingValueClinicLoans_0EAD5A6740DB4AF18F2BF698FA16BB6F" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_ara_LossContingencyAccrualAtCarryingValueClinicLoans_0EAD5A6740DB4AF18F2BF698FA16BB6F" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PercentageTaxSavingsPayableToStockholders" xlink:label="loc_ara_PercentageTaxSavingsPayableToStockholders_692B1B1510266654D2C8F698FA169FD1" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_ara_PercentageTaxSavingsPayableToStockholders_692B1B1510266654D2C8F698FA169FD1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_3B39A0E77D9FDE0EEA4BF698FA16DE32" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_3B39A0E77D9FDE0EEA4BF698FA16DE32" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OwnershipInterestInJointVenture" xlink:label="loc_ara_OwnershipInterestInJointVenture_1E90BE3569575CF11D92F698FA164A56" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_ara_OwnershipInterestInJointVenture_1E90BE3569575CF11D92F698FA164A56" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_RelatedPartyTransactionExpensesPercentageOfEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:label="loc_ara_RelatedPartyTransactionExpensesPercentageOfEarningsBeforeInterestTaxesDepreciationAndAmortization_2EA0387D0BD853216C6EF698FA165CB6" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_ara_RelatedPartyTransactionExpensesPercentageOfEarningsBeforeInterestTaxesDepreciationAndAmortization_2EA0387D0BD853216C6EF698FA165CB6" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_RelatedPartyTransactionExpensesIncentiveFeeExpense" xlink:label="loc_ara_RelatedPartyTransactionExpensesIncentiveFeeExpense_6D3680B57454037AFE47F698FA16DB6A" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_ara_RelatedPartyTransactionExpensesIncentiveFeeExpense_6D3680B57454037AFE47F698FA16DB6A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NotesReceivableRelatedPartiesCurrent" xlink:label="loc_us-gaap_NotesReceivableRelatedPartiesCurrent_CB7BCBAE3488A2AD83FBF6A04A2FF6E7" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_us-gaap_NotesReceivableRelatedPartiesCurrent_CB7BCBAE3488A2AD83FBF6A04A2FF6E7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_492DF629E1E3729CEA24F6A072E66485" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_492DF629E1E3729CEA24F6A072E66485" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OwnershipPercentage" xlink:label="loc_ara_OwnershipPercentage_3AEA1AAD322AEC9B0580F698FA164A9F" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_ara_OwnershipPercentage_3AEA1AAD322AEC9B0580F698FA164A9F" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_RelatedPartyTransactionLoanGuarantee" xlink:label="loc_ara_RelatedPartyTransactionLoanGuarantee_FCFCDA774E2003980C84F698FA162AC9" xlink:type="locator"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_0DBB2F0CBC406D82A25EF698FA15B0D9" xlink:to="loc_ara_RelatedPartyTransactionLoanGuarantee_FCFCDA774E2003980C84F698FA162AC9" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ScheduleIiValuationAndQualifyingAccounts" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsAbstract_6F9AF90DA7D763CD0ECCE3FDA4C06ABE" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_12D92AAFF3CC9D2B6BC8E3FDA4D10B7A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsAbstract_6F9AF90DA7D763CD0ECCE3FDA4C06ABE" xlink:to="loc_us-gaap_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_12D92AAFF3CC9D2B6BC8E3FDA4D10B7A" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/ScheduleIiValuationAndQualifyingAccountsDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsAbstract_1E2A933291CBEFFEA0D7C38B4D1BDBE5" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_C747FB4458F52C192CA2C38B4D1B6BED" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsAbstract_1E2A933291CBEFFEA0D7C38B4D1BDBE5" xlink:to="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_C747FB4458F52C192CA2C38B4D1B6BED" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_C1C794EB1D83887B747EC38B4D1B6594" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_C747FB4458F52C192CA2C38B4D1B6BED" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_C1C794EB1D83887B747EC38B4D1B6594" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_BA7FBDE36E75AEE0EA00C38B4D1BF366" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_C1C794EB1D83887B747EC38B4D1B6594" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_BA7FBDE36E75AEE0EA00C38B4D1BF366" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsMember" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsMember_5A3486A6E554012C8F6FC38B4D1BF65B" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_BA7FBDE36E75AEE0EA00C38B4D1BF366" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsMember_5A3486A6E554012C8F6FC38B4D1BF65B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_F68E2E426C706EC7BCAAC38B4D1C0E88" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureTable_C747FB4458F52C192CA2C38B4D1B6BED" xlink:to="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_F68E2E426C706EC7BCAAC38B4D1C0E88" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_B222187B29DAB79EDB9BC38B4D1CD52A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_F68E2E426C706EC7BCAAC38B4D1C0E88" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_B222187B29DAB79EDB9BC38B4D1CD52A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_D07F10F196F371AD5690C38B4D1CFD02" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_F68E2E426C706EC7BCAAC38B4D1C0E88" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_D07F10F196F371AD5690C38B4D1CFD02" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_E1140C9C9AE5F3BE0BA1C38B4D1CE23C" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_F68E2E426C706EC7BCAAC38B4D1C0E88" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_E1140C9C9AE5F3BE0BA1C38B4D1CE23C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_97B2D05AD341A123D460C38B4D1CD8E8" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAndQualifyingAccountsDisclosureLineItems_F68E2E426C706EC7BCAAC38B4D1C0E88" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_97B2D05AD341A123D460C38B4D1CD8E8" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/SelectedQuarterlyFinancialDataUnaudited" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_CBED2C16AA9A62A75EDEBB4037B1C720" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_3705EABD556F56820EBEBB4037B1F288" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_CBED2C16AA9A62A75EDEBB4037B1C720" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_3705EABD556F56820EBEBB4037B1F288" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/SelectedQuarterlyFinancialDataUnauditedDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_352156DD7CF779A4C3B9BB40379EE3BB" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:label="loc_us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_2D69B3DDFAFCD6FD6F23BB4037A1F09F" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_352156DD7CF779A4C3B9BB40379EE3BB" xlink:to="loc_us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_2D69B3DDFAFCD6FD6F23BB4037A1F09F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_F2EDEB5903284E9AC472BB4037A3D8D3" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_352156DD7CF779A4C3B9BB40379EE3BB" xlink:to="loc_us-gaap_OperatingIncomeLoss_F2EDEB5903284E9AC472BB4037A3D8D3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_CC77ABE69F23DE557304BB4037A43380" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_352156DD7CF779A4C3B9BB40379EE3BB" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_CC77ABE69F23DE557304BB4037A43380" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_9A0169B1479B137767EFBB4037A449FD" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_352156DD7CF779A4C3B9BB40379EE3BB" xlink:to="loc_us-gaap_NetIncomeLoss_9A0169B1479B137767EFBB4037A449FD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_09015DDF85DB879FAF1ABB4037A4F538" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_352156DD7CF779A4C3B9BB40379EE3BB" xlink:to="loc_us-gaap_EarningsPerShareBasic_09015DDF85DB879FAF1ABB4037A4F538" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_E44FCA0BA9AE66192185BB4037A442BC" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_352156DD7CF779A4C3B9BB40379EE3BB" xlink:to="loc_us-gaap_EarningsPerShareDiluted_E44FCA0BA9AE66192185BB4037A442BC" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/SelectedQuarterlyFinancialDataUnauditedTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_553DD263BA8D50C56BCCC004083F9BD6" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_56A0636425D683F9613DC004083F242E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_553DD263BA8D50C56BCCC004083F9BD6" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_56A0636425D683F9613DC004083F242E" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/StockBasedCompensation" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_E0A3D4B74A28D0A0C63BF6A41064CD3F" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2E597BA3D91738363E2EF6A41064207D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_E0A3D4B74A28D0A0C63BF6A41064CD3F" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2E597BA3D91738363E2EF6A41064207D" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/StockBasedCompensationAssumptionsUsedForOptionsGrantedDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_249CEC0314B1FC7CC37BC004089C1011" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8B0A0D73CB7070770F8C004089C442D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_249CEC0314B1FC7CC37BC004089C1011" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8B0A0D73CB7070770F8C004089C442D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_34921BD24057288F553EC09787C04F67" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8B0A0D73CB7070770F8C004089C442D" xlink:to="loc_us-gaap_AwardTypeAxis_34921BD24057288F553EC09787C04F67" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E5DF072BCD8FFFD4C84AC09787C263A9" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_34921BD24057288F553EC09787C04F67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E5DF072BCD8FFFD4C84AC09787C263A9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_04BB780EF3F00A929F89C0983C00B995" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_E5DF072BCD8FFFD4C84AC09787C263A9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_04BB780EF3F00A929F89C0983C00B995" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_77F81CFDB4CDFF2EA6F2C004089CA653" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8B0A0D73CB7070770F8C004089C442D" xlink:to="loc_us-gaap_RangeAxis_77F81CFDB4CDFF2EA6F2C004089CA653" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_59694E0338EAC57A769DC004089CDF62" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_77F81CFDB4CDFF2EA6F2C004089CA653" xlink:to="loc_us-gaap_RangeMember_59694E0338EAC57A769DC004089CDF62" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_661DDF83591675F67CCBC004089C9FC0" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_59694E0338EAC57A769DC004089CDF62" xlink:to="loc_us-gaap_MinimumMember_661DDF83591675F67CCBC004089C9FC0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_AF56D69E12CE2AD92A96C004089CE1BF" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_59694E0338EAC57A769DC004089CDF62" xlink:to="loc_us-gaap_MaximumMember_AF56D69E12CE2AD92A96C004089CE1BF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6FE1B3269F99110F386FC004089C95FF" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_E8B0A0D73CB7070770F8C004089C442D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6FE1B3269F99110F386FC004089C95FF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_D378AB90EF06C4526471C004089D3353" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6FE1B3269F99110F386FC004089C95FF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_D378AB90EF06C4526471C004089D3353" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0EC5D7257E973139E190C004089DFB99" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6FE1B3269F99110F386FC004089C95FF" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0EC5D7257E973139E190C004089DFB99" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_D78F345526DA0670E380C004089D5999" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6FE1B3269F99110F386FC004089C95FF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_D78F345526DA0670E380C004089D5999" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_77A4A7C729D49661BAF1C004089D6006" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6FE1B3269F99110F386FC004089C95FF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_77A4A7C729D49661BAF1C004089D6006" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_42B1CCCCB9270EBEB404C004089D3433" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6FE1B3269F99110F386FC004089C95FF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_42B1CCCCB9270EBEB404C004089D3433" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2AF40226F7276182FEB2C004089D4E3B" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6FE1B3269F99110F386FC004089C95FF" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2AF40226F7276182FEB2C004089D4E3B" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/StockBasedCompensationEquityGrantsAssumptionsAndActivityDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8F179B858CBF3319424DBB4038503E4C" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FA5D842F17AC5887E5FBBB40385051DC" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8F179B858CBF3319424DBB4038503E4C" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FA5D842F17AC5887E5FBBB40385051DC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1A95C22078095A5CFC3DBB4038501990" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FA5D842F17AC5887E5FBBB40385051DC" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1A95C22078095A5CFC3DBB4038501990" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_C95A45A9163FBB4CAE1CBB4038501172" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1A95C22078095A5CFC3DBB4038501990" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_C95A45A9163FBB4CAE1CBB4038501172" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenseMember" xlink:label="loc_us-gaap_OperatingExpenseMember_0D7727527957F53402CBBB4038501153" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_C95A45A9163FBB4CAE1CBB4038501172" xlink:to="loc_us-gaap_OperatingExpenseMember_0D7727527957F53402CBBB4038501153" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5BAD3112D127BC9C519DBB4038509BF4" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_C95A45A9163FBB4CAE1CBB4038501172" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5BAD3112D127BC9C519DBB4038509BF4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_683173DA814DAD31323DBB403850870F" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_FA5D842F17AC5887E5FBBB40385051DC" xlink:to="loc_us-gaap_StatementLineItems_683173DA814DAD31323DBB403850870F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_CD37BB29F6C6F6300DA8BB403850BAD1" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_683173DA814DAD31323DBB403850870F" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_CD37BB29F6C6F6300DA8BB403850BAD1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_25590A80BAFADE343E16BB403850C885" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_683173DA814DAD31323DBB403850870F" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_25590A80BAFADE343E16BB403850C885" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_AED491C8F0981F863E8CF6FAB7003546" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_185B415A1A0C8B16F271F6FAB700A433" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_AED491C8F0981F863E8CF6FAB7003546" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_185B415A1A0C8B16F271F6FAB700A433" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_3FD659EC31E4592FF21CF6FAB700B51C" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_185B415A1A0C8B16F271F6FAB700A433" xlink:to="loc_us-gaap_AwardTypeAxis_3FD659EC31E4592FF21CF6FAB700B51C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_C95FD83B666128823E69F6FAB7008812" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3FD659EC31E4592FF21CF6FAB700B51C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_C95FD83B666128823E69F6FAB7008812" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_7004E5856DBFBF346B89F6FAB700CAE2" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_C95FD83B666128823E69F6FAB7008812" xlink:to="loc_us-gaap_RestrictedStockMember_7004E5856DBFBF346B89F6FAB700CAE2" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_EBE87A1D6C8321A4FDECF6FAB701D6FD" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_185B415A1A0C8B16F271F6FAB700A433" xlink:to="loc_us-gaap_PlanNameAxis_EBE87A1D6C8321A4FDECF6FAB701D6FD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_EFC1565C36D9CBB08781F6FAB701F6BC" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_EBE87A1D6C8321A4FDECF6FAB701D6FD" xlink:to="loc_us-gaap_PlanNameDomain_EFC1565C36D9CBB08781F6FAB701F6BC" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_AmericanRenalHoldingsInc.2005EquityIncentivePlanMember" xlink:label="loc_ara_AmericanRenalHoldingsInc.2005EquityIncentivePlanMember_68587B1FC9751ACBA4AEF6FAB701E4F5" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_EFC1565C36D9CBB08781F6FAB701F6BC" xlink:to="loc_ara_AmericanRenalHoldingsInc.2005EquityIncentivePlanMember_68587B1FC9751ACBA4AEF6FAB701E4F5" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_AmericanRenalAssociatesHoldingsInc.2010StockIncentivePlanMember" xlink:label="loc_ara_AmericanRenalAssociatesHoldingsInc.2010StockIncentivePlanMember_685CF9B8668DD710F002F6FAB7014658" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_EFC1565C36D9CBB08781F6FAB701F6BC" xlink:to="loc_ara_AmericanRenalAssociatesHoldingsInc.2010StockIncentivePlanMember_685CF9B8668DD710F002F6FAB7014658" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_AmericanRenalAssociatesHoldingsInc.2011StockOptionPlanForNonemployeeDirectorsMember" xlink:label="loc_ara_AmericanRenalAssociatesHoldingsInc.2011StockOptionPlanForNonemployeeDirectorsMember_1A155177C757F580F649F6FAB70168C6" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_EFC1565C36D9CBB08781F6FAB701F6BC" xlink:to="loc_ara_AmericanRenalAssociatesHoldingsInc.2011StockOptionPlanForNonemployeeDirectorsMember_1A155177C757F580F649F6FAB70168C6" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_OmnibusIncentivePlanTwentySixteenMember" xlink:label="loc_ara_OmnibusIncentivePlanTwentySixteenMember_210C197CD83EDF674532F6FAB701FC78" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_EFC1565C36D9CBB08781F6FAB701F6BC" xlink:to="loc_ara_OmnibusIncentivePlanTwentySixteenMember_210C197CD83EDF674532F6FAB701FC78" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_07E7C1C0CDBA487BA534F6FAB701BC47" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_185B415A1A0C8B16F271F6FAB700A433" xlink:to="loc_us-gaap_RangeAxis_07E7C1C0CDBA487BA534F6FAB701BC47" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_9E31F9AC7DE5353F1471F6FAB701C905" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_07E7C1C0CDBA487BA534F6FAB701BC47" xlink:to="loc_us-gaap_RangeMember_9E31F9AC7DE5353F1471F6FAB701C905" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_59146DDF4259AF956822F6FAB701966D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_9E31F9AC7DE5353F1471F6FAB701C905" xlink:to="loc_us-gaap_MinimumMember_59146DDF4259AF956822F6FAB701966D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_11EDB12E8E24C2722476F6FAB702C113" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_9E31F9AC7DE5353F1471F6FAB701C905" xlink:to="loc_us-gaap_MaximumMember_11EDB12E8E24C2722476F6FAB702C113" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_07D67FBF73796C2FEE3DF6FAB7027FF4" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_185B415A1A0C8B16F271F6FAB700A433" xlink:to="loc_us-gaap_StatementLineItems_07D67FBF73796C2FEE3DF6FAB7027FF4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8EC017CC56EF874D0D4BF7612C4BACA5" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_07D67FBF73796C2FEE3DF6FAB7027FF4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8EC017CC56EF874D0D4BF7612C4BACA5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4BFC131AA9A684235918F6FAB702CE42" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_07D67FBF73796C2FEE3DF6FAB7027FF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4BFC131AA9A684235918F6FAB702CE42" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_99515B2BAB60A23FAE4FF6FAB7027E52" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_07D67FBF73796C2FEE3DF6FAB7027FF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_99515B2BAB60A23FAE4FF6FAB7027E52" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_25357CFE648F9C930A5DF6FAB70276E7" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_07D67FBF73796C2FEE3DF6FAB7027FF4" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_25357CFE648F9C930A5DF6FAB70276E7" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_EFE988472C89DAB0149CF6FAB702553E" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_07D67FBF73796C2FEE3DF6FAB7027FF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_EFE988472C89DAB0149CF6FAB702553E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A322BF5EFEED936E55D5F6FAB702302B" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_07D67FBF73796C2FEE3DF6FAB7027FF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_A322BF5EFEED936E55D5F6FAB702302B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_17F4D6ED8529B2B67FABF6FAB702FA68" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_07D67FBF73796C2FEE3DF6FAB7027FF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_17F4D6ED8529B2B67FABF6FAB702FA68" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/StockBasedCompensationRestrictedStockActivityDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0A7C2C91C51DC98A1D56C0759EE5CC1C" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D779551C72656E8A4E39C075A7843155" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0A7C2C91C51DC98A1D56C0759EE5CC1C" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D779551C72656E8A4E39C075A7843155" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_9DA3875685083DD4F688C075A7864BD0" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D779551C72656E8A4E39C075A7843155" xlink:to="loc_us-gaap_AwardTypeAxis_9DA3875685083DD4F688C075A7864BD0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BC311B0B586263B2BCE1C075A78C516B" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9DA3875685083DD4F688C075A7864BD0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BC311B0B586263B2BCE1C075A78C516B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_1364649B75957EF09E52C075C401D876" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_BC311B0B586263B2BCE1C075A78C516B" xlink:to="loc_us-gaap_RestrictedStockMember_1364649B75957EF09E52C075C401D876" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27F2FC8150F957766DBEC075A790B639" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D779551C72656E8A4E39C075A7843155" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27F2FC8150F957766DBEC075A790B639" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_A55E50E8F09B2E2065D6C0A3FC459601" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27F2FC8150F957766DBEC075A790B639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_A55E50E8F09B2E2065D6C0A3FC459601" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43188DEC4A9B399DD382C075C19CD125" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_A55E50E8F09B2E2065D6C0A3FC459601" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43188DEC4A9B399DD382C075C19CD125" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6556D444841E185855B7C075CB671390" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_A55E50E8F09B2E2065D6C0A3FC459601" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6556D444841E185855B7C075CB671390" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2FB121104027A364EE6BC075D4D2D64C" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_A55E50E8F09B2E2065D6C0A3FC459601" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2FB121104027A364EE6BC075D4D2D64C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_EF2BD8345970A6BC616FC075DD77F6E3" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_A55E50E8F09B2E2065D6C0A3FC459601" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_EF2BD8345970A6BC616FC075DD77F6E3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_B650E2F5716B60766146C0A4BA1F4FE8" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_A55E50E8F09B2E2065D6C0A3FC459601" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_B650E2F5716B60766146C0A4BA1F4FE8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_F06FB897B44D6E5DE333C0A6C8664A90" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27F2FC8150F957766DBEC075A790B639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_F06FB897B44D6E5DE333C0A6C8664A90" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6B73A207057C1CCFF645C075C6D37228" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_F06FB897B44D6E5DE333C0A6C8664A90" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6B73A207057C1CCFF645C075C6D37228" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2AEF016BF70EACBC2706C075D137E509" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_F06FB897B44D6E5DE333C0A6C8664A90" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2AEF016BF70EACBC2706C075D137E509" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_D8B004EEF29D98F8A5F1C075DBFA5B0B" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_F06FB897B44D6E5DE333C0A6C8664A90" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_D8B004EEF29D98F8A5F1C075DBFA5B0B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_474D5E4FBA4043E4524AC075E0C17AF5" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_F06FB897B44D6E5DE333C0A6C8664A90" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_474D5E4FBA4043E4524AC075E0C17AF5" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6BBEED12276D445FAF7AC0A70B5A6DDD" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_F06FB897B44D6E5DE333C0A6C8664A90" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6BBEED12276D445FAF7AC0A70B5A6DDD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C4C0EB95A6A433FD1299C08C8C0E0DBB" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27F2FC8150F957766DBEC075A790B639" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_C4C0EB95A6A433FD1299C08C8C0E0DBB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_47C3557E70DB50F78B68C08C8BE978A6" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27F2FC8150F957766DBEC075A790B639" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_47C3557E70DB50F78B68C08C8BE978A6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_E5DCDCB81FCA15F55147C08E5E79AE41" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27F2FC8150F957766DBEC075A790B639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_E5DCDCB81FCA15F55147C08E5E79AE41" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/StockBasedCompensationStockOptionActivityDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_C39CEBAB77B6D45F3051C004089672E9" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D99F6D633D0E0E34E5AFC0040896C8B2" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_C39CEBAB77B6D45F3051C004089672E9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D99F6D633D0E0E34E5AFC0040896C8B2" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_53331ED277800E8E8A51C067C6FA87E9" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D99F6D633D0E0E34E5AFC0040896C8B2" xlink:to="loc_us-gaap_RangeAxis_53331ED277800E8E8A51C067C6FA87E9" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_1CD765A64E1916C3A708C067C6FB56C6" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_53331ED277800E8E8A51C067C6FA87E9" xlink:to="loc_us-gaap_RangeMember_1CD765A64E1916C3A708C067C6FB56C6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_104DE4D2A3A6A313CC08C067C81FDC81" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_1CD765A64E1916C3A708C067C6FB56C6" xlink:to="loc_us-gaap_MinimumMember_104DE4D2A3A6A313CC08C067C81FDC81" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_23CBEFF0BC2DF5FDFB69C067F03BF957" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_1CD765A64E1916C3A708C067C6FB56C6" xlink:to="loc_us-gaap_MaximumMember_23CBEFF0BC2DF5FDFB69C067F03BF957" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaap_VestingAxis_43F857F0F24217C4E38BC00408966180" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D99F6D633D0E0E34E5AFC0040896C8B2" xlink:to="loc_us-gaap_VestingAxis_43F857F0F24217C4E38BC00408966180" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaap_VestingDomain_55ED9E9E7B79995E49ACC00408965C1F" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_43F857F0F24217C4E38BC00408966180" xlink:to="loc_us-gaap_VestingDomain_55ED9E9E7B79995E49ACC00408965C1F" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_MarketAndPerformanceBasedVestingMember" xlink:label="loc_ara_MarketAndPerformanceBasedVestingMember_F18BCFCF4A5FE5982A45C0040897E356" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_55ED9E9E7B79995E49ACC00408965C1F" xlink:to="loc_ara_MarketAndPerformanceBasedVestingMember_F18BCFCF4A5FE5982A45C0040897E356" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PerformanceAndTimeBasedVestingMember" xlink:label="loc_ara_PerformanceAndTimeBasedVestingMember_FDAB93D93CD61FF5491EC0040897E6A3" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_55ED9E9E7B79995E49ACC00408965C1F" xlink:to="loc_ara_PerformanceAndTimeBasedVestingMember_FDAB93D93CD61FF5491EC0040897E6A3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8D59EBBB56DC1714A450C00408971F23" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_D99F6D633D0E0E34E5AFC0040896C8B2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8D59EBBB56DC1714A450C00408971F23" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7A5F746B313839DBCC2EC0040897114A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8D59EBBB56DC1714A450C00408971F23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7A5F746B313839DBCC2EC0040897114A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C42F5DF0EA051477475AC0040897CA03" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7A5F746B313839DBCC2EC0040897114A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C42F5DF0EA051477475AC0040897CA03" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E77B0926F8F0658129FFC00408970A35" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7A5F746B313839DBCC2EC0040897114A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_E77B0926F8F0658129FFC00408970A35" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_05AAC860DE323AD9FF71C0040897C196" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7A5F746B313839DBCC2EC0040897114A" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_05AAC860DE323AD9FF71C0040897C196" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D16B1ED0549BE5A95CD3C0040897299D" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7A5F746B313839DBCC2EC0040897114A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D16B1ED0549BE5A95CD3C0040897299D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5BB210943457609A71D4C0040897608B" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7A5F746B313839DBCC2EC0040897114A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5BB210943457609A71D4C0040897608B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_3D1768E31592CB450126C0040897170E" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7A5F746B313839DBCC2EC0040897114A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_3D1768E31592CB450126C0040897170E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7289DBC0952572CFAC03C004089717FD" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7A5F746B313839DBCC2EC0040897114A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7289DBC0952572CFAC03C004089717FD" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_69D7EAB1C9E29DEBA066C0040897F7F8" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8D59EBBB56DC1714A450C00408971F23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_69D7EAB1C9E29DEBA066C0040897F7F8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_683DED69228A208F08FFC00408977CD0" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_69D7EAB1C9E29DEBA066C0040897F7F8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_683DED69228A208F08FFC00408977CD0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1CC9FD9B0891E40BC98DC0040897F663" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_69D7EAB1C9E29DEBA066C0040897F7F8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1CC9FD9B0891E40BC98DC0040897F663" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_CC00816DCAFEA8B7BDC3C0040897BB72" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_69D7EAB1C9E29DEBA066C0040897F7F8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_CC00816DCAFEA8B7BDC3C0040897BB72" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_B46B06AC76E30F7DFD47C004089852EC" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_69D7EAB1C9E29DEBA066C0040897F7F8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_B46B06AC76E30F7DFD47C004089852EC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0DAA549BB0A7FA1EF6F2C00408989918" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_69D7EAB1C9E29DEBA066C0040897F7F8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0DAA549BB0A7FA1EF6F2C00408989918" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_4E82D75E740382003A23C0040898DDB1" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_69D7EAB1C9E29DEBA066C0040897F7F8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_4E82D75E740382003A23C0040898DDB1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_E02095A2B0A3BEA16AC6C00408983425" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_69D7EAB1C9E29DEBA066C0040897F7F8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_E02095A2B0A3BEA16AC6C00408983425" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract" xlink:label="loc_ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_7C3D830A3940B26683F3C0040898B6AE" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8D59EBBB56DC1714A450C00408971F23" xlink:to="loc_ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_7C3D830A3940B26683F3C0040898B6AE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_348EB058039C9C853A73C0040898046E" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_7C3D830A3940B26683F3C0040898B6AE" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_348EB058039C9C853A73C0040898046E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_DDDA144C8B11823C78BCC00408981B5D" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_7C3D830A3940B26683F3C0040898B6AE" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_DDDA144C8B11823C78BCC00408981B5D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_E5E5A4ACA61B26DFAC1EC0040898035E" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract_7C3D830A3940B26683F3C0040898B6AE" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_E5E5A4ACA61B26DFAC1EC0040898035E" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract" xlink:label="loc_ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_C1EC396204687B5C9BB0C00408987405" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8D59EBBB56DC1714A450C00408971F23" xlink:to="loc_ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_C1EC396204687B5C9BB0C00408987405" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3BA077DC9ECBF2C97E8EC00408981CD0" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_C1EC396204687B5C9BB0C00408987405" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3BA077DC9ECBF2C97E8EC00408981CD0" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_493E3C87111F442C04F0C00408988DEC" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_C1EC396204687B5C9BB0C00408987405" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_493E3C87111F442C04F0C00408988DEC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_118B4C066B750E13FB07C004089800BF" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ara_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueAbstract_C1EC396204687B5C9BB0C00408987405" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_118B4C066B750E13FB07C004089800BF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0DE5CAD4952C99502AC0C00408981285" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8D59EBBB56DC1714A450C00408971F23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_0DE5CAD4952C99502AC0C00408981285" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4DDAF4F79DA6B6E7C725C004089836FA" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8D59EBBB56DC1714A450C00408971F23" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_4DDAF4F79DA6B6E7C725C004089836FA" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_612B3784594A45729B9EC004089852AE" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8D59EBBB56DC1714A450C00408971F23" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_612B3784594A45729B9EC004089852AE" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/StockBasedCompensationTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_935664DA0A343D804A36C00408A9FCEE" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_35D044BCBAB8631FCB83C00408A95ECC" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_935664DA0A343D804A36C00408A9FCEE" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_35D044BCBAB8631FCB83C00408A95ECC" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8D6DB76C58598395E44C00408A9068E" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_935664DA0A343D804A36C00408A9FCEE" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8D6DB76C58598395E44C00408A9068E" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_AF702A605EE677A43FE3C00408A9B30D" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_935664DA0A343D804A36C00408A9FCEE" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_AF702A605EE677A43FE3C00408A9B30D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_7B6FE7D38131C24261C9C071B2275F49" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_935664DA0A343D804A36C00408A9FCEE" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_7B6FE7D38131C24261C9C071B2275F49" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/SubsequentEvent" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_C91669BF48F11771D740D28641F5231C" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_62134E3C3958593A3C28D28641F816C2" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_C91669BF48F11771D740D28641F5231C" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_62134E3C3958593A3C28D28641F816C2" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_CC4FF364BC0B941DBB37BB4039F81E85" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_65AC36DD34DD6C8BFFD9BB4039F928D8" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_CC4FF364BC0B941DBB37BB4039F81E85" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_65AC36DD34DD6C8BFFD9BB4039F928D8" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_FF614ABD65FACCD0E3C5F8BB164A7B2A" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_05E8276346B6318818F6F8BB164A7DD6" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_FF614ABD65FACCD0E3C5F8BB164A7B2A" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_05E8276346B6318818F6F8BB164A7DD6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_580C7BC6B802D5C94C25F8BB164BF248" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_05E8276346B6318818F6F8BB164A7DD6" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_580C7BC6B802D5C94C25F8BB164BF248" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaap_TypeOfAdoptionMember_F09FA7E5FDAA95833BDAF8BB164BD9BE" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_580C7BC6B802D5C94C25F8BB164BF248" xlink:to="loc_us-gaap_TypeOfAdoptionMember_F09FA7E5FDAA95833BDAF8BB164BD9BE" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingStandardsUpdate201609Member" xlink:label="loc_us-gaap_AccountingStandardsUpdate201609Member_3D9D5306B458A70808E5F8BB164B98E8" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_F09FA7E5FDAA95833BDAF8BB164BD9BE" xlink:to="loc_us-gaap_AccountingStandardsUpdate201609Member_3D9D5306B458A70808E5F8BB164B98E8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_A4D9E186DE4FE406CB19F8BB164BFD82" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_05E8276346B6318818F6F8BB164A7DD6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_A4D9E186DE4FE406CB19F8BB164BFD82" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_E41DA2C18BDB09D2655EF8BB164B0F35" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_A4D9E186DE4FE406CB19F8BB164BFD82" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_E41DA2C18BDB09D2655EF8BB164B0F35" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingMember" xlink:label="loc_us-gaap_BuildingMember_735F04807184B0595581F8BB164B969F" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_E41DA2C18BDB09D2655EF8BB164B0F35" xlink:to="loc_us-gaap_BuildingMember_735F04807184B0595581F8BB164B969F" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_EquipmentAndInformationSystemMember" xlink:label="loc_ara_EquipmentAndInformationSystemMember_E8B575AACB8F60601F5EF8BB164B8ED8" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_E41DA2C18BDB09D2655EF8BB164B0F35" xlink:to="loc_ara_EquipmentAndInformationSystemMember_E8B575AACB8F60601F5EF8BB164B8ED8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_813229AF3A48673CA14BF8BB164B960C" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_05E8276346B6318818F6F8BB164A7DD6" xlink:to="loc_us-gaap_RangeAxis_813229AF3A48673CA14BF8BB164B960C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_33F54AA48E078DD70D9DF8BB164B5382" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_813229AF3A48673CA14BF8BB164B960C" xlink:to="loc_us-gaap_RangeMember_33F54AA48E078DD70D9DF8BB164B5382" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_CBC938F8F83F130958C2F8BB164B7B03" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_33F54AA48E078DD70D9DF8BB164B5382" xlink:to="loc_us-gaap_MinimumMember_CBC938F8F83F130958C2F8BB164B7B03" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_0B145FDFB7C938FBC6DEF8BB164C4927" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_33F54AA48E078DD70D9DF8BB164B5382" xlink:to="loc_us-gaap_MaximumMember_0B145FDFB7C938FBC6DEF8BB164C4927" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9EDD00115BD287D4D7CBF8BB164C1156" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_05E8276346B6318818F6F8BB164A7DD6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9EDD00115BD287D4D7CBF8BB164C1156" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_750334AE7F9D0239A048F8BB164C2A26" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9EDD00115BD287D4D7CBF8BB164C1156" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_750334AE7F9D0239A048F8BB164C2A26" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueServicesNetMember" xlink:label="loc_us-gaap_SalesRevenueServicesNetMember_1772BB8A354F5307E65FF8BB164C711D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_750334AE7F9D0239A048F8BB164C2A26" xlink:to="loc_us-gaap_SalesRevenueServicesNetMember_1772BB8A354F5307E65FF8BB164C711D" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_0A0680AEED23A8A8BD18F8BB164CA04C" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_05E8276346B6318818F6F8BB164A7DD6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_0A0680AEED23A8A8BD18F8BB164CA04C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_880D71B28AB977582D14F8BB164C5A6F" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_0A0680AEED23A8A8BD18F8BB164CA04C" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_880D71B28AB977582D14F8BB164C5A6F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_6DD2A92492985CB0919BF8BB164C13E3" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_880D71B28AB977582D14F8BB164C5A6F" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_6DD2A92492985CB0919BF8BB164C13E3" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CBE484EDB10EBBEF939FF8BB164C7591" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_05E8276346B6318818F6F8BB164A7DD6" xlink:to="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CBE484EDB10EBBEF939FF8BB164C7591" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_C8ED711D7993B5D2DC0BF8BB164CF1DF" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_CBE484EDB10EBBEF939FF8BB164C7591" xlink:to="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_C8ED711D7993B5D2DC0BF8BB164CF1DF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember_68DF931DE19F027955C1F8BB164C6514" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_C8ED711D7993B5D2DC0BF8BB164CF1DF" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember_68DF931DE19F027955C1F8BB164C6514" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_555685FE646A9FEE8400F8BB164CAFED" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_05E8276346B6318818F6F8BB164A7DD6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_555685FE646A9FEE8400F8BB164CAFED" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_726EB3B27D73A22C48E9F8BB164CD428" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_555685FE646A9FEE8400F8BB164CAFED" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_726EB3B27D73A22C48E9F8BB164CD428" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_AF158ABF6974BB3E1A37F8BB164C70B4" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_726EB3B27D73A22C48E9F8BB164CD428" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_AF158ABF6974BB3E1A37F8BB164C70B4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7367185B5B13BA50AAD1F8BB164C818C" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_05E8276346B6318818F6F8BB164A7DD6" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7367185B5B13BA50AAD1F8BB164C818C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_19C3BB05BC2C51E23C53F8BB164CC403" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7367185B5B13BA50AAD1F8BB164C818C" xlink:to="loc_us-gaap_SegmentReportingAbstract_19C3BB05BC2C51E23C53F8BB164CC403" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_D12214B48AFB4F7C79CAF8BB164C23A4" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_19C3BB05BC2C51E23C53F8BB164CC403" xlink:to="loc_us-gaap_NumberOfReportableSegments_D12214B48AFB4F7C79CAF8BB164C23A4" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetAbstract" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_5D5E8E0992D37F5870ABF8BB164C940A" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7367185B5B13BA50AAD1F8BB164C818C" xlink:to="loc_us-gaap_AccountsReceivableNetAbstract_5D5E8E0992D37F5870ABF8BB164C940A" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PercentageOfReceivableUnderGovernmentsBundledPaymentSystem" xlink:label="loc_ara_PercentageOfReceivableUnderGovernmentsBundledPaymentSystem_C055B3B98AD7618CFDDAF8BB164D09AE" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_5D5E8E0992D37F5870ABF8BB164C940A" xlink:to="loc_ara_PercentageOfReceivableUnderGovernmentsBundledPaymentSystem_C055B3B98AD7618CFDDAF8BB164D09AE" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PercentageOfTotalReceivablesWherePatientIsPrimaryPayor" xlink:label="loc_ara_PercentageOfTotalReceivablesWherePatientIsPrimaryPayor_96A9B44C17B6F6D7C3FCF8BB164D361A" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_5D5E8E0992D37F5870ABF8BB164C940A" xlink:to="loc_ara_PercentageOfTotalReceivablesWherePatientIsPrimaryPayor_96A9B44C17B6F6D7C3FCF8BB164D361A" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PatientAccountsReceivableGross" xlink:label="loc_ara_PatientAccountsReceivableGross_E3ACBAABC8AE360BB8EAF8BB164DA38B" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_5D5E8E0992D37F5870ABF8BB164C940A" xlink:to="loc_ara_PatientAccountsReceivableGross_E3ACBAABC8AE360BB8EAF8BB164DA38B" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_PercentageOfAccountsReceivableOfTotalPatient" xlink:label="loc_ara_PercentageOfAccountsReceivableOfTotalPatient_AF1C91F128311292CCA5F8BB164D6D5A" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_5D5E8E0992D37F5870ABF8BB164C940A" xlink:to="loc_ara_PercentageOfAccountsReceivableOfTotalPatient_AF1C91F128311292CCA5F8BB164D6D5A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_47EEF329A115AE60C082F8BB164D23AB" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7367185B5B13BA50AAD1F8BB164C818C" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_47EEF329A115AE60C082F8BB164D23AB" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7946529B503302300ABDF8BB164D3B9B" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_47EEF329A115AE60C082F8BB164D23AB" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7946529B503302300ABDF8BB164D3B9B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_C0B1582619B05AC91717F8BB164D2C0F" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7367185B5B13BA50AAD1F8BB164C818C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_C0B1582619B05AC91717F8BB164D2C0F" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_D66FA29DB0330B0A5A71F8BB164DF316" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_C0B1582619B05AC91717F8BB164D2C0F" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_D66FA29DB0330B0A5A71F8BB164DF316" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_B6566F5169DB4AB83AA3F8BB164D1D8E" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7367185B5B13BA50AAD1F8BB164C818C" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_B6566F5169DB4AB83AA3F8BB164D1D8E" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ImpairmentOfIntangibleAssetsIndefiniteLivedIncludingGoodwill" xlink:label="loc_ara_ImpairmentOfIntangibleAssetsIndefiniteLivedIncludingGoodwill_5F8F9E2699A5AB70C37CF8BB164D07D8" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_B6566F5169DB4AB83AA3F8BB164D1D8E" xlink:to="loc_ara_ImpairmentOfIntangibleAssetsIndefiniteLivedIncludingGoodwill_5F8F9E2699A5AB70C37CF8BB164D07D8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetImpairmentChargesAbstract" xlink:label="loc_us-gaap_AssetImpairmentChargesAbstract_9D67B23819A15F7B81E9F8BB164DB6B6" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7367185B5B13BA50AAD1F8BB164C818C" xlink:to="loc_us-gaap_AssetImpairmentChargesAbstract_9D67B23819A15F7B81E9F8BB164DB6B6" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_E22DD75EE29F1C813D71F8BB164DC002" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract_9D67B23819A15F7B81E9F8BB164DB6B6" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_E22DD75EE29F1C813D71F8BB164DC002" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_5FDCAD9A04796C274B51F8BB164DEA50" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract_9D67B23819A15F7B81E9F8BB164DB6B6" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_5FDCAD9A04796C274B51F8BB164DEA50" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_09C470D0E88BCA633E01F8BB164D3C13" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_7367185B5B13BA50AAD1F8BB164C818C" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_09C470D0E88BCA633E01F8BB164D3C13" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_11A7453DC403721D4B06F8BB164DDD7D" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_09C470D0E88BCA633E01F8BB164D3C13" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_11A7453DC403721D4B06F8BB164DDD7D" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ExcessTaxBenefitForStockOptionsExercisedNet" xlink:label="loc_ara_ExcessTaxBenefitForStockOptionsExercisedNet_08E12E66DDAEDB651C4CF8BB164D3D69" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_09C470D0E88BCA633E01F8BB164D3C13" xlink:to="loc_ara_ExcessTaxBenefitForStockOptionsExercisedNet_08E12E66DDAEDB651C4CF8BB164D3D69" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_B2612F1AF8F52F6016EEF8BB164E98E1" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_09C470D0E88BCA633E01F8BB164D3C13" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_B2612F1AF8F52F6016EEF8BB164E98E1" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:label="loc_us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_E933F82A5AE6919DDBC3F8BB164E2F1E" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_09C470D0E88BCA633E01F8BB164D3C13" xlink:to="loc_us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_E933F82A5AE6919DDBC3F8BB164E2F1E" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_20871572F6CF0E9E8B37E4685688CC76" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_20871572F6CF0E9E8B37E4685688CC76" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_C64722F036DA0840DF86E4685688B1D8" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_UseOfEstimates_C64722F036DA0840DF86E4685688B1D8" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_5125A14B010AC5EEACC0E46856887923" xlink:type="locator"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_5125A14B010AC5EEACC0E46856887923" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_1E7D7CF282BCEF6C9106E4685688D6EF" xlink:type="locator"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_1E7D7CF282BCEF6C9106E4685688D6EF" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_F980E57EBE3EEBA5BF4BE4685689C763" xlink:type="locator"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_F980E57EBE3EEBA5BF4BE4685689C763" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_8B0D205B77885DB4CEC2E468568A4B9C" xlink:type="locator"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_8B0D205B77885DB4CEC2E468568A4B9C" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_2189661CC1935C7827A0E468568A867B" xlink:type="locator"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_2189661CC1935C7827A0E468568A867B" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6F39D83535C64A6FE8BEE468568B9486" xlink:type="locator"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6F39D83535C64A6FE8BEE468568B9486" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_B3B74CE64D2F5E217AD3E468568B15D7" xlink:type="locator"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_B3B74CE64D2F5E217AD3E468568B15D7" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_GoodwillAndIntangibleAssetsIntangibleAssetsGoodwillAndIndefiniteLivedPolicyPolicyTextBlock" xlink:label="loc_ara_GoodwillAndIntangibleAssetsIntangibleAssetsGoodwillAndIndefiniteLivedPolicyPolicyTextBlock_4C2A32D868FDB72B1AF7E468568BC47A" xlink:type="locator"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_ara_GoodwillAndIntangibleAssetsIntangibleAssetsGoodwillAndIndefiniteLivedPolicyPolicyTextBlock_4C2A32D868FDB72B1AF7E468568BC47A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3B0F8A9197C725723A21E468568B0502" xlink:type="locator"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3B0F8A9197C725723A21E468568B0502" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure" xlink:label="loc_us-gaap_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_E05B1C746D37C5952437E468568BBA36" xlink:type="locator"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_E05B1C746D37C5952437E468568BBA36" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_715D5D253F75E03A558EE468568B3113" xlink:type="locator"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_715D5D253F75E03A558EE468568B3113" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_NoncontrollingInterestPolicyPolicyTextBlock" xlink:label="loc_ara_NoncontrollingInterestPolicyPolicyTextBlock_34DAD306DFA7892D6B97E468568BA955" xlink:type="locator"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_ara_NoncontrollingInterestPolicyPolicyTextBlock_34DAD306DFA7892D6B97E468568BA955" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_DD3570F60878D4A44047E468568D4EEB" xlink:type="locator"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_DD3570F60878D4A44047E468568D4EEB" xlink:type="arc"/>
<link:loc xlink:href="ara-20171231.xsd#ara_InterestRateSwapsPolicyPolicyTextBlock" xlink:label="loc_ara_InterestRateSwapsPolicyPolicyTextBlock_CD36576C98651A328BDDE468568DE47A" xlink:type="locator"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_ara_InterestRateSwapsPolicyPolicyTextBlock_CD36576C98651A328BDDE468568DE47A" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3BF5FEEFA682DAB2A789E468568D5DF3" xlink:type="locator"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C9E2748F8FF4148D3BCE46856882EFF" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3BF5FEEFA682DAB2A789E468568D5DF3" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_56746B05561F5D5B7203BB4039EB6FF8" xlink:type="locator"/>
<link:loc xlink:href="ara-20171231.xsd#ara_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock" xlink:label="loc_ara_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_D43E4033A16C308010C8BB4039EBEE32" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56746B05561F5D5B7203BB4039EB6FF8" xlink:to="loc_ara_ScheduleOfPropertyPlantAndEquipmentUsefulLifeTableTextBlock_D43E4033A16C308010C8BB4039EBEE32" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/VariableInterestEntities" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesAbstract" xlink:label="loc_us-gaap_VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesAbstract_F20431448F85554DF250F6A410DF0BF0" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_E86A29AFA8DEC35797DBF6A410DF817A" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesAbstract_F20431448F85554DF250F6A410DF0BF0" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_E86A29AFA8DEC35797DBF6A410DF817A" xlink:type="arc"/>
</link:presentationLink>
<link:presentationLink xlink:role="http://www.americanrenal.com/role/VariableInterestEntitiesDetails" xlink:type="extended">
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesAbstract" xlink:label="loc_us-gaap_VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesAbstract_6AFA482FA8B5E1614D6FBB403957E24C" xlink:type="locator"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableInterestEntityConsolidatedCarryingAmountAssets" xlink:label="loc_us-gaap_VariableInterestEntityConsolidatedCarryingAmountAssets_E97211FDD0D8AB97D325BB4039571895" xlink:type="locator"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesAbstract_6AFA482FA8B5E1614D6FBB403957E24C" xlink:to="loc_us-gaap_VariableInterestEntityConsolidatedCarryingAmountAssets_E97211FDD0D8AB97D325BB4039571895" xlink:type="arc"/>
<link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_VariableInterestEntityConsolidatedCarryingAmountLiabilities" xlink:label="loc_us-gaap_VariableInterestEntityConsolidatedCarryingAmountLiabilities_717F1AC4CBA018AD53E9BB403957800C" xlink:type="locator"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesAbstract_6AFA482FA8B5E1614D6FBB403957E24C" xlink:to="loc_us-gaap_VariableInterestEntityConsolidatedCarryingAmountLiabilities_717F1AC4CBA018AD53E9BB403957800C" xlink:type="arc"/>
</link:presentationLink>
</link:linkbase>

↑Top
Filing Submission 0001498068-18-000012   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., Apr. 17, 11:50:24.2pm ET